Nanostructured Colloidal Gelatin Gels for Bone Tissue Regeneration by Wang, H.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/106975
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
 
 
1 
 
 
 
 
 
Nanostructured Colloidal Gelatin Gels  
for Bone Tissue Regeneration 
 
 
 
 
 
 
 2 
 
Colofon 
The research presented in this thesis was financially supported by funding KNAW, 
China-Netherlands Programme Strategic Alliances (PSA) (No.2008DFB50120). 
 
Publication of this thesis was financially supported by: 
 
TA Instruments, Etten-Leur, The Netherlands 
 
 
Netherlands Society for Biomaterials and Tissue Engineering 
 
 
 
 
Thesis Radboud University Nijmegen Medical Center, with summary in English and 
Dutch. 
Nanostructured colloidal gelatin gels for bone tissue regeneration. 
Huanan Wang, Nijmegen, 2013. 
All rights reserved. 
 
ISBN: 
 
Layout:   Huanan Wang 
Cover design:    Proefschriftmaken.nl || Uitgeverij BOXPress 
Printed by:    Proefschriftmaken.nl || Uitgeverij BOXPress 
Published by:    Uitgeverij BOXPress, Oisterwijk 
 
 
3 
 
 
 
Nanostructured Colloidal Gelatin Gels  
for Bone Tissue Regeneration 
 
 
Proefschrift 
 
 
Ter verkrijging van de graad van doctor 
aan de Radboud Universiteit Nijmegen 
op gezag van de rector magnifcus prof. mr. S.C.J.J. Kortmann, 
volgens besluit van het college van decanen 
in het openbaar te verdedigen op woensdag 10 april 2013 
om 13.30 uur precies 
door 
 
 
Huanan Wang 
 
 
  geboren op 1 december 1980 
te Wafangdian, P.R. China 
 2 
 
Colofon 
The research presented in this thesis was financially supported by funding KNAW, 
China-Netherlands Programme Strategic Alliances (PSA) (No.2008DFB50120). 
 
Publication of this thesis was financially supported by: 
 
TA Instruments, Etten-Leur, The Netherlands 
 
 
Netherlands Society for Biomaterials and Tissue Engineering 
 
 
 
 
Thesis Radboud University Nijmegen Medical Center, with summary in English and 
Dutch. 
Nanostructured colloidal gelatin gels for bone tissue regeneration. 
Huanan Wang, Nijmegen, 2013. 
All rights reserved. 
 
ISBN: 
 
Layout:   Huanan Wang 
Cover design:    Proefschriftmaken.nl || Uitgeverij BOXPress 
Printed by:    Proefschriftmaken.nl || Uitgeverij BOXPress 
Published by:    Uitgeverij BOXPress, Oisterwijk 
 
 
3 
 
 
 
Nanostructured Colloidal Gelatin Gels  
for Bone Tissue Regeneration 
 
 
Proefschrift 
 
 
Ter verkrijging van de graad van doctor 
aan de Radboud Universiteit Nijmegen 
op gezag van de rector magnifcus prof. mr. S.C.J.J. Kortmann, 
volgens besluit van het college van decanen 
in het openbaar te verdedigen op woensdag 10 april 2013 
om 13.30 uur precies 
door 
 
 
Huanan Wang 
 
 
  geboren op 1 december 1980 
te Wafangdian, P.R. China 
 4 
 
Promotoren 
Prof. dr. J.A. Jansen  
Prof. dr. Y. Li (Sichuan Universiteit, P.R. China) 
 
Copromotor 
Dr. S.C.G. Leeuwenburgh 
 
Manuscriptcommissie 
Prof. dr. W.T.S. Huck 
Prof. dr. P. Buma  
Prof. dr.ir. W.E. Hennink (Universiteit Utrecht) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Paranimfen 
Xiangzhen Yan 
Arnold W.G. Nijhuis 
 
 
5 
 
 
 
Nanostructured Colloidal Gelatin Gels  
for Bone Tissue Regeneration 
 
 
Doctoral thesis 
 
 
to obtain the degree of doctor 
from Radboud University Nijmegen 
on the authority of the Rector Magnificus, prof. mr. S.C.J.J. Kortmann, 
according to the decision of the Council of Deans 
to be defended in public on Wednesday, April 10, 2013 
at 13.30 hours 
by 
 
 
Huanan Wang 
 
 
born on December 1, 1980 
in Wafangdian, P.R. China 
 4 
 
Promotoren 
Prof. dr. J.A. Jansen  
Prof. dr. Y. Li (Sichuan Universiteit, P.R. China) 
 
Copromotor 
Dr. S.C.G. Leeuwenburgh 
 
Manuscriptcommissie 
Prof. dr. W.T.S. Huck 
Prof. dr. P. Buma  
Prof. dr.ir. W.E. Hennink (Universiteit Utrecht) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Paranimfen 
Xiangzhen Yan 
Arnold W.G. Nijhuis 
 
 
5 
 
 
 
Nanostructured Colloidal Gelatin Gels  
for Bone Tissue Regeneration 
 
 
Doctoral thesis 
 
 
to obtain the degree of doctor 
from Radboud University Nijmegen 
on the authority of the Rector Magnificus, prof. mr. S.C.J.J. Kortmann, 
according to the decision of the Council of Deans 
to be defended in public on Wednesday, April 10, 2013 
at 13.30 hours 
by 
 
 
Huanan Wang 
 
 
born on December 1, 1980 
in Wafangdian, P.R. China 
 6 
 
Supervisors 
Prof. dr. J.A. Jansen  
Prof. dr. Y. Li (Sichuan University, P.R. China) 
 
Co-supervisor 
Dr. S.C.G. Leeuwenburgh 
 
Doctoral Thesis Committee  
Prof. dr. W.T.S. Huck 
Prof. dr. P. Buma  
Prof. dr.ir. W.E. Hennink (Utrecht University) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ushers 
Xiangzhen Yan 
Arnold W.G. Nijhuis 
 
 
7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my beloved daughter, wife and parents 
谨以此书献给我的女儿、妻子和父母 
 6 
 
Supervisors 
Prof. dr. J.A. Jansen  
Prof. dr. Y. Li (Sichuan University, P.R. China) 
 
Co-supervisor 
Dr. S.C.G. Leeuwenburgh 
 
Doctoral Thesis Committee  
Prof. dr. W.T.S. Huck 
Prof. dr. P. Buma  
Prof. dr.ir. W.E. Hennink (Utrecht University) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ushers 
Xiangzhen Yan 
Arnold W.G. Nijhuis 
 
 
7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my beloved daughter, wife and parents 
谨以此书献给我的女儿、妻子和父母 
 8 
 
 
 
 
9 
 
CONTENTS 
 
CHAPTER 
1 
General introduction 
 
11 
CHAPTER 
2  
The use of micro- and nanospheres as functional components for 
bone tissue regeneration 
 
21 
CHAPTER 
3  
 
Oppositely charged gelatin nanospheres as building blocks for 
injectable and biodegradable gels 
 
57 
CHAPTER 
4  
 
Comparison of micro- vs. nano-structured colloidal gelatin gels for 
sustained delivery of osteogenic proteins: bone morphogenetic 
proteins-2 and alkaline phosphatates 
 
77 
CHAPTER 
5  
 
Combined delivery of BMP-2 and bFGF from nanostructured 
colloidal gelatin gels and its effect on bone regeneration in vivo 
 
105 
CHAPTER 
6  
 
Bone regeneration in critical-sized defects using growth factor-
loaded nanostructured colloidal gelatin gels incorporated into 
porous titanium scaffolds 
 
135 
CHAPTER 
7  
 
Development of organic/inorganic colloidal composite gels made 
of self-assembling gelatin and calcium phosphate nanoparticles 
 
159 
CHAPTER 
8 
 
Summary, closing remarks and future perspectives 
Samenvatting, slotwoord en toekomstperspectieven 
 
189 
 
Acknowledgements  
List of Publications  
Curriculum Vitae 
207 
215 
219 
 
 8 
 
 
 
 
9 
 
CONTENTS 
 
CHAPTER 
1 
General introduction 
 
11 
CHAPTER 
2  
The use of micro- and nanospheres as functional components for 
bone tissue regeneration 
 
21 
CHAPTER 
3  
 
Oppositely charged gelatin nanospheres as building blocks for 
injectable and biodegradable gels 
 
57 
CHAPTER 
4  
 
Comparison of micro- vs. nano-structured colloidal gelatin gels for 
sustained delivery of osteogenic proteins: bone morphogenetic 
proteins-2 and alkaline phosphatates 
 
77 
CHAPTER 
5  
 
Combined delivery of BMP-2 and bFGF from nanostructured 
colloidal gelatin gels and its effect on bone regeneration in vivo 
 
105 
CHAPTER 
6  
 
Bone regeneration in critical-sized defects using growth factor-
loaded nanostructured colloidal gelatin gels incorporated into 
porous titanium scaffolds 
 
135 
CHAPTER 
7  
 
Development of organic/inorganic colloidal composite gels made 
of self-assembling gelatin and calcium phosphate nanoparticles 
 
159 
CHAPTER 
8 
 
Summary, closing remarks and future perspectives 
Samenvatting, slotwoord en toekomstperspectieven 
 
189 
 
Acknowledgements  
List of Publications  
Curriculum Vitae 
207 
215 
219 
 
 10 
 
CHAPTER 1
General introduction
 10 
 
CHAPTER 1
General introduction
Chapter 1 
 
12 
 
1. Bone tissue regeneration 
One of the most potent approaches in the emerging field of regenerative medicine is 
the development of instructive biomaterials which can be implanted to replace or 
regenerate human tissues and organs to restore or establish normal function[1, 2]. 
Despite tremendous research efforts to develop substitution materials for tissue 
engineering and regeneration, the use of allogenic and autogenic grafts still remains 
the clinical “gold standard” for regeneration of the majority of tissues and organs[3]. 
Nevertheless, the well-known drawbacks of allo- and autografts (e.g. limited 
availability and immunocompatibility, disease transmission, and the need for an 
additional surgical intervention and corresponding donor site morbidity[4]) are a 
continuous incentive to develop synthetic biomaterials that can substitute for the use 
of allogenic and autogenic grafts.  
Bone is the prime target for regenerative medicine therapies, which is the second 
most transplanted tissue after blood with over 2.2 million bone grafting procedures 
being performed annually worldwide in order to repair bone defects in orthopedic 
surgery, maxillofacial surgery and trauma surgery[5, 6]. Bone tissues are a 
hierarchically ordered, three-dimensional structure composed of inorganic 
nanocrystals (apatitic calcium phosphate, CaP) embedded in nanofibrous network of 
collagen. This nanostructured composition endows natural bone with its unique 
combination of biological, architectural and mechanical properties. 
 
2. Conventional biomaterials for bone tissue regeneration 
To allow for regeneration of bone tissue, synthetic biomaterials should be 
biocompatible, biodegradable without producing toxic by-products, non-immunogenic 
and exhibit physicochemical, topographical and mechanical properties that facilitate 
cell attachment, spreading and production of the mineralized bone extracellular 
matrix. In addition to acting as artificial extracellular matrix (ECM), synthetic 
biomaterials can also serve as reservoir of biologically active signaling molecules that 
can regulate cell function and triggering tissue repair upon a sustained presence in 
the physiological environment[7, 8]. 
However, conventional pre-shaped, monolithic scaffolds exhibit inherent limitations 
such as i) poor control over spatiotemporal presentation of bioactive molecules, ii) 
Chapter 1 
 
13 
 
lack of vascularization in large tissue constructs, iii) the absence of cell-recognition 
peptide sequences that modulate cell attachment, iv) poor filling of irregularly shaped 
defects, and v) suboptimal handling properties for clinical applications. Generally, this 
lack of functionality and capacity to provide biological cues towards tissue 
regeneration is a continuous driving force to develop a novel generation of smart 
biomaterials of improved functionality and equal or even superior performance to 
autologous bone[2, 9]. 
Since bone tissue has a remarkable capacity for self-healing, the process of bone 
healing is a source of inspiration for the design of such novel, smart biomaterials for 
bone substitution. Bone regeneration is a cascade of events involving complex 
interactions between the immune, hematopoietic, and vascular systems, in which the 
cellular behavior and ultimately the tissue response are strongly regulated by the 
spatial and temporal presentation of numerous morphogenetic signaling factors[10, 11]. 
Mimicking this spatiotemporally presentation of these factors by controlled delivery 
from a suitable carrier material is considered a powerful tool to stimulate bone 
regeneration. However, conventional carrier materials (e.g. collagen sponges) 
revealed a poor capacity to control the delivery of osteogenic growth factors and this 
has resulted into detrimental side effects such as bone tissue overgrowth, ectopic 
bone formation, inflammation and even carcinogenicity resulting from (over)dosing of 
GFs such as BMP-2[12]. The disappointing performance of conventional carrier 
materials as well as the increased knowledge on the spatiotemporal presentation of 
multiple growth factors has prompted the development of a new generation of carrier 
materials with improved controllability over release of therapeutic proteins. 
 
3. Colloidal gels for bone tissue regeneration 
During the past decade, “bottom-up” strategies towards design of scaffolds for tissue 
engineering have received increasing interest. According to this approach, scaffolds 
of high structural complexity and biological functionality can be fabricated by 
assembly of micro- or nanoscale particles as building blocks. To this end, micro- and 
nanospheres are obvious candidates as functional units, which can be equipped with 
desired physicochemical and biological properties to establish constructs that mimic 
the function and composition of natural tissues in the body. To engineer scaffolds by 
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using particulate building blocks, three main fabrication strategies can be discerned, 
i.e. synthesis by random packing, directed assembly and rapid prototyping. 
In that respect, colloidal gels, a novel class of hydrogels that allow for a facile 
“bottom-up” approach towards the design of biomaterials, have recently attracted 
increasing attention[13-16]. Colloidal gels are made of micro- or nanoparticles as 
building blocks for assembly into shape-specific and cohesive scaffolds. Due to the 
small size of particulate building blocks, colloidal gels exhibit properties which can be 
superior to monolithic bulk scaffolds in many aspects, including i) enhanced 
controllability over the properties of macroscopic scaffolds by fine-tuning the 
characteristics of sub-populations of particulate building blocks, ii) 
injectability/moldability allowing for optimal filling of irregularly shaped defects using 
minimally invasive approaches, and iii) the absence of harsh gelling/crosslinking 
reactions to trigger in situ gel formation due to the mild, physical crosslinking 
mechanism of the particulate network[13-23]. With respect to drug delivery, the small 
size of the particulate building blocks is particularly attractive in view of i) the ease of 
incorporation of therapeutic agents into micro- and nanoparticles[18, 24], ii) the high 
responsiveness to external stimuli such as pH and temperature[15], iii) the ease of 
surface functionalization of the particles[25, 26], and iv) the possibility of forming 
gradient scaffolds[27, 28]. 
 
4. Objectives of this study 
Recently, oppositely charged polymeric micro- and nanospheres made of dextran or 
poly(lactic-co-glycolic acid) (PLGA) have been developed to form injectable/moldable 
scaffolds, which showed great potential as scaffold for controlled delivery and tissue 
regeneration. However, challenges remained for these colloidal gel systems, which 
are mainly related to the necessity to derive polymer spheres by grafting charged - 
and potentially cytotoxic[29] - groups onto the polymer backbone. In case of PLGA, the 
release of acidic degradation by-products such as lactic and glycolic acid can 
denature entrapped signaling proteins and cause inflammatory responses of the host 
tissue. Finally, materials such as PLGA and dextran lack cell-adhesive peptide 
sequences required for the attachment of anchorage-dependent mesenchymal stem 
cells such as fibro- and osteoblasts.  
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In the current PhD study, the unique functional properties of gelatin (Gel) 
macromolecules have been exploited to overcome all of the above-mentioned 
drawbacks of existing particulate-based colloidal gel systems. Gelatin is 
characterized by an excellent biocompatibility, controllable biodegradability and non-
immunogenicity. Consequently, gelatin has found widespread applications in various 
biomedical areas[30]. Both cationic and anionic gelatins are commercially available 
without the necessity of additional functionalization[30]. This unique feature of gelatin 
has been exploited to develop gelatin-based drug delivery vehicles that form polyion 
complexes with various oppositely charged biomolecules[30, 31], but its potential for 
electrostatic self-assembly has not been studied yet. Moreover, gelatin does not 
produce harmful by-products upon enzymatic degradation as it is derived from 
collagen which is the most abundant protein in animals. Finally, the polymer chains of 
gelatin contain motifs such as RGD sequences which modulate cell adhesion[31], 
thereby improving the final biological behavior of gelatin-based materials over 
polymers that lack these cell-recognition sites. 
 
To this end, the following scientific questions were addressed: 
1. What is the current state of art for the use of micro- and nanospheres as functional 
components for bone tissue regeneration (Chapter 2)? 
 
2. Can oppositely charged gelatin nanospheres be employed as building blocks for 
“bottom-up” synthesis into cohesive colloidal gels (Chapter 3)? 
 
3. What is the effect of using gelatin micro- versus nanospheres on the mechanical 
and biological performance (in vitro) of colloidal gelatin gels (Chapter 4)? 
 
4. Can nanostructured colloidal gelatin gels be used as carrier materials for 
programmed delivery of angiogenic and osteogenic growth factors to stimulate bone 
regeneration in vivo (Chapter 5)? 
 
5. Can growth-factor loaded, nanostructured colloidal gelatin gels be loaded into 
porous titanium scaffolds for the treatment of critical-sized segmental bone defects in 
vivo (Chapter 6)? 
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6. Can colloidal gels be formed by using organic and inorganic colloidal particles as 
building blocks for injectable composite gels to be used in bone regeneration 
(Chapter 7)? 
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1. Introduction 
Despite extensive efforts in the field of bone tissue engineering, the use of 
autologous and allogeneic tissues still remains the clinical “gold standard” for bone 
substitution therapies. Nevertheless, the well-known drawbacks of autografts and 
allografts (such as short of supply, need for additional surgery corresponding to 
donor site morbidity etc.) are a continuous incentive to develop synthetic materials 
that can eventually replace auto- and allografts. Tissue engineering typically aims at 
reconstructing tissues by combining scaffolds composed of biodegradable 
biomaterials, isolated cells of the engineered tissue or pluripotent stem cells with the 
addition of bioactive signals (e.g. growth factors)[1]. This therapeutic strategy has 
shown great promise in the field of bone tissue regeneration, which focuses on 
restoring the functionality of diseased or damaged hard tissues caused by ageing 
and pathological conditions[2]. 
In this approach, three-dimensional (3D) porous scaffolds play an essential role by 
providing artificial extracellular matrices that mechanically and structurally support 
cellular activity such as cell attachment, proliferation and differentiation, which finally 
result into bone formation. To this end, these scaffolds should be biocompatible, 
biodegradable without producing toxic by-products, non-immunogenic, while 
exhibiting appropriate physicochemical, topographical and mechanical properties. In 
addition to acting as artificial extracellular matrix (ECM), scaffolds can also serve as 
reservoir of biologically active signalling molecules with a sustained presence to the 
physiological environment, thereby regulating cell function and triggering tissue 
repair[3-5].  
However, conventional monolithic scaffolds that are typically combined with cells and 
growth factors are still far from leading to successful bone reconstruction in a clinical 
setting, mainly because of the limited control that can be exerted over biodegradation 
and drug delivery. For instance, direct incorporation of growth factors by adsorption 
onto bulk scaffolds normally leads to uncontrolled burst release upon implantation 
and an overdose of growth factors that give rise to bone hyperplasia[6]. A simple but 
effective solution for these problems has been brought forward in the 1990s by 
introducing microspheres as drug delivery vehicles into a continuous matrix in order 
to obtain sustained release of biomolecules without compromising the properties of 
the bulk scaffold[3-5,7]. 
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In that way, scaffolds of higher complexity and functionality can be designed that 
exhibit several advantages over conventional monolithic bulk scaffolds. First of all, 
micro-/nanospheres have been widely accepted as a useful tool for controlled drug 
delivery due to their inherently small size and corresponding large specific surface 
area, a high drug loading efficiency, a high reactivity towards surrounding tissues in 
vivo as well as a high diffusibility and mobility of drug loaded particles[3-5,8,9]. Second, 
the size and morphology of micro-/nanospheres allow them to quickly respond to 
stimuli from the surrounding environment, such as temperature[10], pH[8,11-13], 
magnetic fields[14,15], ultrasounds and irradiation[10]. Consequently, these spheres can 
serve as stimulus-sensitive delivery vehicles for biologically or chemically active 
agents and subsequently establish triggered release by responding to external 
stimulation[3]. Third, by introducing spheres as porogen, the porosity of classical 
scaffolding materials can be improved significantly, thereby allowing for tissue 
infiltration into the interior of scaffolds[16]. Alternatively, mechanically weak scaffolds 
can be stabilized by adding micro-/nanospheres as reinforcement phase[17] or 
crosslinking agent[18], thus providing the mechanical strength that is required for bone 
regeneration in load-bearing applications. Fourth, micro-/nanospheres can be used 
as microscopic bioreactors to induce formation of apatite crystals and subsequent 
mineralization of hydrogels by releasing the resultant minerals, thus forming self-
hardening biomaterials for bone regeneration[19]. This approach is inspired by the 
function of matrix vesicles in human skeletal tissues, which function as microcapsules 
embedded in extracellular matrix to create a compartmentalized environment for the 
nucleation and formation of bone minerals[20]. Fifth, microspheres made of 
cytocompatible polymers containing cell-adhesive peptide sequences can serve as 
cell delivery vehicle by either cell encapsulation inside spheres or cell attachment at 
the exposed surface of the spheres. In that way, cell attachment sites are offered for 
the adhesion of anchorage-dependent mesenchymal stem cells such as 
osteoblasts[21]. By further incorporating these cell-laden microspheres into the 
continuous phase of porous scaffolds or hydrogels, relatively bio-inert scaffolds can 
be transformed into constructs with an upgraded biological activity[22]. Sixth, the 
spherical nature of micro- and nanospheres allows for the development of injectable 
and/or moldable formulations such as suspensions and (colloidal) gels to be applied 
using minimally invasive surgery[23,24].  
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In view of the above-mentioned points, this manuscript addresses the most recent 
developments regarding the use of micro- or nanospheres for applications in bone 
tissue engineering. Rather than providing preparation details of micro- and 
nanospheres, we have categorized micro- and nanospheres for use in bone 
regeneration by biomaterial class (polymer, ceramic and composites) as well as 
summarized the various strategies that employ these spheres as functional 
components for bone tissue engineering. 
 
2. Material classification of micro- and nanospheres 
Generally, spherical biomaterials such as micro- and nanospheres should be made of 
biocompatible and biodegradable materials that do not release toxic degradation 
products. In addition, processing of these materials should be easy to enable 
production of micro- and nanospheres of the desired size and morphology. To meet 
with these requirements, polymeric, ceramic and composite materials have been 
extensively investigated. 
 
2.1. Polymeric micro-/nanospheres 
Polymeric microspheres were first introduced for biomedical applications in the 1970s, 
initially as drug delivery system based on polymers derived from lactic acid. Since 
then, polymers have evolved as the material class that is most frequently used as 
drug delivery vehicle in tissue regeneration, primarily because of their ease of 
processing and versatility with respect to the control over physicochemical properties 
(such as their degradability).  
Natural polymers are of great importance for bone tissue engineering, basically due 
to their intrinsic biocompatibility and biodegradability. This class of polymers is often 
favored over synthetic ones due to their abundant side groups in their molecular 
chains that allow for further functionalization. Furthermore, natural polymers such as 
collagen and gelatin contain motifs such as RGD (Arginine-Glycine-Aspartic acid) 
sequences which can modulate cell adhesion, thereby improving the cellular behavior 
over polymers that lack these cell-recognition sites. Although natural polymers often 
possess inherent cues for directing stem cell fate, their biological activity can be lost 
during processing, which may induce an immune response. On the contrary, many 
synthetic polymers can be considered as neutral biomaterials that can be 
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functionalized to desire to render them instructive by promoting stem cell 
differentiation. Typical advantages of synthetic polymers include ease of 
manufacturing and modification, reasonable costs, sufficient supply, no risk of 
disease transfer, and strong control over polymer properties such as molecular 
weight and corresponding degradation rates[25]. Additionally, the explicit definition of 
the polymeric composition and structure provides the resulting micro-/nanospheres 
with tailorable morphological and physiochemical properties that are beneficial for 
large-scale preparation and application. 
 
2.1.1. Collagen  
Collagen is the most extensively investigated natural polymer since the ECM of many 
mesenchymal tissues (including bone and cartilage) are mainly composed of 
collagen as organic phase. Collagen is an attractive candidate material for bone 
regeneration due to its excellent biocompatibility, desirable biodegradability and 
negligible immunogenicity[26,27]. Collagen microspheres have been developed using 
emulsification methods[28,29], in which homogenization of a water-in-oil emulsion is 
followed by gelation of collagen droplets resulting into spherical collagen. The 
resulting microspheres have been used as microcarriers for bioactive factors in bone 
regeneration[30-33], which showed controllable drug release kinetics by tailoring the 
collagen crosslinking density or by introducing bridging forces (such as electrostatic 
interactions) between biomolecules and the microsphere polymer network[30,32]. 
Nevertheless, only limited progress on collagen microspheres for tissue engineering 
has been made most likely owing to their poor mechanical stability, suboptimal 
processing conditions and possible denaturation upon processing[26,27]. To address 
this, Chan et al. developed reconstituted collagen-MSC microspheres based on the 
self-assembly between collagen and MSCs, which exhibited desired stability as cell 
delivery carriers for tissue engineering[34]. In a similar approach towards stabilization 
of collagen, composite microspheres have been developed by blending collagen with 
other polymers (e.g. agarose[35] and chitosan[31]) to improve gelation and mechanical 
properties. Apart from physicochemical performance, collagen extracted from 
animals also has the intrinsic risk to cause immune reactions and/or transmit 
infectious agents[36]. Therefore, recent developments in the field of bioengineered 
materials using recombinant collagen hold great promise for tissue engineering 
applications, since recombinant collagen can be a safe, predictable and chemically 
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defined source of collagen (by tailoring the amino acid sequence) to manufacture into 
materials various formulations (such as microspheres)[37,38]. 
 
2.1.2. Gelatin 
As a derivative from collagen, gelatin has been widely used for biomedical 
applications[21,39]. Superior characteristics of gelatin include beneficial biological 
properties comparable to collagen, ease of processing into microspheres, gentle 
gelling behavior, controllable degradation characteristics by tailoring crosslinking 
conditions, and abundant presence of functional groups that allow for further 
functionalization and modification via chemical derivatization. These properties make 
gelatin optimal for use as delivery vehicle for drugs or proteins. Specifically, the 
unique electrical nature of gelatin (commercially available as both positively or 
negatively charged polymers at neutral pH) enables gelatin to encapsulate bioactive 
molecules by forming polyion complexes[21,40]. In addition, biomolecules can be 
loaded on gelatin micro-/nanospheres by diffusional loading after preparation of the 
microspheres, thus separating the crosslinking step from the drug loading step. As a 
result, controlled and sustained release kinetics can be obtained by fine-tuning the 
properties of the polymeric network without exposing biomolecules to harsh 
conditions, such as organic solvents that can deactivate highly sensitive agents such 
as growth factors[24,41-44]. These growth factor-laden gelatin microspheres function 
also as injectable fillers for the treatment of osseous defects, which have been 
proven to support cell attachment, proliferation and differentiation, and subsequently 
induce bone regeneration[43,45].  
On the other hand, gelatin nanospheres have become increasingly attractive as 
particulate carrier systems owing to their high drug loading efficacy, ease of surface 
modification and high uptake by cells[46,47]. Gelatin nanospheres can be prepared by 
using emulsion[48] or desolvation[49-51] methods. Desolvation is a process during which 
a homogeneous solution of charged macromolecules undergoes phase separation, 
and nanoparticles can be formed by following a nucleation-particle growth 
mechanism[49-51]. Interestingly, injectable colloidal gels using gelatin nanospheres as 
building blocks have been developed recently in our group that are characterized by 
high elasticity, excellent handling properties, ease of functionalization and cost-
effectiveness, which shows a great potential for tissue engineering (see Direct 
assembly section)[52]. 
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Despite of the favorable properties, critical concerns of gelatin are related to its 
potential to induce immunogenic responses and the poor control on its 
physicochemical behavior due to the animal origin. To overcome these drawbacks, 
microspheres made of recombinant gelatin with well-defined and tunable molecular 
weights, amino acid sequences (such as RGD peptides), and isoelectric points has 
been developed recently using emulsion methods[53].  
 
2.1.3. Fibrin  
Fibrin can be prepared by combining fibrinogen with thrombin, which are both derived 
from the patient’s own blood thereby fabricating an autologous scaffold that does not 
induce an excessive foreign body reaction[54
]
. Fibrin microspheres can be prepared 
using simple emulsion methods, which have been used as a platform for high-yield 
isolation of mesenchymal stem cells (MSCs)[55,56]. Moreover, these microspheres can 
also serve as construct to support in vitro MSCs expansion and osteogenic 
differentiation, which consequently formed a calcified matrix embedding 
osteoblasts,[57] and further to induce ectopic bone formation[58] as well as 
reconstruction of critical-size bone defects in vivo[59]. However, the rapid 
degradation rate and poor mechanical stability of fibrin have been stated as the main 
limitation for bone tissue engineering[54]. To overcome this problem, composite 
microspheres were developed to stabilize the fibrin matrix. Perka et al. developed 
alginate/fibrin composite microspheres for cell encapsulation, which solved the 
problems of both alginate’s shortage of bioactive sequence for cell attachment and 
fibrin’s poor capacity for cell encapsulation[60].  
 
2.1.4. Chitosan 
Chitosan is a frequently used hydrophilic polysaccharide derived from chitin, which 
exhibits favorable physicochemical and biological properties for biomedical 
applications including biocompatibility, intrinsic antibacterial nature, and ease of 
processing.[61] Chitosan-based micro-/nanospheres can be prepared using various 
methods,[62] among which emulsification has been used most frequently due to the 
gentle processing conditions.[63] These micro-/nanospheres have been widely used 
as drug delivery systems for pharmaceutical or tissue engineering applications 
because of the abundant functional groups in the chitosan polymer backbone that 
allow for further functionalization,[64] and the capacity of chitosan to form polyion 
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using emulsion[48] or desolvation[49-51] methods. Desolvation is a process during which 
a homogeneous solution of charged macromolecules undergoes phase separation, 
and nanoparticles can be formed by following a nucleation-particle growth 
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Despite of the favorable properties, critical concerns of gelatin are related to its 
potential to induce immunogenic responses and the poor control on its 
physicochemical behavior due to the animal origin. To overcome these drawbacks, 
microspheres made of recombinant gelatin with well-defined and tunable molecular 
weights, amino acid sequences (such as RGD peptides), and isoelectric points has 
been developed recently using emulsion methods[53].  
 
2.1.3. Fibrin  
Fibrin can be prepared by combining fibrinogen with thrombin, which are both derived 
from the patient’s own blood thereby fabricating an autologous scaffold that does not 
induce an excessive foreign body reaction[54
]
. Fibrin microspheres can be prepared 
using simple emulsion methods, which have been used as a platform for high-yield 
isolation of mesenchymal stem cells (MSCs)[55,56]. Moreover, these microspheres can 
also serve as construct to support in vitro MSCs expansion and osteogenic 
differentiation, which consequently formed a calcified matrix embedding 
osteoblasts,[57] and further to induce ectopic bone formation[58] as well as 
reconstruction of critical-size bone defects in vivo[59]. However, the rapid 
degradation rate and poor mechanical stability of fibrin have been stated as the main 
limitation for bone tissue engineering[54]. To overcome this problem, composite 
microspheres were developed to stabilize the fibrin matrix. Perka et al. developed 
alginate/fibrin composite microspheres for cell encapsulation, which solved the 
problems of both alginate’s shortage of bioactive sequence for cell attachment and 
fibrin’s poor capacity for cell encapsulation[60].  
 
2.1.4. Chitosan 
Chitosan is a frequently used hydrophilic polysaccharide derived from chitin, which 
exhibits favorable physicochemical and biological properties for biomedical 
applications including biocompatibility, intrinsic antibacterial nature, and ease of 
processing.[61] Chitosan-based micro-/nanospheres can be prepared using various 
methods,[62] among which emulsification has been used most frequently due to the 
gentle processing conditions.[63] These micro-/nanospheres have been widely used 
as drug delivery systems for pharmaceutical or tissue engineering applications 
because of the abundant functional groups in the chitosan polymer backbone that 
allow for further functionalization,[64] and the capacity of chitosan to form polyion 
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complexes with charged proteins to obtain sustained release[65,66]. Of particular 
interest are that chitosan-based microspheres have been used as injectable bone 
fillers, which can encapsulate osteoconductive mineral (calcium phosphates) 
particles in the microspheres followed by ionically crosslinking using 
tripolyphosphate[67]. In vitro studies confirmed the cytocompatibility of these chitosan-
based microsphere constructs that support MSCs attachment and their subsequent 
proliferation and differentiation into the osteoblastic phenotype[63]. Chitosan has also 
been processed into nanosphere formulations for targeted delivery of small 
biomolecules[62]. Similar to microspheres, drugs or biomolecules can be loaded in 
chitosan nanospheres by either incorporation during particle preparation or by 
incubation with pre-formed spheres. Chitosan nanospheres are a highly promising 
candidate for gene delivery due to a combination of the intrinsic advantages of 
nanoparticles (related to their exceptionally high specific surface area), the possibility 
to chemically modify polymer properties and the capacity to form polyelectrolyte 
complexes with negatively charged DNA due to the positive charge of chitosan[62,68].  
 
2.1.5. Alginate  
Favorable characteristics of alginate including its biocompatibility, non-
immunogenicity, hydrophilicity and cost-effectiveness make alginate highly suitable 
for many applications in drug delivery and tissue engineering[69,70]. The most 
pronounced advantage of alginates relates to its gentle gelling behavior by which 
alginate microspheres can be formed using ionic crosslinking in the presence of 
divalent cations like Ca2+. This unique feature of alginate has facilitated widespread 
usage of alginate for mild encapsulation of sensitive biomolecules and/or cells[71-73]. It 
has been shown that growth factors for bone tissue engineering loaded within 
alginate microspheres display controlled release kinetics,[74,75] while cells immobilized 
within alginate microspheres showed a positive response when used as an injectable 
system for regeneration of skeletal tissue[76,77]. Another attractive feature of using 
alginate microspheres for bone regeneration involves its intrinsic capacity to induce 
calcification in vivo without using biological or chemical additives. In a recent study by 
Lee et al., injectable calcium-crosslinked alginate microspheres mineralized in vivo by 
forming traces of hydroxyapatite (HAp) after being implanted subcutaneously or 
intramuscularly[78]. The mechanism of the in vivo calcification was shown to relate to 
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calcium ions from the crosslinked alginate hydrogel that interacted with surrounding 
phosphate ions to form precipitated calcium phosphates[78]. 
On the other hand, two critical drawbacks limit alginates from further applications, i.e. 
the poorly controllable - and often slow - degradation process upon implantation in 
bone defects, and the lack of cell attachment sites for anchorage-dependent 
osteoblasts. Gamma irradiation and partial oxidation of alginate have been performed 
to obtain microspheres with desirable biodegradability[72,79]. On the other hand, by 
combining alginates with components containing cell-recognition sites (e.g. fibrin[60]) 
or by modifying alginate with RGD sequences[80], alginate-based microspheres 
revealed a significantly improved biological response in terms of the improved 
adhesion, proliferation and differentiation towards the osteogenic lineage of 
encapsulated cells.  
 
2.1.6. Poly(α-hydroxy-esters) 
Poly(α-hydroxy-esters), such as poly(lactic acid) (PLA), poly(glycolic acid) (PGA), 
poly(lactic-co-glycolic acid) (PLGA) and poly(caprolactone) (PCL), are the most 
frequently used synthetic polymers for biomedical applications owing to their 
biocompatibility, hydrolytic degradation process, proper mechanical properties, ease 
of manufacture, etc. Micro-/nanospheres made of poly(α-hydroxy-esters) (typically 
prepared by emulsification) have also been widely investigated as drug delivery 
vehicles or tissue engineering scaffolds with respect to bone regeneration[81-83]. By 
fine-tuning their physicochemical characteristics including molecular weight, particle 
size and morphology, and surface properties, the biological performances of these 
polyester spheres can be controlled to a large extent, such as loading efficiency of 
drug/protein encapsulation, pharmacokinetics of drug release, cell and tissue 
response after implantation. For instance, Jeon et al. developed heparin-
functionalized PLGA nanospheres with an improved capacity for controlled growth 
factor delivery[84], which showed enhanced osteogenesis of stem cells in vitro and 
extensively improved bone formation in vivo[85]. Noteworthy is that except of being 
delivery vehicles, PLGA micro- and nano-spheres have recently been extensively 
investigated as building blocks to establish 3D tissue-engineered scaffolds (see 
Directed assembly section)[86,87].  
The disadvantages, however, of poly(α-hydroxy-esters)-based micro-/nanospheres 
for the wide-spread use in bone tissue engineering include i) hydrophobicity resulting 
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into poor cell adhesion and incapability of loading hydrophilic molecules or drugs, ii) 
acidic degradation product causing inflammatory tissue response and denaturation of 
bioactive proteins, iii) degradation by autocatalysis leading to unpredictable 
degradation behavior, and iv) low capacity of loading therapeutic components due to 
the harsh preparation process and limited penetration into the polymer network[88]. 
 
2.2. Inorganic micro-/nanospheres 
With regard to potential use of polymers in bone regeneration, it must be emphasized 
that most biodegradable polymers lack osteoconductivity, osteoinductivity and 
mechanical strength. In contrast, inorganic biomaterials such as calcium phosphates 
(CaP) exhibit excellent biological properties and mechanical strength resulting from 
their similarity to the inorganic phase of native bone tissue, which have been widely 
accepted as materials of choice for bone repair, and fabricated into bulk or micro-
/nanoparticulate bone substitutes. To the best of our knowledge, however, only 
limited progress has been obtained on CaP micro-/nanospheres, as opposed to 
numerous researches focusing on non-spherical CaP particles[89-91], partially because 
of the difficulty to process CaP into spherical shape. Still, microspheres made of 
CaP[92-94], bioglass[95,96] or other bioactive ceramics[97,98] have been developed which 
function as delivery vehicles for growth factors[95] or as particulate bone void fillers for 
bone regenerative medicine[97]. A versatile methodology for the preparation of 
bioceramic microspheres involves droplet formation of a mixture of ceramic powders 
and a hydrogel solution (i.g. alginate, chitosan, gelatin etc.) followed by gelation of 
the polymer phase that can be subsequently removed by thermal decomposition[98-
101]. CaP microspheres with monodispersity and controllable porosity and particle size 
have been developed as injectable scaffolds for bone regeneration using this method, 
which supported in vitro attachment, proliferation and osteogenic differentiation of 
bone marrow stromal cells that ultimately resulted into formation of microsphere-cell 
clusters[99]. Green et al. developed calcium carbonate (vaterite) microspheres 
containing with RGD peptide sequences, which acted as a template to stimulate 
mineralization and MSC differentiation in vitro, and augment in vivo bone formation in 
impaction bone grafting[97]. 
Despite advantages such as ease of manufacture, low cost of production, and 
beneficial biological properties, inorganic micro-/nanospheres are still far from 
widespread use for bone tissue engineering. Plausible reasons relate to the difficulty 
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of controlling the degradation rate, poor control over drug delivery (often related to 
the high affinity of bioceramics with proteins), and the propensity for growth factors to 
denature during adsorption to CaP[102].  
 
2.3. Composite micro-/nanospheres 
Inspired by the hierarchical composite structure and unsurpassed functionality of 
native bone tissue, composite scaffolds that combine the advantages but eliminate 
the drawbacks of each component have gained considerable interest for bone 
regeneration over the past decades. By mimicking the organic/inorganic composition 
of bone, biodegradable polymers and bioactive ceramics have been combined to 
fabricate composite micro-/nanospheres which improve the biological performance of 
polymers as well as provide bioceramics with ease of processing and controllable 
degradation. Thus, composite microspheres have been fabricated by incorporating 
calcium phosphates into biodegradable polymers such as collagen[103], gelatin[104,105], 
chitosan[106], and PLGA[107,108] etc. These composite microspheres were shown to 
display improved performance in many aspects, such as enhanced hydrophilicity 
(compared to pure PLGA microspheres)[109], higher drug/protein encapsulation 
efficiency[110], improved cytocompatibility[109], reduced biodegradation and drug 
release rates[104], and strongly upregulated in vitro calcifying capability[104]. 
Furthermore, composite nanospheres where calcium phosphate nanocrystals are 
incorporated into polymeric nanospheres have been synthesized by employing 
nanosized organic templates such as liposomes[111] or polymer nanogels[112]. For 
example, gelatin/hydroxyapatite (HAP) composite nanospheres have recently 
developed by biomimetically inducing HAP crystallization inside gelatin spheres 
under physiological conditions for applications in bone tissue engineering[113]. 
On the other hand, copolymer micro-/nanospheres have been prepared which 
possess advantageous properties of both polymers. Jiang et al. blended chitosan into 
PLGA microspheres to benefit from the neutralization reaction between chitosan and 
acidic PLGA degradation products, thus improving in vitro and in vivo biocompatibility 
and osteogenity over pure PLGA microspheres[65,114,115]. Copolymer nanospheres 
can be obtained by using the coacervation technique[62], in which polyelectrolyte 
complexation can be achieved between oppositely charged polymers. This 
processing method enabled the synthesis of a new class of composite nanospheres 
typically made of polycationic chitosan and negatively charged polymers (i.g. 
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alginate[116], dextran sulfate[117], etc). These hybrid copolymer nanospheres exhibited 
improved physical properties (e.g. in vivo stability), desirable surface properties (e.g. 
hydrophilicity/hydrophobicity and surface charge)[118,119] and improved 
pharmacological performance[116] resulting into better control over drug delivery. For 
instance, chitosan-PLGA and alginate-PLGA nanospheres have been newly 
developed as positively and negatively charged building blocks for colloidal gels 
system that self-assemble due to electrostatic interactions. These gels exhibited 
proper injectability and negligible cytotoxicity to MSCs[119].  
 
 
 
 
 
 
 
Figure 1. Number of 
publications on the use of 
micro-/nanospheres for 
biomedical applications in the 
past decade by combining 
keywords “microspheres AND 
biomedical” or “nanospheres 
AND biomedical”, respectively 
(PubMed).  
2.4. Comparison between microspheres and nanospheres 
While microspheres (defined as having diameters between 1-1000 µm) have been 
investigated for several decades in the biomedical field, the potential of nanospheres 
(here defined as ranging in diameter from 10 to 1000 nm) for biomedical applications 
has been researched over the past decade only. Both micro- and nanospheres have 
gained tremendous interest as reflected in Figure 1, which shows the number of 
publications on the use of either microspheres or nanospheres for biomedical 
applications over the past decade. While the number of publication on microspheres 
is steadily increasing, nanospheres have been rapidly catching up with microspheres 
in less than ten years, reflecting the increasing importance of nanotechnology in 
biomedical research.  
With regard to controlled delivery and tissue engineering applications, nanospheres 
exhibit specific advantages and disadvantages compared to microspheres. First of all, 
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unlike particles in micro-scale which would release high local drug concentrations, 
nanospheres can be directly endocytosed, thereby allowing for accumulation of 
nanoparticule-encapsulated drugs. In that way, a desired therapeutic effect can be 
obtained with lower amounts of drugs while minimizing cytotoxicity or other undesired 
side effects[9,68,120]. Additionally, nanospheres are capable of passing through the 
smallest capillary vessels (due to their inherent small size), thus avoiding rapid 
clearance by phagocytes so that their effective residence time in the body can be 
prolonged[121,122]. Therefore, nanospheres are now increasingly accepted as suitable 
tools for potential applications based on cellular delivery, including cell imaging and 
intracellular gene delivery to control cell differentiation/survival[123,124]. Moreover, the 
exceptionally high specific surface area of nanospheres broadens the range of 
applications related to tissue engineering. For instance, nanospheres are more 
competent than larger particles to serve as delivery vehicles due to their enhanced 
affinity to therapeutic components and quicker response to outer stimuli from the 
surrounding environment. Finally, nanospheres can be used as building blocks for 
bottom-up synthesis of colloidal systems such as injectable gels for bone 
regeneration. Nanosphere-based colloidal systems generally display superior 
properties (i.e. higher stability and better injectability/moldability) compared to 
microsphere-based systems owing to higher interparticle forces[52,87,125,126].  
Still, nanospheres also display several drawbacks compared to microspheres that are 
related to i) lack of cost-effective preparation techniques for nanospheres that allow 
for easy upscaling without using harsh processing conditions, ii) reduced stability 
under in vitro and in vivo conditions due to their intrinsic high surface area that 
maximizes interaction with the physiological environment, iii) the tendency of 
nanospheres to aggregate into microscale that mitigates potential benefits of the use 
of nanoscale particles, and finally iv) unsuitability for various applications in bone 
tissue engineering that require micron-scale particles such as the creation of 
macroporosity and delivery of cells. 
 
3. Strategies of using micro-/nanospheres for scaffolds design 
Generally, microspheres can be used as i) a dispersed phase surrounded by a 
continuous matrix (solid polymers, hydrogel polymers or CaP cements), or as 
building blocks to establish integral scaffolds without surrounding matrix by a bottom-
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up approach. In the following section, various strategies will be discussed that 
employ micro-/nanospheres for the design of scaffolds for bone tissue engineering 
with improved functionality. 
 
Figure 2. Schematic representation of the use of micro-/nanospheres for spatiotemporal 
control over delivery of bioactive molecules. A) Spatial control of biomolecule delivery by 
employing a gradient distribution of micro-/nanospheres as delivery vehicles. B) Temporal 
control of biomolecule delivery using micro-/nanosphere with differing release characteristics. 
 
3.1. Micro-/nanospheres as discrete components embedded into continuous 
matrices 
By simply incorporating micro-/nanospheres into a continuous matrix (such as solid 
polymers, hydrogels or CaP cements), physicochemical and biological characteristics 
of these composite systems can be improved in terms of e.g. delivery of bioactive 
and/or chemical agents[127], porosity[16], mechanical strength[17] and cell 
encapsulation[22]. 
 
3.1.1. Micro-/nanospheres embedded into solid polymers 
One of the most common reasons to introduce micro-/nanospheres into solid (i.e. 
non-swelling) polymers is to provide bulk scaffolds with the capability to control the 
release of drugs[3-5,128,129]. Especially for the delivery of bioactive molecules, the 
simple incorporation of growth factors into bulk scaffolds might lead to denaturation of 
these biomolecules due to exposure to harsh preparation conditions, hydrophobic 
surfaces of polymers, acidic degradation products, etc[130]. Previous studies have 
shown that incorporation of PLGA microspheres (as carriers for bone morphogenetic 
protein-2 (BMP-2) into polyurethane scaffolds was accompanied by a reduced initial 
burst release followed by a sustained release of BMP-2 that promoted new bone 
formation compared to microsphere-free scaffolds[131]. 
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Moreover, the use of micro-/nanospheres as delivery system allows for accurate 
spatiotemporal control over the release of growth factors, which are essential for 
successful bone regeneration by inducing osteogenesis as well as angiogenesis. To 
establish delivery of multiple biomolecules with programmed release kinetics, 
different micro-/nanosphere populations can be employed that carry various growth 
factors. By tailoring the physicochemical properties of these degradable spheres, 
distinct release behavior can be obtained, resulting into temporally controlled drug 
delivery[132] (Figure 2A). For example, dual delivery of vascular endothelial growth 
factor (VEGF) and platelet-derived growth factor (PDGF) was established by pre-
encapsulating PDGF using PLGA microspheres, which were subsequently 
incorporated into porous VEGF-containing PLGA scaffolds prepared by gas foaming 
technique[83]. Similarly, several other studies have focused on delivery of multiple 
growth factors by utilizing different microsphere populations to carry various 
biomolecules, such as the combination of poly(4-vinyl pyridine) and alginate 
microspheres to load and release BMP-2 and BMP-7 independently[74]. 
 
Figure 3. Experimental design and resulting photographs of two modes of cell delivery using 
hydrogels: cells were directly encapsulated into hydrogels to form conventional Gel construct 
(top); alternatively, cell-laden microspheres were incorporated into hydrogels to form 
microsphere/hydrogel composite system (GC) (bottom). The former strategy resulted into cell 
death, while the latter one led to cell survival and proliferation in the hydrogel. Cytoskeleton 
F-actin (red) was counterstained with nuclei (blue). Reprinted from [22] with permission. 
Copyright 2011, Elsevier. 
Besides temporally controlled delivery, to spatially control the distribution of growth 
factors inside the scaffolds is also of substantial importance primarily owing to the 
concentration-dependent effect of growth factor[133]. Specifically for osteochondral 
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up approach. In the following section, various strategies will be discussed that 
employ micro-/nanospheres for the design of scaffolds for bone tissue engineering 
with improved functionality. 
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employing a gradient distribution of micro-/nanospheres as delivery vehicles. B) Temporal 
control of biomolecule delivery using micro-/nanosphere with differing release characteristics. 
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tissue engineering, gradient-based bioactive signal delivery can induce both 
osteogenic and chondrogenic regeneration in the interfacial area[134].To this end, 
Wang et al. developed scaffolds containing microspheres that formed growth factor 
gradients through the materials for osteochondral reconstruction[135]. In this study, 
BMP-2 and insulin-like growth factor I (IGF-I) (that induce osteogenic and 
chondrogenic differentiation of MSCs, respectively) were encapsulated using silk or 
PLGA microspheres, which were subsequently embedded into porous silk scaffolds 
to form reverse concentration gradients of two factors (as illustrated in Figure 2B). 
This signal gradients, in turn, stimulated hMSCs to differentiate into osteoblasts and 
chondrocytes, respectively[135]. 
 
3.1.2. Micro-/nanospheres embedded into hydrogels 
Hydrogels made of biodegradable polymers are promising material candidates for 
regenerative medicine due to their unique combination of biocompatibility, 
biodegradability and injectability[69,136,137]. The incorporation of micro-/nanospheres 
into hydrogels can further upgrade the functionality of pure hydrogels from passively 
accepted implants to instructive and inductive scaffolds with improved 
physicochemical and biological properties. 
First of all, the control over drug delivery kinetics is improved significantly upon 
introduction of micro-/nanospheres into hydrogel matrices[127]. Additionally, micro-
/nanospheres can serve as stimulus-sensitive delivery vehicles for biologically or 
chemically active agents in order to realize triggered release in response to external 
stimulation[3]. A representative example of this latter approach was reported by 
Westhaus et al., who incorporated spheres (liposomes) as functional components 
into alginate matrices to create stimulus-sensitive self-hardening injectables. 
Thermosensitive liposomes (which can be considered as nanospheres) loaded with 
Ca2+ ions were mixed with alginate solutions, and the gelation of the resulting 
mixture was subsequently induced by thermally triggered Ca2+ release from 
liposomes at 37ºC[138]. These composite systems displayed excellent flowability at 
room temperature, while gelling rapidly at body temperature, which confirmed the 
potential of this composite system for use as injectable cell-laden or acellular bone 
defect fillers[139]. In a bioinspired approach towards tissue regeneration using 
hydrogel matrices, micro-/nanosphere have also been considered as microscopic 
bioreactors that mimic matrix vesicles in human skeletal tissues. These vesicles act 
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as microcapsules embedded in extracellular matrix to create a compartmentalized 
environment, e.g. for the nucleation and formation of bone mineral[20]. By mimicking 
this natural process, calcium and phosphate-loaded liposomes were combined with 
collagen hydrogels, which induced the formation of apatite crystals and subsequent 
mineralization of hydrogels, thus forming self-hardening biomaterials for bone 
regeneration[19]. 
Furthermore, micro-/nanospheres can serve as reinforcement components[17] or 
crosslinking agents[18] to provide hydrogels with additional mechanical support. For 
example, β-tricalcium phosphate (β-TCP) microsphere/alginate composite systems 
encapsulating MSCs have been developed as injectable 3D constructs for bone 
tissue engineering, in which inorganic microspheres of high stiffness reinforced the 
initial mechanical strength of the composites[17]. Subsequently, the degradation of β-
TCP provided sustained supply of Ca2+ as crosslinking agents to decelerate the 
degradation of the alginate matrix. On the other hand, spheres can also induce a 
physical crosslinking process into hydrogel-based constructs. For instance, positively 
charged PLA microspheres have been utilized to form a polyion complex with anionic 
polyelectrolytes (such as hyaluronic acid (HA)) to induce gelation of HA without 
introducing reactive chemicals that can be cytotoxic[18].  
Microspheres made of biodegradable and cytocompatible polymers can serve as cell 
delivery vehicle to improve the biological performance of tissue engineering 
constructs. Conventional hydrogel-based cell delivery has shown limited success, 
primarily due to the lack of sufficient adhesion of anchorage-dependent cells (such as 
osteoblasts) to rather inert gels such as PEG-based hydrogels. This phenomenon 
leads to cell death as well as the strict confinement of cells that impedes cell 
migration and cell-cell interactions[22]. Therefore, the introduction of microspheres into 
hydrogels is an alternative way to provide focal adhesions and subsequent space for 
cell proliferation upon concomitant sphere degradation[22,140-142]. Wang et al. 
proposed an injectable osteogenic scaffold based on a cell-laden microsphere-
encapsulated hydrogel using gelatin microspheres as cell carriers and agarose gels 
as a continuous matrix, which exhibited strong potential for cell transplantation and 
bone regeneration (Figure 3)[22,141,142]. 
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3.1.3. Microspheres embedded into CaP cements 
Although calcium phosphate cements (CPCs) have been extensively used for bone 
repair and regeneration, disadvantages still exist such as slow degradation rate in 
vivo, lack of macroporosity, and poor capability of controlled release. To improve their 
performance, biodegradable polymeric microspheres (made of e.g. PLGA[16], 
poly(trimethylene carbonate) (PTMC)[143], gelatin[144,145] and pectin[146]) have been 
introduced into cements. Thus, macroporosity can be introduced upon degradation of 
microspheres, which can create space for cell and tissue ingrowth and subsequently 
accelerate the resorption of CPCs[16]. The incorporation of microspheres in CPC can 
further enable cell delivery into cements to form cell-laden cements that might speed 
up new bone formation[147,148]. Xu et al. developed a hybrid system by encapsulating 
stem cells in alginate biodegradable microspheres that were subsequently 
incorporated into CPC, thus protecting cells from excessive fluctuations in pH and 
electrolyte concentrations during CPC setting reaction that are known to be 
detrimental for cell survival[147,148]. 
 
Figure 4. Schematic representation of using micro-/nanospheres as building blocks for 
bottom-up design of scaffolds by random packing (A), directed assembly (B) and rapid 
prototyping (C). Directed assembly can be induced by interparticle forces such as 
electrostatic (D), magnetic (E) and hydrophobic (F) interactions. 
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3.2. Micro-/nanospheres as building blocks for bottom-up fabrication of 
scaffolds  
The traditional tissue engineering strategy typically employs “top-down” approach by 
loading a premade bulk scaffold with signalling biomolecules and cells to generate a 
cellularized construct that instructs towards bone tissue regeneration. This 
conventional approach is accompanied by several drawbacks including limited cell 
penetration inside the scaffolds, loss of cell viability over time, poor control over drug 
delivery, and suboptimal clinical handling properties[149,150]. On the contrary, the so-
called “bottom-up” strategy towards developing scaffolds for tissue engineering has 
become increasingly attractive by developing novel engineered scaffolds with precise 
combination of cells, biomolecules and synthetic biomaterials. In this approach, 
scaffolds of high functionality can be fabricated by assembly of micro- or nanoscale 
particles as building blocks. To this end, micro- and nanospheres are obvious 
candidates as functional units, which can be equipped with desired physicochemical 
and biological properties to establish constructs that mimic the function and 
composition of natural tissues in the body. To engineer scaffolds by using particulate 
building blocks, three main fabrication strategies can be discerned, i.e. synthesis by 
random packing, directed assembly and rapid prototyping (as illustrated in Figure 4).  
 
3.2.1. Random packing  
Micro-/nanospheres can be randomly packed together to form a macroscopic three-
dimensional scaffold[150] (Figure 4A). This type of scaffolds has been developed using 
collagen[23], gelatin[24], fibrin[59], chitosan[67,151], alginate[78] and PLGA[86] micro-
/nanospheres as building blocks for injectable formulations. By functionalizing each 
type of spheres separately, the structure of the resulting scaffolds can be precisely 
controlled at microscale[152]. For instance, the composition and function of the 
scaffolds can be customized by encapsulation of signalling biomolecules[153], 
bioactive minerals[33,154], or by loading osteogenic cells at the outer sphere surface. 
However, a critical concern of applying these microsphere-based scaffolds into bone 
defects is their poor integrity resulting from weak interparticle interactions, which lead 
to a poor mechanical stability c.q. high flowability of the scaffolds[54] and migration of 
individual particles from defect sites upon implantation[155]. Therefore, different 
methods have been explored to preserve the agglomeration of micro-/nanosphere-
based formulations at confined defect sites by using glues[155] or crosslinkers[156]. 
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Another approach involves thermal fusion of polymeric microspheres into integrated 
macroscopic scaffolds as described by Laurencin’s group using PLGA[157] and 
chitosan[158] microspheres. The tight packing of microspheres resulted into porous 
scaffolds with high pore interconnectivity, controllable pore size and amount of 
porosity, and mechanical properties comparable to cancellous bone[157]. Further 
studies on these sintered microsphere-based scaffolds confirmed their capacity to 
release biomolecules in a controlled manner[81,134], cytocompatibility in vitro[159,160] 
and osteoconductivity in vivo[161]. 
 
Figure 5. Schematic diagram (A) and resulting photographs (B-F) of injectable colloidal gels 
based on using oppositely charged gelatin nanospheres as building blocks showing the self-
assembly (B, C) and gel formation (D, E, F) of gelatin nanospheres of opposite charge (“+/-” 
denotes the mixture of oppositely charged particles) as opposed to systems made of similarly 
charged nanospheres (“+” and “-” denote positive and negatively charged particles, 
respectively). Adapted from [54] with permission. Copyright Wiley-VCH Verlag GmbH & Co. 
KGaA. 
3.2.2. Directed assembly (self-assembling scaffolds) 
Directed assembly of micro-/nanospheres into cohesive macroscopic constructs can 
be achieved by introducing attractive interparticle forces (such as electrostatic forces, 
magnetic forces, or hydrophobic interactions) (Figure 4B). This approach overcomes 
the limitations of the random packing strategy and provides micro-/nanosphere-based 
scaffolds with enhanced structural integrity and mechanical stability. Due to the 
gentle physical crosslinking conditions that characterize these self-assembling 
systems, cytotoxic crosslinking chemicals to bridge particles are not necessary 
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anymore. Additionally, irregular osseous defects can be filled conveniently by using 
micro-/nanosphere-based formulations that exhibit excellent injectable and/or 
moldable as well as close packing of the spherical building blocks.  
 
Assembly driven by electrostatic interactions  
Charged micro-/nanospheres have been used for more than one decade as drug 
delivery vehicles because polyion complexes can be formed with charged 
biomolecules due to attractive electrostatic interactions. Interestingly, electrostatic 
forces have also been found to serve as cohesive interparticle force to induce self-
assembly of micro-/nanospheres of opposite charges[87,162] Consequently, colloidal 
gels based on dextran microspheres or PLGA nanospheres have been developed, 
which show great potential as scaffolds for bone tissue engineering. These gels 
exhibited excellent injectability, moldability and capability of self-recovery after 
shearing, due to the formation of a physically crosslinked particulate network. In 
addition, these colloidal gels acted as reservoirs for sustained delivery of entrapped 
drug with near zero-order drug release kinetic in vitro (for PLGA nanospheres[163]) 
and stimulated osteoconductive bone formation in vivo[163]. However, challenges 
remained for these micro-/nanosphere colloidal gels, including i) the necessity to 
derivatize dextran or PLGA by chemically grafting charged groups onto the polymer 
backbone[125], ii) the release of harmful degradation by-products of PLGA, iii) the 
absence of cell-adhesive peptide sequences required for cell attachment, and iv) the 
disruption of the network structure by screening of particle charges at a low pH or 
high ionic strength[162].  
To overcome these disadvantages, oppositely charged gelatin nanospheres have 
been developed using commercially available cationic and anionic gelatin, which 
facilitated the fabrication of gelatin micro-/nanospheres with positive and negative 
charges without the necessity of additional functionalization[52]. As a result, the 
combination of oppositely charged gelatin nanospheres gave rise to injectable and 
biodegradable colloidal gels with high elasticity at low nanosphere concentrations 
owing to electrostatic self-assembly between and tight packing of gelatin 
nanospheres (Figure 5). Due to their favorable clinical handling, ease of 
functionalization and cost-effectiveness, these gels show great potential for 
application as bone fillers for tissue regeneration and/or programmed drug release of 
multiple biomolecules at predetermined release rate. 
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Assembly driven by magnetic interactions  
In view of the increasing research interest in targeted drug delivery, the potential of 
magnetic micro-/nanospheres has also been investigated extensively. Magnetic 
spheres can be prepared by entrapping magnetic iron oxide nanoparticles within or 
onto the surface of micro-/nanospheres[164]. For instance, magnetic nanoparticles 
have been entrapped into dexamethasone-containing PLGA microspheres, which 
subsequently functioned as targeting drug-carriers to provide localized and sustained 
drug release for the treatment of bone-related diseases[165]. These magnetic delivery 
vehicles increase the spatial accuracy and elongate drug action due to an increased 
residence time at the targeting site. Furthermore, magnetic spheres have also been 
used to render commercially available scaffolds magnetic[166], thus developing 
magnetic scaffolds that attract and uptake magnetic microcarriers loaded with 
bioactive agents via magnetic forces. 
Similar to charged particles, magnetic micro-/nanospheres can also be used as 
building blocks to induce self-assembly into macroscopic constructs. Alsberg et al. 
combined thrombin-coated magnetic microspheres with fibrinogen solution to form 
fibrin gels with defined architecture at the nanoscale in which magnetic forces were 
used to position thrombin-coated magnetic microspheres in a defined two-
dimensional array to guide the self-assembly of fibrin fibrils[167].  
Strikingly, magnetic nanospheres have also been utilized to pattern cells and form a 
scaffold-free cellularized structure for tissue engineering and regeneration. Magnetic 
cationic liposomes (MCLs) have been prepared which can be uptaken by cells via 
electrostatic attraction between cationic liposomes and negatively charged cell 
membranes[14,15]. These liposome-labeled cells can be further guided using a magnet 
to form complex cell patterns with 3D multilayered cellular structure[15]. For example, 
MSCs were magnetically labeled with MCLs and cultured under the influence of a 
magnetic field, which induced the formation of a multilayered structure after 24h while 
the MSCs maintained the ability to differentiate into various cells including 
osteoblasts after long-term in vitro cell culture[168]. Further in vivo studies revealed 
that these cellular constructs improved new bone formation, which confirmed the 
great potential of applying this scaffold-free methodology for bone tissue engineering. 
Assembly driven by hydrophobic interactions  
Self-assembling hydrogels based on oligolactate-grafted dextran microspheres have 
been developed by employing hydrophobic interactions between oligolactate chains 
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on the surface of microspheres as the driven forces[169]. The resulting microscopic 
network displayed high elasticity with tailorable gel properties by modifying the 
chemical and physical composition of the microsphere-based gels. Interestingly, the 
gels showed self-recovery behavior after shear-thinning, which indicated that the 
physical crosslinking of the gel network was reversible, which is beneficial for 
potential use as injectable formulation in tissue regeneration[169]. 
 
Figure 6. Scaffolds consisting of CaP/PHBV composite microspheres prepared by rapid 
prototyping using selective laser sintering technique. A) Schematic diagram of the scaffold 
model designed by computer; Microcomputed tomography (B) and scanning electron 
microscopy (C, D) of the resulting scaffolds after rapid prototyping. Adapted from [170] with 
reproduction permission. Copyright 2011, Elsevier. 
 
3.2.3. Rapid prototyping  
Rapid prototyping (RP) techniques have been recently advocated for the design of 
bone tissue engineering scaffolds. Using RP, constructs with customized architecture 
can be created from computer-aided-design data using micro-/nanospheres as 
building blocks to assemble into scaffolds layer-by-layer (Figure 4C). For instance, 
microspheres consisting of polymer (such as poly(hydroxybutyrate-co-
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hydroxyvalerate) (PHBV)) or composite (such as CaP/PHBV) have been prepared 
using emulsification, which were further fabricated into 3D porous scaffolds using 
selective laser sintering (Figure 6)[170,171]. The resulting scaffolds exhibited an 
interconnected porous structure and high amount of porosity, thereby serving as a 
suitable environment for osteoblastic cell attachment, proliferation and differentiation. 
Besides the application of RP techniques for scaffold design, Mironov et al. have 
introduced the novel concept of 3D organ printing, in which scaffold-free cellularized 
tissues or organ constructs can be fabricated layer-by-layer using tissue spheroids as 
building blocks[172,173] In continuous organ printing procedures, tissue spheroids can 
be dispensed using with or without hydrogels as carrier[173] This new technology may 
represent a viable alternative to traditional approaches in tissue engineering based 
on biodegradable scaffolds. 
 
4. Conclusions 
The potential of microspheres in bone tissue engineering has been explored for 
several decades, whereas nanospheres have been increasingly advocated over the 
past decade.  Generally, microspheres can be used as either a dispersed phase 
surrounded by a continuous matrix (solid polymers, hydrogel polymers or CaP 
cements) or as building blocks to establish integral macroscopic scaffolds by a 
bottom-up approach without surrounding matrix. Compared to traditional monolithic 
scaffolds, scaffolds for bone regeneration comprising micro- and nanospheres 
display advantages that are related to i) an improved control over sustained delivery 
of therapeutic agents, signalling biomolecules and even pluripotent stem cells, ii) the 
introduction of spheres as stimulus-sensitive delivery vehicles for triggered release, iii) 
the use of spheres to introduce porosity and/or improve the mechanical properties of 
bulk scaffolds by acting as porogen or reinforcement phase, iv) the use of spheres as 
compartmentalized microreactors for dedicated biochemical processes, v) the use of 
spheres as cell delivery vehicle, and finally vi) the possibility to prepare injectable 
and/or moldable formulations to be applied using minimally invasive surgery. 
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1. Introduction 
The emergence of regenerative medicine has led to a paradigm shift in the design of 
novel biomaterials, which are now increasingly considered as (bio)active scaffolds 
that induce tissue regeneration as opposed to the more traditional concept of 
passively accepted implant materials[1]. In order to present biological stimuli to the 
physiological environment and trigger tissue repair, optimal integration of synthetic 
biomaterials within the surrounding tissue is of paramount importance. In that respect, 
hydrogels made from biodegradable polymers are ideal candidates since they are 
generally biocompatible, biodegradable, and, in some cases, injectable[2-4]. In 
addition, polymeric hydrogels can act as reservoir for sustained release of 
therapeutic and signaling agents[4]. Nevertheless, current gel-based materials exhibit 
a rather poor ability to present multiple signaling molecules at programmed time-
points and release rates. Colloidal gels, on the other hand, have recently been 
identified as a promising “bottom-up” strategy for design of highly functional scaffolds 
by employing micro- or nanoscale particles as building blocks to assemble into 
shape-specific bulk materials[5-13]. To this end, interparticle interactions such as 
electrostatic forces[14], magnetic forces[14], hydrophobic interactions[15] and steric 
hindrance[16] can be exploited to induce self-assembly of micro- or nanoparticles into 
integrated scaffolds. By incorporation of bioactive agents (e.g. enzymes, growth 
factors and/or biomineral nanocrystals) into these particulate building blocks of 
variable biodegradability, injectable gels with microscale resolution and complexity 
can be formed. This new class of materials would offer virtually unlimited degree of 
freedom with respect to their capacity for programmed drug release of multiple 
biomolecules at predetermined release rates. 
Charged polymeric micro- or nanospheres are the most obvious building blocks for 
the design of such injectable and biodegradable gels, since physical crosslinking 
based on electrostatic interactions is generally favored over the use of chemical 
crosslinking to achieve sustained drug release[17], cell attachment[18] or hydrogel 
formation[19]. Recently, oppositely charged dextran microspheres[20] or poly(lactic-co-
glycolic acid) (PLGA) nanospheres[21] have been used to form moldable scaffolds, but 
only indirect proof for electrostatic self-assembly was provided based on rheological 
characterization, while the underlying gel formation mechanism was not elucidated. 
Moreover, disadvantages of these gels include i) the necessity to derivatize dextran 
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or PLGA by grafting charged groups onto the polymer backbone, which moreover 
induced cytotoxicity,[20b] ii) the release of harmful degradation by-products such as 
lactic and glycolic acid (in case of PLGA nanospheres), which can denature 
entrapped signaling proteins[22] and cause inflammatory responses[23] of the host 
tissue, and iii) the absence of cell-adhesive peptide sequences required for the 
attachment of anchorage-dependent mesenchymal stem cells such as fibro- and 
osteoblasts[17]. 
The unique functional properties of gelatin (Gel) macromolecules have been 
exploited in the current study to overcome all of the above-mentioned drawbacks of 
existing particulate-based gel systems. Gelatin is well-known for its excellent 
biocompatibility, controllable biodegradability and non-immunogenicity, and 
consequently it has found widespread applications in various biomedical areas[17]. 
Gelatin is a cheap product that is commercially available of both positive (cationic 
gelatin (GelA) from porcine skin, isoelectric point (IEP) ~9) or negative (anionic 
gelatin (GelB) from bovine skin, IEP ~5) charge at neutral pH without the necessity of 
additional functionalization[17, 24]. This unique feature of gelatin has been investigated 
to develop gelatin-based drug delivery vehicles that form polyion complexes with 
oppositely charged biomolecules (e.g. basic fibroblast growth factor (bFGF) 
interacted with GelB)[17], even so its potential for electrostatic self-assembly has not 
been studied yet. Moreover, gelatin does not produce harmful by-products upon 
enzymatic degradation as it is derived from collagen which is the most abundant 
protein in animals. Finally, gelatin chains contain motifs such as RGD sequences 
which modulate cell adhesion,[17] thereby improving the final biological behavior over 
polymers that lack these cell-recognition sites. 
Here, we demonstrate that upon mixing oppositely charged GelA and GelB 
nanospheres it is possible to form injectable and biodegradable colloidal gels. 
Dynamic light scattering (DLS) was used to provide direct evidence for the formation 
of cohesive aggregates of several micrometers in size due to the attractive 
electrostatic interaction between unmodified, oppositely charged gelatin nanospheres 
under diluted conditions. Elastic gels were formed at relatively low solid contents 
(defined as w/v% of gelatin solid nanospheres in dispersions) owing to electrostatic 
self-assembly between the nanospheres as well as additional stabilization of the gels 
caused by a tight packing of nanospheres. The shear-thinning behavior of the gels 
allowed injection through conventional medical syringes, while gel elasticity was 
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maintained at ionic strengths comparable to physiological fluids. These properties 
make this gel a simple, cheap and easily functionalizable gel that can be applied in 
tissue-repairing surgeries in which drug-loaded, injectable formulations are required. 
 
2. Materials and Methods 
2.1. Materials 
Gelatin A (from porcine skin, 300 Bloom, isoelectric point (IEP) ~9) and gelatin B 
(from bovine skin, 225 Bloom, IEP ~5) were purchased from Sigma-Aldrich. 
Glutaraldehyde (GA, 25 wt% solution in water) was commercially available from 
Acros Organics. All other materials were purchased from Sigma-Aldrich. 
 
2.2. Preparation of Gel nanospheres 
Gelatin nanospheres were prepared by a two step desolvation method[25]. A gelatin 
solution (5 w/v%) was obtained by dissolving gelatin in distilled water under constant 
heating. Acetone (25 ml) was added to the gelatin solution to precipitate high 
molecular weight gelatin. After removing the supernatant, gelatin was re-dissolved in 
water at 50 ºC. After cooling to room temperature and adjusting the pH of the gelatin 
solution to 2.5, acetone (75 ml) was added dropwise (~2 ml min-1) into a vigorously 
stirred (1000 rpm) gelatin solution to form gelatin nanospheres. Subsequently, GA 
was added to the nanosphere suspension. To investigate the influence of GA 
crosslinking density on the size and charge of the nanospheres, various molar ratios 
of GA relative to the amount of free amine groups present in gelatin ([NH2]gelatin) were 
used. After crosslinking for 16 hr, glycine solution (100 mM) was added into the 
nanosphere suspension to block unreacted aldehyde groups from GA. The 
suspension was then subjected to three cycles of centrifugation (13,200 rpm for 5 
min) and re-suspension in deionized water by vortexing, after which the pH of 
nanosphere suspension was adjusted to 7.0. After freeze-drying, nanospheres were 
stored at 4 ºC until further use.  
 
2.3. Characterization of nanospheres 
Dynamic light scattering (DLS, Zetasizer Nano-S, Malvern Instruments Ltd.) was 
used to measure (the change in) particle size by dispersing gelatin nanospheres 
GelA, GelB, and GelA+B in deionized water at a solid content of 0.01 w/v% 
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(measuring time 60 min, one measurement per min). To monitor the effect of ionic 
strength on the change in particle size upon mixing oppositely charged nanoparticles, 
equal amounts of GelA and GelB nanospheres (both at 0.005 w/v% in solid content) 
were mixed in solutions with different ionic strength (1, 10 and 100 mM NaCl, pH 7.0) 
and monitored by DLS. 
The zeta potential of gelatin nanospheres was measured using a Laser Doppler 
electrophoresis with a Zetasizer Nano-Z (Malvern Instruments Ltd.) by dispersing 
particles in HEPES buffer (5 mM, pH 7.0).  
The morphology of gelatin nanospheres was observed by transmission (TEM, JEOL 
1010) and scanning electron microscopy (SEM, JEOL 6301). 
 
2.4. Preparation of nanosphere-based gels 
Lyophilized nanospheres were dispersed in deionized water with different solid 
contents (5-20 w/v%) in 2 ml Eppendorf® tubes and stored at 4 ºC for 2 hr to allow for 
complete swelling of nanoparticles. Mixtures containing oppositely charged 
nanoparticles were prepared by mixing equal weight percents of GelA and GelB 
nanospheres. An inverted-vial test[15] was carried out for nanosphere dispersions of 5 
w/v% solid content by inverting Eppendorf® tubes containing 400 µl of either 
oppositely (GelA+B) or similarly (GelA or GelB) charged nanosphere dispersions and 
recording photographs after equilibration for 1 min. 
 
2.5. Rheological characterizations 
The viscoelastic properties of nanosphere dispersions were characterized using a 
rheometer (AR2000ex, TA Instruments). All measurements were performed using a 
flat steel plate geometry (20mm diameter) at 25 ºC with a gap distance of 500µm. 
First, oscillatory stress and strain sweeps were performed to determine the linear 
viscoelastic region for each sample. Subsequently, the storage modulus G’, loss 
modulus G” and tan(δ) were determined using an oscillatory time sweep test for 10 
min at a constant stress of 1 Pa and constant frequency of 1 Hz. The effect of ionic 
strength on gel strength was tested by measuring G’ of nanosphere dispersions (10 
w/v% solid content) in solutions of different ionic strengths (1, 10, 100, 500, 1000 mM 
NaCl, pH 7.0). The viscosity of nanosphere-based gels was evaluated by performing 
a stepped flow test with increasing rate of shear force (10 - 250 s-1, 1 Hz frequency). 
The recovery kinetics of gelatin nanosphere-based gels after network destruction 
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were investigated by adopting a rheological method as described by Haines-Butterick 
et al.[28], which mimics the clinical injection procedure (i.e. single gel destruction by 
high shear forces upon extrusion through narrow syringes). Briefly, viscoelastic 
properties (G’ and G’’) of GelA+B gels (15 w/v% solid content, pH 7.0, 1 mM NaCl) 
were measured as a function of time in an oscillatory time sweep (5 min, 1% strain, 1 
Hz frequency) before and after severe destruction of the gel network (1000% strain, 1 
min, 1 Hz frequency).  
 
Figure 1. The effect of crosslinking density (A) and pH (B) on the zeta potential of Gel 
nanospheres. C) Particle size of nanosphere suspensions (1 mM NaCl, pH 7.0) containing 
gelatin nanospheres of similar (GelA or GelB) or opposite charge (GelA+B) measured by 
DLS (insert showing suspension stability for GelA, GelB and GelA+B samples). D) The effect 
of ionic strength on aggregation of GelA+B nanospheres (in solutions of 1, 10 and 100 mM 
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NaCl, pH 7.0) (insert showing suspension stability for three different ionic strengths). E, F, G) 
TEM images of GelA, GelB and GelA+B nanospheres, respectively (scale bar = 2 µm). 
 
2.6. Statistics 
All measurements were performed in triplicate (n=3), and the results were analyzed 
using Student’s t-test and depicted as average ± standard deviation. A value of P < 
0.01 was accepted as statistically significant. 
 
Figure 2. SEM images of GelA (A), GelB (B) and mixture of GelA and GelB nanospheres at 
pH 7.0 (C) and pH 4.0 (D) (scale bar = 100 nm). 
 
3. Results and discussion 
Oppositely charged GelA and GelB nanospheres were prepared using a desolvation 
method (see Experimental for more details)[25]. The size of the nanospheres 
decreased with increased crosslinking density to about 400 and 250 nm for GelA and 
GelB in swollen state, respectively (Fig. S1 in Supplemental data), while the 
polydispersity index was below 0.2 for all groups indicative of a rather narrow size 
distribution. As expected from the differences in isoelectric point of both commercially 
available types of gelatin, GelA and GelB nanospheres were oppositely charged at 
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low-density crosslinking conditions, but GelA nanospheres lost their positive charge 
at high-density crosslinking conditions due to excessive consumption of positively 
charged amine groups (-NH2) by the crosslinker glutaraldehyde (GA) (Fig. 1A)
[26]. 
Therefore, a fixed crosslinking density with a molar ratio of GA/free amine of 1 was 
chosen for further experiments to maximize the charge difference between GelA and 
GelB nanospheres. The pH dependence of the zeta-potential of both types of 
nanospheres is shown in Fig. 1B, revealing that nanospheres of gelatin type A and B 
were oppositely charged between 5 to 8, implying that attractive electrostatic 
interactions will prevail at pH 7. 
To study electrostatic interactions between oppositely charged nanospheres in more 
detail, DLS was used to monitor the particle size of suspensions of GelA, GelB as 
well as mixtures of GelA and GelB nanospheres (GelA+B) as a function of time (Fig. 
1C). Particle sizes in GelA and GelB suspensions did not change in time, reflecting 
that the repulsive forces between nanospheres of similar charge prevented 
agglomeration. In contrast, a linear increase in particle size was detected for mixtures 
of GelA and GelB nanospheres, which eventually resulted into sedimentation of large 
aggregates after 1 hr equilibration (Fig. 1C, insert). These results suggest that 
repulsive electrostatic forces between gelatin nanospheres of similar charge were 
sufficiently strong to stabilize the suspension by maximization of the interparticle 
distance. Attractive forces between oppositely charged nanospheres, on the contrary, 
induced self-assembly into large aggregates that sedimented when gravitational 
forces were able to overcome the random Brownian motion upon exceeding a certain 
critical aggregate size. To provide further evidence for the electrostatic nature of the 
interparticle forces leading to aggregation, mixtures of GelA and GelB nanospheres 
were dispersed in solutions of different ionic strength. Upon increasing the ionic 
strength of the solution a decrease in particle size (Fig. 1D) and extent of 
sedimentation (Fig. 1D insert) were observed. This strongly suggests that salts 
interfere with gelatin particles, implying that aggregation is mainly driven by 
electrostatic interactions. The electrical double layer surrounding charged particles is 
compressed with increasing ionic strength, thereby reducing the driving force for self-
assembly. This phenomenon was also observed using transmission electron 
microscopy (TEM), which revealed that large clusters of several microns formed 
when gelatin nanospheres of opposite charges were mixed (Fig. 1G). These kinds of 
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clusters were completely absent in suspensions of gelatin nanospheres of similar 
charge (Fig. 1E and 1F).  
Scanning electron microscopy (SEM) was utilized to visualize the morphology of 
lyophilized gelatin nanospheres of similar or opposite charge (Fig. 2). First of all, the 
diameters of GelA and GelB nanospheres were found to be 198±41nm and 
148±28nm, respectively. This narrow size distribution observed by SEM was in line 
with the low polydispersity index measured by DLS (Fig. S1 in Supplemental data). 
For similarly charged nanospheres (Fig. 2A and 2B), interparticle distances were 
considerably larger at pH 7 than for a sample containing a mixture of oppositely 
charged nanospheres, which showed a clear interconnection between particles 
(Fig.2C). As observed before, attractive electrostatic forces induced a compact 
packing of oppositely charged nanospheres. Interestingly, this clustering of 
oppositely charged nanospheres was not observed when the pH of the solution was 
lowered to 4.0 (Fig. 2D), since both types of nanospheres were positively charged 
under this acidic condition (Fig. 1B) resulting in interparticle repulsion.  
The combined evidence from DLS and TEM observations at dilute nanosphere 
concentrations unambiguously proved that electrostatic forces can be exploited for 
bottom-up synthesis of cohesive aggregates. To translate this proof-of-principle into 
fabrication of macroscopic gels, the viscoelastic properties of highly concentrated 
nanosphere dispersions were studied by rheology. Oscillatory stress and strain 
sweeps confirmed that all relevant rheological characterizations were performed 
within the linear viscoelastic region (Fig. S2 and S3 in Supplemental data). All 
dispersions of oppositely charged nanospheres displayed significantly higher G’ than 
dispersions of similarly charged gelatin (Fig. 3A), and dispersions of GelA 
nanospheres were more elastic than GelB. Moreover, all dispersions displayed tan(δ) 
values below 1, indicating that the gelatin nanosphere dispersions could be 
characterized as gels since the elastic modulus G’ generally exceeded the viscous 
modulus G” (Fig. 3B). In order to provide further evidence for the process of gel 
formation, a simple inverted-vial test was performed[15] which clearly revealed that 
gels based on GelA+B nanospheres (solid content 5 w/v%) were much less flowable 
than similarly charged GelA or GelB nanosphere dispersions of equal solid content 
(Fig. 3C). With increasing solid content, the elastic moduli of the gels made of 
GelA+B nanospheres strongly increased from 10 Pa at 5 w/v% to >10 kPa at 20 
w/v%. At solid contents of 10 w/v% and higher, gels were formed with tan(δ) values 
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interactions will prevail at pH 7. 
To study electrostatic interactions between oppositely charged nanospheres in more 
detail, DLS was used to monitor the particle size of suspensions of GelA, GelB as 
well as mixtures of GelA and GelB nanospheres (GelA+B) as a function of time (Fig. 
1C). Particle sizes in GelA and GelB suspensions did not change in time, reflecting 
that the repulsive forces between nanospheres of similar charge prevented 
agglomeration. In contrast, a linear increase in particle size was detected for mixtures 
of GelA and GelB nanospheres, which eventually resulted into sedimentation of large 
aggregates after 1 hr equilibration (Fig. 1C, insert). These results suggest that 
repulsive electrostatic forces between gelatin nanospheres of similar charge were 
sufficiently strong to stabilize the suspension by maximization of the interparticle 
distance. Attractive forces between oppositely charged nanospheres, on the contrary, 
induced self-assembly into large aggregates that sedimented when gravitational 
forces were able to overcome the random Brownian motion upon exceeding a certain 
critical aggregate size. To provide further evidence for the electrostatic nature of the 
interparticle forces leading to aggregation, mixtures of GelA and GelB nanospheres 
were dispersed in solutions of different ionic strength. Upon increasing the ionic 
strength of the solution a decrease in particle size (Fig. 1D) and extent of 
sedimentation (Fig. 1D insert) were observed. This strongly suggests that salts 
interfere with gelatin particles, implying that aggregation is mainly driven by 
electrostatic interactions. The electrical double layer surrounding charged particles is 
compressed with increasing ionic strength, thereby reducing the driving force for self-
assembly. This phenomenon was also observed using transmission electron 
microscopy (TEM), which revealed that large clusters of several microns formed 
when gelatin nanospheres of opposite charges were mixed (Fig. 1G). These kinds of 
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clusters were completely absent in suspensions of gelatin nanospheres of similar 
charge (Fig. 1E and 1F).  
Scanning electron microscopy (SEM) was utilized to visualize the morphology of 
lyophilized gelatin nanospheres of similar or opposite charge (Fig. 2). First of all, the 
diameters of GelA and GelB nanospheres were found to be 198±41nm and 
148±28nm, respectively. This narrow size distribution observed by SEM was in line 
with the low polydispersity index measured by DLS (Fig. S1 in Supplemental data). 
For similarly charged nanospheres (Fig. 2A and 2B), interparticle distances were 
considerably larger at pH 7 than for a sample containing a mixture of oppositely 
charged nanospheres, which showed a clear interconnection between particles 
(Fig.2C). As observed before, attractive electrostatic forces induced a compact 
packing of oppositely charged nanospheres. Interestingly, this clustering of 
oppositely charged nanospheres was not observed when the pH of the solution was 
lowered to 4.0 (Fig. 2D), since both types of nanospheres were positively charged 
under this acidic condition (Fig. 1B) resulting in interparticle repulsion.  
The combined evidence from DLS and TEM observations at dilute nanosphere 
concentrations unambiguously proved that electrostatic forces can be exploited for 
bottom-up synthesis of cohesive aggregates. To translate this proof-of-principle into 
fabrication of macroscopic gels, the viscoelastic properties of highly concentrated 
nanosphere dispersions were studied by rheology. Oscillatory stress and strain 
sweeps confirmed that all relevant rheological characterizations were performed 
within the linear viscoelastic region (Fig. S2 and S3 in Supplemental data). All 
dispersions of oppositely charged nanospheres displayed significantly higher G’ than 
dispersions of similarly charged gelatin (Fig. 3A), and dispersions of GelA 
nanospheres were more elastic than GelB. Moreover, all dispersions displayed tan(δ) 
values below 1, indicating that the gelatin nanosphere dispersions could be 
characterized as gels since the elastic modulus G’ generally exceeded the viscous 
modulus G” (Fig. 3B). In order to provide further evidence for the process of gel 
formation, a simple inverted-vial test was performed[15] which clearly revealed that 
gels based on GelA+B nanospheres (solid content 5 w/v%) were much less flowable 
than similarly charged GelA or GelB nanosphere dispersions of equal solid content 
(Fig. 3C). With increasing solid content, the elastic moduli of the gels made of 
GelA+B nanospheres strongly increased from 10 Pa at 5 w/v% to >10 kPa at 20 
w/v%. At solid contents of 10 w/v% and higher, gels were formed with tan(δ) values 
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below 0.1, corresponding to the formation of elastic, solid-like gels. Wang et al. 
pointed out that the cohesion of colloidal gel systems results from the contribution of 
the volume fraction of solid nanoparticles as well as the contribution of the particle 
movement frequency as determined by interparticle interactions[21a]. According to this 
notion, increasing the solid content of the gels should result in a higher contribution 
from the volume fraction to the gel strength, as reflected by a tighter packing of 
nanospheres resulting in increased G’ values. On the other hand, higher G’ of 
GelA+B nanosphere dispersions compared to GelA or GelB dispersions originated 
mainly from additional attractive electrostatic forces between oppositely charged 
particles that formed a strong network of connected nanospheres. The higher 
elasticity of gels composed of GelA nanospheres compared to GelB can be attributed 
to the larger gel strength (Bloom number) and nanosphere size as well as the smaller 
absolute zeta potential value of GelA relative to GelB nanospheres. As a result, the 
contribution caused by particle movement frequency was enhanced as determined by 
reduced repulsive interactions between GelA nanospheres. 
At higher solid contents, the packing effect of the nanospheres started to dominate 
the reinforcing contribution to the gel strength caused by electrostatic interactions 
due to decreased interparticle distances, as indicated by the loss of statistical 
differences between gels composed of GelA+B vs. GelA nanospheres at 20 w/v% 
solid content (Fig. 3A). To assess the relative contribution of electrostatic interactions 
to the gel elasticity, rheological studies were also performed for gels made of 
mixtures of GelA and GelB as a function of ionic strength (Fig. 3D). Elastic moduli of 
gels (10 w/v% solid content) decreased gradually with increasing ionic strength, 
which can be explained by effective shielding of the particle charge by counterions at 
high ionic strength. This dependence of viscoelastic properties on additives (such as 
salts) in physically crosslinked gels was also observed by other authors[27], who 
discussed the influence of salt concentration and pH on the rheological behavior of 
physical gels in more detail. However, gel elasticity was still considerable (G’ of 
around 800-900 Pa) at high ionic strength (1 M NaCl), at which condition electrostatic 
interactions can be considered as negligible based on DLS observations (see Fig. 
1D). These findings contrast the results obtained by van Tomme et al. who observed 
that dextran microsphere-based gels lost their elasticity completely at high ionic 
strength (0.5 M NaCl)[20a]. Moreover, gels based on gelatin nanospheres were 
considerably more elastic than gels made of dextran microspheres at a similar solid 
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content, suggesting that nanosphere-based gels can be packed more densely than 
microsphere-based systems. The intrinsically larger specific surface area of 
nanosphere-based systems appears to induce more resistance to shear forces due 
to the larger contact area between the nanospheres as compared to gels containing 
microspheres, resulting into additional mechanical stabilization. 
 
Figure 3. Elastic modulus G’ (A) and tan(δ) (B) of nanosphere dispersions of various solid 
contents containing nanospheres of similar (GelA or GelB) or opposite charge (GelA+B). *** 
= P < 0.001, ** = P < 0.01. C) Photographs of nanosphere dispersions (5 w/v% solid content) 
of oppositely charged (GelA+B) and similarly charged (GelA or GelB) nanospheres after an 
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inverted-vial test. D) G’ and tan(δ) of GelA+B nanosphere dispersions (10 w/v% solid content) 
as a function of the ionic strength (pH 7.0). E) Viscosity and shear-thinning behavior of 
GelA+B nanosphere dispersions of various solid contents (5-20 w/v%) and different 
compositions (20 w/v% of GelA, GelB and GelA+B) (insert showing the extrusion of an 
elastic gel composed of oppositely charged gelatin nanospheres from a conventional medical 
syringe (15 w/v% solid content)). (F) Gel recovery after gel destruction assessed by 
monitoring G’ and G” as a function of time: region I, II and III shows initial gel strength, gel 
destruction and gel recovery, respectively, of GelA+B nanosphere gels (15 w/v% solid 
content). 
 
To investigate the injectability of the colloidal gels, viscosities of GelA, GelB and 
mixed GelA+B nanosphere gels of solid content of 5-20 w/v% were measured as a 
function of shear rate (Fig.3E). The initial gel viscosities at low shear rate confirmed 
again the higher stability of GelA+B nanosphere gels compared to GelA and GelB of 
similar solid content. Higher viscosities were measured for gelatin nanosphere-based 
gels compared to PLGA-based gels of similar solid content[21], which might be related 
to the lower water uptake by PLGA nanospheres compared to gelatin nanospheres. 
Shear-thinning behavior was observed for all gelatin nanosphere dispersions as a 
result of increasing shear rate similar to observations by Wang et al. for PLGA 
nanoparticles[21]. The cohesive forces owing to attractive electrostatic interaction and 
tight nanosphere packing were destroyed at high shear rate resulting into the low 
viscosities that allow for injection through narrow syringes. In order to study the 
capacity of GelA+B gels (15 w/v% solid content) to recover its elasticity after gel 
destruction at higher shear rates (similar to gel extrusion through narrow syringes), a 
simple rheological test was performed as adopted from Haines-Butterick et al[28]. As 
shown in Fig. 3F, application of a high shear strain (1000% for 1 min) resulted into 
complete network destruction which transformed the gel into a liquid-like material of 
negligible elasticity (G’). Upon removal of this destructive shear, gel rigidity was 
restored almost instantaneously for ~70% (relative to the initial G’) within 4 sec after 
gel destruction, while ~90% of the initial gel elasticity recovered within 5 min after gel 
destruction. This self-healing behavior of these nanosphere-based gels can be 
attributed to the fast and reversible re-establishment of the electrostatic interactions 
between oppositely charged gelatin nanospheres as well as re-arrangement of 
nanosphere packing upon gel equilibration. Compared to other physically crosslinked 
gels such as peptide-based hydrogels[28], nanosphere-based gel recovery was much 
faster. 
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This shear-thinning and self-healing behavior makes gelatin nanosphere-based gels 
suitable for extrusion and injection by syringes. As is clearly illustrated in Fig. 3E 
(insert), homogeneous gel-threads were formed upon injection through a 
conventional medical syringe. Previous studies on the injectability of gels made of 
oppositely charged dextran microspheres reported adverse effects with respect to 
expulsion of the water phase, the so-called filter-pressing effect, for highly charged 
microspheres that were packed too tightly[20d]. This filter-pressing phenomenon[29] 
was not observed in the current gelatin nanosphere-based system, most likely 
because of the smaller pore sizes in the gelatin nanosphere network, which reduced 
the flowability of the aqueous phase. 
 
4. Conclusions 
In conclusion, this study has provided firm evidence for a feasible bottom-up 
approach for the preparation of injectable gels by employing oppositely charged 
gelatin nanospheres as building blocks. Compared to previous studies on 
comparable colloidal gels systems, gels based on gelatin nanospheres displayed 
significantly improved performance (e.g. enhanced gel elasticity, favorable 
injectability and improved stability at high ionic strength) without the need to 
chemically modify these commercially available macromolecules. In addition, the 
inherent presence of cell-binding peptide sequences will ensure beneficial biological 
behavior in terms of cell attachment, proliferation and differentiation. Due to their 
favorable clinical handling, ease of functionalization and cost-effectiveness, these 
nanosphere-based gels show great potential for application as injectable gels for 
tissue regeneration and/or programmed drug release of multiple biomolecules at 
predetermined release rate. 
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6. Supplemental data 
 
Figure S1. The effect of crosslinking density (molar ratio of GA to [NH2]gelatin) on  particle size 
of swollen GelA and GelB nanospheres.  
 
 
Figure S2. Representative oscillatory rheological characterization performed to determine the 
linear viscoelastic region of GelA+B nanosphere dispersions (15 w/v% solid content, pH 7.0, 
1mM NaCl): (A) oscillatory strain sweep (0.1-1000% strain at 1 Hz) and (B) oscillatory stress 
sweep (0.1-1400 Pa at 1 Hz). 
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Figure S3. Oscillatory rheological characterization performed to determine the linear 
viscoelastic region of GelB nanosphere dispersions (5 w/v% solid content, pH 7.0, 1mM 
NaCl): (A) oscillatory strain sweep (0.1-100 % strain at 1 Hz) and (B) oscillatory strain sweep 
(0.1-10 Pa at 1 Hz). 
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1. Introduction 
The increasing demand for biomaterials of improved efficacy for tissue regeneration 
has prompted the development of hydrogels that induce tissue regeneration by 
presenting effective biological cues at target tissues[1-5]. A recent study on the clinical 
efficacy of BMP-2 delivery has confirmed that growth factor delivery from 
conventional carrier materials is associated with serious clinical complications[6], 
which stresses the need for novel carrier materials for controlled delivery of growth 
factor. In that respect, colloidal gels are a novel and innovative class of hydrogels, 
which have recently emerged as a promising “bottom-up” strategy for design of highly 
functional scaffolds with strong capacity for programmed biomolecules delivery. By 
employing micro- or nanoscale particles as building blocks, shape-specific, 
macroscopic materials of high functionality can be fabricated[4, 5, 7-9]. Due to the small 
size of the particulate building blocks, colloidal gels have several advantages over 
monolithic scaffolds. First, micro- and nano-sized building blocks render colloidal gels 
injectable, thereby allowing for optimal filling of irregularly shaped tissue defects and 
material-tissue integration by using minimally invasive approaches[10, 11]. Second, 
physically crosslinked particulate networks resulting from strong interparticle forces 
are beneficial for many biomedical applications[12], such as encapsulation of bioactive 
molecules[13, 14] or cells[15, 16]. Especially, micro- and nanoparticles are suitable 
carriers for controlled delivery of biomolecules[17, 18]. By loading these particles with 
therapeutic[19] or signaling[14] agents, the resulting bulk colloidal gels offer a virtually 
unlimited freedom with respect to their capacity for controlled and sustained delivery 
of bioactive agents to stimulate tissue regeneration[3, 4, 20]. 
Colloidal gels made of oppositely charged gelatin nanospheres have recently been 
developed successfully in our laboratory, which were shown to be cohesive and self 
healing due to the strong cohesive interactions (electrostatic as well as hydrophobic 
interactions) between cationic and anionic nanospheres[10]. Gelatin has several 
benefits as material for colloidal gels since gelatin i) is known for its excellent 
biocompatibility, controllable biodegradability and non-immunogenicity, ii) is cheap 
and commercially available as both cationic (gelatin type A, isoelectric point (IEP) ~9) 
or anionic (gelatin type B, IEP ~5) polymer without the necessity of additional 
functionalization, iii) does not produce harmful by-products upon enzymatic 
degradation, and iv) contains motifs such as RGD sequences which modulate cell 
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adhesion. Still, their capacity for controlled delivery of biomolecules has not been 
confirmed yet.  
Gelatin microspheres, on the other hand, are already widely used for controlled 
delivery of several biomolecules because of their biodegradability[21, 22], 
biocompatibility[23], ease of processing[24], gentle gelling behavior[24], and ease of 
incorporation biominerals[25] and biomolecules[26-28]. Especially, positively or 
negatively charged gelatin microspheres enable controlled and sustained release of 
growth factors by forming polyion complexes between charged proteins and 
oppositely charged gelatin carriers[26, 28-30]. Van Tomme et al.[31, 32] already 
demonstrated the feasibility of forming elastic gels using oppositely charged dextran 
microspheres (~10 µm in diameter), but no study has been executed yet on utilizing 
cationic and anionic gelatin microspheres as building blocks for physically crosslinked 
colloidal gels.  
The final goal of the current study was to develop a colloidal gelatin gel with strong 
capacity for controlled delivery of osteogenic growth factors. To this end, the clinical 
handling properties as well as the capacity for drug delivery was studied for colloidal 
gels made of either oppositely charged gelatin microspheres or nanospheres. More 
specifically, the viscoelastic properties, injectability, degradability and capacity for 
release of osteogenic proteins were evaluated for both nano- and micro-structured 
colloidal gelatin gels. We hypothesized that colloidal gels made of nanospheres 
would exhibit advantages with respect to their viscoelastic and drug-releasing 
behavior due to the small particle size and corresponding stronger electrostatic 
interparticle forces[33] as well as larger specific surface area allowing for more 
extensive sorption of drugs.  
To prove our hypothesis, viscoelastic properties of colloidal gels made of gelatin 
micro- vs. nanospheres have been investigated thoroughly using rheological 
characterizations and injectability tests. Further, the capacity of micro- or 
nanosphere-based gels for controlled delivery of biomolecules was investigated by 
studying the release kinetics of two selected osteogenic proteins, i.e. bone 
morphogenetic protein (BMP-2) and alkaline phosphatase (ALP). In vitro protein 
release was measured by labeling the biomolecules with 125I and monitoring their 
release. 
 
 
Chapter 4 
 
78 
 
1. Introduction 
The increasing demand for biomaterials of improved efficacy for tissue regeneration 
has prompted the development of hydrogels that induce tissue regeneration by 
presenting effective biological cues at target tissues[1-5]. A recent study on the clinical 
efficacy of BMP-2 delivery has confirmed that growth factor delivery from 
conventional carrier materials is associated with serious clinical complications[6], 
which stresses the need for novel carrier materials for controlled delivery of growth 
factor. In that respect, colloidal gels are a novel and innovative class of hydrogels, 
which have recently emerged as a promising “bottom-up” strategy for design of highly 
functional scaffolds with strong capacity for programmed biomolecules delivery. By 
employing micro- or nanoscale particles as building blocks, shape-specific, 
macroscopic materials of high functionality can be fabricated[4, 5, 7-9]. Due to the small 
size of the particulate building blocks, colloidal gels have several advantages over 
monolithic scaffolds. First, micro- and nano-sized building blocks render colloidal gels 
injectable, thereby allowing for optimal filling of irregularly shaped tissue defects and 
material-tissue integration by using minimally invasive approaches[10, 11]. Second, 
physically crosslinked particulate networks resulting from strong interparticle forces 
are beneficial for many biomedical applications[12], such as encapsulation of bioactive 
molecules[13, 14] or cells[15, 16]. Especially, micro- and nanoparticles are suitable 
carriers for controlled delivery of biomolecules[17, 18]. By loading these particles with 
therapeutic[19] or signaling[14] agents, the resulting bulk colloidal gels offer a virtually 
unlimited freedom with respect to their capacity for controlled and sustained delivery 
of bioactive agents to stimulate tissue regeneration[3, 4, 20]. 
Colloidal gels made of oppositely charged gelatin nanospheres have recently been 
developed successfully in our laboratory, which were shown to be cohesive and self 
healing due to the strong cohesive interactions (electrostatic as well as hydrophobic 
interactions) between cationic and anionic nanospheres[10]. Gelatin has several 
benefits as material for colloidal gels since gelatin i) is known for its excellent 
biocompatibility, controllable biodegradability and non-immunogenicity, ii) is cheap 
and commercially available as both cationic (gelatin type A, isoelectric point (IEP) ~9) 
or anionic (gelatin type B, IEP ~5) polymer without the necessity of additional 
functionalization, iii) does not produce harmful by-products upon enzymatic 
degradation, and iv) contains motifs such as RGD sequences which modulate cell 
Chapter 4 
 
79 
 
adhesion. Still, their capacity for controlled delivery of biomolecules has not been 
confirmed yet.  
Gelatin microspheres, on the other hand, are already widely used for controlled 
delivery of several biomolecules because of their biodegradability[21, 22], 
biocompatibility[23], ease of processing[24], gentle gelling behavior[24], and ease of 
incorporation biominerals[25] and biomolecules[26-28]. Especially, positively or 
negatively charged gelatin microspheres enable controlled and sustained release of 
growth factors by forming polyion complexes between charged proteins and 
oppositely charged gelatin carriers[26, 28-30]. Van Tomme et al.[31, 32] already 
demonstrated the feasibility of forming elastic gels using oppositely charged dextran 
microspheres (~10 µm in diameter), but no study has been executed yet on utilizing 
cationic and anionic gelatin microspheres as building blocks for physically crosslinked 
colloidal gels.  
The final goal of the current study was to develop a colloidal gelatin gel with strong 
capacity for controlled delivery of osteogenic growth factors. To this end, the clinical 
handling properties as well as the capacity for drug delivery was studied for colloidal 
gels made of either oppositely charged gelatin microspheres or nanospheres. More 
specifically, the viscoelastic properties, injectability, degradability and capacity for 
release of osteogenic proteins were evaluated for both nano- and micro-structured 
colloidal gelatin gels. We hypothesized that colloidal gels made of nanospheres 
would exhibit advantages with respect to their viscoelastic and drug-releasing 
behavior due to the small particle size and corresponding stronger electrostatic 
interparticle forces[33] as well as larger specific surface area allowing for more 
extensive sorption of drugs.  
To prove our hypothesis, viscoelastic properties of colloidal gels made of gelatin 
micro- vs. nanospheres have been investigated thoroughly using rheological 
characterizations and injectability tests. Further, the capacity of micro- or 
nanosphere-based gels for controlled delivery of biomolecules was investigated by 
studying the release kinetics of two selected osteogenic proteins, i.e. bone 
morphogenetic protein (BMP-2) and alkaline phosphatase (ALP). In vitro protein 
release was measured by labeling the biomolecules with 125I and monitoring their 
release. 
 
 
Chapter 4 
 
80 
 
2. Materials and methods 
2.1. Materials 
Gelatin A (GelA, from porcine skin, 300 Bloom, IEP ~9) and gelatin B (GelB from 
bovine skin, 225 Bloom, IEP ~5) were purchased from Sigma-Aldrich. Glutaraldehyde 
(GA, 25 wt% solution in water) was commercially available from Acros Organics. 
Recombinant human Bone Morphogenetic Protein-2 (BMP-2, carrier-free, catalog 
number: 355BM/CF, Molecular Mass 13 kDa, IEP 8.5) was purchased from R&D 
systems. Alkaline phosphatase (ALP, from bovine intestine, molecular weight ~160 
kDa, IEP 5.7) and all other materials were purchased from Sigma-Aldrich. 
 
2.2. Preparation of gelatin nanospheres and microspheres 
Gelatin nanospheres were prepared using a two-step desolvation method as 
reported previously[10]. Briefly, acetone (100 ml) was added to 100 ml gelatin solution 
(5 w/v%) to precipitate high molecular weight gelatin, after which the supernatant was 
removed, and gelatin was re-dissolved in water at 50 ºC. After adjusting the pH to 2.5, 
300 ml acetone was added dropwise (~2 ml.min-1) into the vigorously stirred (1,000 
rpm) gelatin solution to form gelatin nanospheres. Subsequently, GA was added 
(room temperature) to stabilize gelatin particles with a relatively low GA crosslinking 
density (molar ratios of GA relative to [NH2]gelatin equal to 1), so as to obtain a positive 
and negative charge for GelA and GelB nanospheres, respectively[10]. After 
crosslinking for 16 h, glycine solution (100 mM) was added to the nanosphere 
suspension to quench unreacted aldehyde groups. The suspension was then 
subjected to three cycles of centrifugation (16,100 g for 5 min) and re-suspension in 
deionized water by vortexing, after which the pH of nanosphere suspension was 
adjusted to pH 7.0. After freeze-drying for 24 hr, nanospheres were stored at 4 ºC 
until further use. 
Gelatin microspheres were prepared using a water-in-oil emulsion method adapted 
from Iwanaga et al[34]. Briefly, 10 ml aqueous solution (10 w/v%) of GelA or GelB was 
added dropwise into 300 ml preheated olive oil with constant heating at 50 ºC, and 
stirred using an upper-stirrer at 500 rpm for 15 min. The resultant homogeneous 
emulsion was chilled to induce physical gelation of gelatin droplets. Thereafter, 100 
ml of chilled acetone was added to the emulsion to dehydrate gelatin microspheres, 
which were collected by filtration (Whatman, 90 mm filter paper grade 2), passed 
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through 20-53 micron sieves (Dual Mfg. Co. Chicago, U.S.A), and finally crosslinked 
using GA (room temperature) with the same crosslinking degree as gelatin 
nanospheres (molar ratios GA/[NH2]gelatin equal to 1). After 16 hr of crosslinking, 
glycine solution (100 mM) was added to quench unreacted aldehyde groups. The 
microspheres were washed by being complied to three cycles of centrifugation and 
re-suspension in acetone/water, and finally collected by freeze-drying for 24 hr.  
 
2.3. Characterization of micro- and nanospheres 
The morphology of gelatin micro- and nanospheres was visualized by scanning 
electron microscopy (SEM, JEOL 6301). Particle size was determined by averaging 
diameters of at least 400 particles using digital image analysis software (Leica Qwin®, 
Leica Microsystems AG, Wetzlar, Germany). ζ-potential of gelatin particles was 
measured by laser doppler electrophoresis using a Zetasizer Nano-Z (Malvern 
Instruments Ltd.) by dispersing particles in HEPES buffer (5 mM, pH 7.0). Water 
content of crosslinked micro- and nanospheres was measured according to a method 
previously described by Holland et al. by comparing the weight of gelatin spheres 
before and after complete swelling of gelatin spheres in deionized water[35]. All 
measurements were performed in triplicate. 
The GA crosslinking density of gelatin spheres was quantified by measuring the 
residual amount of free amine groups in crosslinked gelatin using the 2,4,6-
trinitrobenzene sulfonic acid (TNBS) assay. Dried gelatin particles (2-4 mg) were 
reacted with TNBS (0.01 M) in 2 ml NaHCO3 solution (pH 8.5, 4 w/v%) for 2 hr at 40 
ºC, after which 3 ml HCl (6 M) was added to hydrolyze gelatin at 60 ºC for 1.5 hr. 
After cooling to room temperature, sterile deionized water (5 ml) was added and the 
absorbance was measured at λ=420 nm with an ELISA plate reader (EL800, Bio-Tek 
Instruments. Inc.). The concentration of free amine groups per gram of gelatin was 
calculated by preparing a standard curve using glycine, and assuming a molecular 
weight of 100 kDa for a gelatin molecular chain of 1,000 amino acids[36]. The 
crosslinking density as a function of GA/[NH2]gelatin molar ratio was expressed as 
percentage relative to the primary amine concentration of non-crosslinked gelatin. 
 
2.4. Preparation of colloidal gels made of gelatin micro-/nanospheres 
Lyophilized gelatin micro- or nanospheres were dispersed in 1 mM NaCl solution 
(pH7.0) in 2 ml Eppendorf® tubes at various solid contents (5-25 w/v%), and 
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stored at 4 ºC for at least 2 hr to allow for complete swelling of gelatin spheres. 
Dispersions of either similarly (GelA or GelB) or oppositely charged (GelA+B) 
gelatin spheres were prepared. For the latter group, equal amounts of GelA and 
GelB particles were mixed prior to gel formation by mixing with the liquid phase. 
For nano-structured colloidal gels, solid contents lower than 5 w/v% resulted into 
flowable liquid-like materials with tan(delta) values higher than 1, whereas solid 
contents higher than 20 w/v% led to the formation of heterogeneous gels that 
could neither be extruded from syringes nor characterized using rheometry. For 
microspheres, on the contrary, the corresponding upper and lower limits were 10 
and 25 w/v%, respectively. 
 
2.5. Rheological characterizations 
The viscoelastic properties of colloidal gels made of gelatin micro- or nanospheres 
were characterized using a rheometer (AR2000ex, TA Instruments). Oscillatory 
time, frequency and strain sweeps confirmed that all rheological characterizations 
were performed within the linear viscoelastic region (Supplemental data Fig. S1). 
All measurements were performed using a flat steel plate geometry (20 mm 
diameter) at 25 ºC. The storage modulus G’, loss modulus G” and tan(δ) were 
determined using an oscillatory time sweep test for 5 min at a constant strain of 
1% and frequency of 1 Hz. Recovery kinetics of gelatin colloidal gels after 
shearing were evaluated by adopting a method as described by Haines-Butterick 
et al.[37], which mimics the clinical injection procedure (i.e. single gel destruction 
by high shear forces upon extrusion through narrow syringes). Briefly, viscoelastic 
properties (G’ and G’’) of GelA+B micro- or nanosphere-based gels of various 
solid contents (5-25 w/v%) were measured as a function of time in an oscillatory 
time sweep (5 min, 1% strain, 1 Hz frequency) before and after severe destruction 
of the gel network (1000% strain, 1 min, 1 Hz frequency). The recovery of gel 
strength (G’) at 5 min after network destruction was expressed as percentage 
relative to the initial gel strength for the various colloidal gels.  
 
2.6. Injectability test 
The injectability of the colloidal gels made of either oppositely charged micro- or 
nanospheres was tested using a tensile bench (858 MiniBionix2®, MTS, USA). 
Micro- or nanospheres were weighed and mixed with 1 mM NaCl solution (pH 7.0) 
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in 2 ml medical syringes (BD PlastipakTM, orifice diameter of 1.7 mm) to obtain 1 
ml of micro- (25 w/v% solid content) or nano-structured (15 w/v% solid content) 
gels. 25 w/v% GelA+B microsphere-based gels with the highest elasticity for 
micro-structured gels were compared to 15 w/v% GelA+B nanosphere-based gels 
due to the similar gel strength. After storing at 4ºC for 2 hr, the syringe was fixed 
vertically under the plate of the tensile bench set in a compression mode[38]. A 
compressive force was applied to the plunger of the syringe at a constant velocity 
of 10 mm/min, and removed when the plunger reached the nozzle of the syringe 
(or the compressive force exceeded 80 N). The injection force was recorded as a 
function of the plunger travelling time. Additionally, structural integrity of the 
colloidal gels was evaluated by directly injecting the gels into deionized water and 
recording photographs immediately after injection. 
 
2.7. In vitro degradation  
The degradability of colloidal gelatin gels made of micro- or nanospheres was 
evaluated by incubating them in phosphate buffered saline (PBS) solution containing 
collagenase 1A, and measuring total protein release in the supernatant using the 
bicinchoninic acid (BCA) assay at various time points. Colloidal gels with a solid 
content of 20 w/v% were selected since micro-structured gels of solid content ≤15 
w/v% were not sufficiently cohesive to allow for in vitro testing of gel degradability, 
whereas nano-structured gels of solid content ≥25w/v% were structurally 
heterogeneous and not extrudable through syringes. Briefly, 5 mg gelatin spheres 
were mixed with 25 µl 1 mM NaCl solution (pH 7.0) in 1.5 ml Eppendorf® tubes and 
stored at 4 ºC overnight to allow for complete swelling of gelatin. 1 ml of PBS 
containing 400 ng/ml collagenase 1A and 0.001 w/v% sodium azide was then added 
into the tube which was thereafter incubated at 37 ºC on a rotating plate. At each 
time point, 0.9 ml of supernatant was collected for the BCA assay after centrifugation 
(2767 g, 5 min) to separate gelatin particles, and same volume of fresh medium were 
added. To monitor the morphological change of the gels during degradation, micro- 
and nanospheres were collected after washing with deionized water and observed by 
SEM (JEOL 6301) after freeze-drying for 24 hr. 
 
2. 8. In vitro release of osteogenic proteins BMP-2 and ALP 
BMP-2 and ALP were labeled with 125I according to the iodogen method[39]. Brieﬂy, 
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25 µg of BMP-2 (75 µl, 0.337 mg/ml) or ALP (25 µl, 1 mg/ml) was pipetted into a 
100 μg iodogen coated 1.5 ml Eppendorf® vial together with 10 μl of 125I 
(radioactivity = 1000 µCi, Perkin-Elmer, Boston, MA). The final volume was 
adjusted to 100 μl with 0.5 M phosphate buffer, pH 7.0. The tube was then 
incubated at room temperature for 10 min to allow for completion of the reaction. 
Subsequently, 100 μl of saturated tyrosine solution in PBS was added to react 
with the nonbound 125I. The reaction mixture was then eluted with 0.5% BSA in 1 
mM NaCl (pH 7.0) solution on a prerinsed disposable Sephadex G25M column 
(PD-10; Pharmacia, Uppsala, Sweden). The reaction mixture was eluted and 500 
μl fractions were collected. The fraction with the highest radioactivity was used for 
further studies. The radiochemical purity of the 125I-labeled proteins was 
determined by instant thin layer chromatography (ITLC) on Gelman ITLC-SG 
strips (Gelman Laboratories, Ann Arbor, MI, USA) with 0.1 M citrate, pH 5.0 as the 
mobile phase. The radiochemical purity of BMP-2 and ALP was 97% and 93.5%, 
respectively. The solution containing the radiolabeled proteins were further diluted 
to a concentration of 12 µg/ml. 
Radiolabeled BMP-2 and ALP were loaded onto gelatin spheres by diffusional 
loading by directly mixing protein-containing solutions with lyophilized gelatin 
particles. To ensure complete sorption of biomolecules by gelatin, less volume of 
liquid than required for complete swelling of gelatin spheres was used. The dose of 
both proteins loaded by gelatin was 60 ng per mg gelatin particles[28]. Briefly, 5 mg of 
gelatin spheres were mixed in a 1.5 ml Eppendorf® tube with 25 µl of the solutions 
containing 12 µg/ml 125I-labeled BMP-2 or ALP, obtaining colloidal gels with a solid 
content of 20 w/v%. The mixtures were stored at 4 ºC overnight to allow for complete 
sorption of osteogenic proteins. 1 ml PBS containing 400 ng/ml collagenase 1A and 
0.001 w/v% sodium azide was added to the tube and then incubated at 37 ºC on a 
rotating plate (70 rpm). At each time point, 0.9 ml of supernatant was refreshed with 
the same volume of medium after centrifugation (2767 g, 5min) to sediment the 
gelatin spheres. The release of BMP-2 and ALP at each time point was monitored by 
measuring the residual γ-irradiation from the gelatin samples using a gamma counter 
after refreshing the supernatant media. Consequently, the cumulative release of 
BMP-2 or ALP was determined by normalizing radioactivity at each time point with 
starting radioactivity of each sample. The decay of I125 was taken into account by 
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recording the remaining radioactivity of labeled proteins without loading to gelatin 
spheres. 
 
2.9. Statistics 
Measurements for rheological and injection tests were performed three-fold (n=3), 
while measurements for in vitro degradation and release study were performed 
fourfold (n=4). The results were depicted as average ± standard deviation. The 
statistical analyses were performed using GraphPad InStat software. Differences 
among groups were determined by one-way Analysis of Variance (ANOVA) with a 
Tukey (multiple comparisons) post test, and a value of p < 0.05 was considered as 
significantly different. 
Table 1. Characteristics of lyophilized gelatin micro- and nanospheres. 
Characteristics Microsphere Nanosphere 
GelA GelB GelA GelB 
Particle size 26±6µm 26±5µm 198±41nm 148±28 nm 
ζ-potential (mV) n/a n/a +9.3±0.3 -20.0±0.4 
Water content (%) 80.1±1.9 75.0±1.3 89.2±0.4 87.1±0.5 
Crosslinking density (%) 48.1±2.6 41.3±1.7 41.0±2.7 44.9±6.0 
 
3. Results 
3.1. Characteristics of gelatin micro- and nanospheres 
Gelatin microspheres (average diameter of about 26 μm) were about hundred-fold 
larger than gelatin nanospheres (average diameter of 150-200 nm) (Fig. 1 and Table 
1). GelA and GelB microspheres were of similar size, but GelA nanospheres were 
bigger than GelB nanospheres (Table 1). ζ-potential measurements confirmed the 
positive and negative charge of GelA and GelB nanospheres, respectively, whereas 
the charge of microspheres was not measurable using laser Doppler electrophoresis 
due to rapid sedimentation of microspheres in suspension.  
The GA crosslinking process (with a fixed molar ratio of GA to [NH2]gelatin equal to 1) 
consumed similar amounts of free amine groups for both GelA and GelB micro- or 
nanospheres, since comparable crosslinking densities were observed ranging from 
40-50%. At similar crosslinking densities, nanospheres exhibited significantly higher 
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water contents than microspheres. This enhanced water uptake by nanospheres can 
be explained by their exceptionally small size and corresponding large surface area 
that allows for more ab- and adsorption of water inside the nanospheres as well as 
water entrapment in the pores formed between nanospheres. 
 
Figure 1. SEM images of lyophilized GelA (A, C) and GelB (B, D) micro- (A, B) and 
nanospheres (C, D). 
 
Figure 2. Elastic modulus G’ (A) and tan(δ) (B) of colloidal dispersions in 1 mM NaCl solution 
(pH 7.0) comprising similarly (GelA or GelB) or oppositely (GelA+B) charged micro- (MS) or 
nanospheres (NS) as a function of solid content. Microsphere dispersions of 5 w/v% solid 
content were excluded since these dispersions behaved as highly flowable liquid-like 
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materials, whereas nanosphere dispersions of 25 w/v% solid content were excluded due to 
the difficulty to form homogeneous gels at such high solid content. 
3.2. Viscoelasticity and injectability 
Viscoelastic properties of micro- and nanosphere-based colloidal gels were 
investigated by rheology. As shown in Fig. 2, the viscoelasticity of micro- or 
nanospheres dispersions in 1 mM NaCl was evaluated by measuring the elastic 
modulus (G’) and tan(δ) value as a function of solid content using oscillatory time 
sweeps measurement. In general, elastic moduli G’ strongly increased with 
increasing solid content for both gelatin micro- and nanosphere dispersions (Fig. 2A). 
At the same solid content, nanosphere-based gels were more elastic than 
microsphere-based gels by a factor of about 100. 
 
Figure 3. (A) Representative rheological profile of gel recovery measurement after network 
destruction of colloidal gels composed of oppositely charged micro- (MS) and nanospheres 
(NS). G’ and G” were monitored as a function of time: regions I, II and III show initial gel 
strength, gel destruction and gel recovery, respectively. 25 w/v% GelA+B microsphere-based 
gels with the highest initial gel strength for micro-structured gels were compared to 15 w/v% 
GelA+B nanosphere-based colloidal gels, since these gels exhibited similar initial storage 
moduli (G’). (B) Percentage of gel recovery within 5min after destruction for micro- and nano-
structured colloidal gels with various solid content (5-25 w/v%). 
 
For nanospheres, solid-like colloidal gels were formed in all tested groups as 
evidenced by tan(δ) values < 1, except for 5 w/v% nanosphere dispersions 
containing similarly charged GelB nanospheres. Especially for dispersions with solid 
content > 5 w/v%, highly elastic gels were formed, as evidenced by tan(δ) < 0.1 and 
G’ > 0.4 kPa. Moreover, the binary mixture of oppositely charged gelatin 
nanospheres (GelA+B) showed significantly higher G’ values than colloidal gels of 
similarly charged nanospheres (GelA or GelB), indicating the formation of 
electrostatic attractions between cationic and anionic nanospheres[10]. In general, gel 
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containing similarly charged GelB nanospheres. Especially for dispersions with solid 
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G’ > 0.4 kPa. Moreover, the binary mixture of oppositely charged gelatin 
nanospheres (GelA+B) showed significantly higher G’ values than colloidal gels of 
similarly charged nanospheres (GelA or GelB), indicating the formation of 
electrostatic attractions between cationic and anionic nanospheres[10]. In general, gel 
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elasticity of nanosphere-based gels was as follows: GelA+B > GelA > GelB. These 
differences, however, became less pronounced with increasing the solid content, 
which was related to interparticle cohesions such as hydrophobic interactions starting 
to dominate the reinforcing contribution of electrostatic interactions to the gel strength.   
 
Figure 4. (A) Injectability of GelA+B micro- (MS, 25w/v% solid content) and nanosphere-
based (NS, 15 w/v% solid content) gels. (B) Photographs of MS (left) and NS-based (right) 
gels after the injection test. (C, D) Photographs of MS (C) and NS-based (D) gels after being 
injected into deionized water. Nanosphere-based gels with 15 w/v% solid content were 
compared with microsphere-based gels with 25 w/v% solid content due to their similar initial 
gel strength. 
 
In contrast, with solid content > 10 w/v%, microsphere dispersions also started to 
display gel-like behavior characterized by tan(δ) values < 1. It was observed that no 
significant differences in G’ were found between colloidal gels made of similarly 
(GelA or GelB) or oppositely (GelA+B) charged microspheres, suggesting that 
electrostatic interactions between microspheres were negligible. 
To compare the injectability of micro- and nano-structured colloidal gelatin gels, a 
rheological method was adopted to mimic the clinic injection procedure. As shown in 
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Fig. 3A, both gels displayed much higher G’ than G” in region I, indicating the 
formation of elastic, solid-like materials. Subsequently, the gel network was 
destructed by applying a destructive shear strain (1000% for 1 min), which resulted 
into the transformation of elastic to liquid-like behavior (G’ < G” in region II), thus 
allowing for extrusion through syringes. Upon removal of the external shear stress, G’ 
of nanosphere gels restored instantaneously up to ~60% of initial gel strength within 
5 seconds, and more than 80% within 5 min. This self-healing behavior after shearing, 
however, was not observed for microsphere gels, which showed less than 5 % of gel 
strength recovery within 5 min after network destruction. The percentage of gel 
recovery for both micro- and nano-structured colloidal gels with solid contents 
ranging between 5-25 w/v% was depicted in Fig. 3B, which clearly shows that all 
nanosphere-based gels showed self-healing behavior for all solid contents (>50% 
recovery of gel elasticity within 5min) whereas none of the microsphere-based 
colloidal gels was self-healing (<10% recovery of gel elasticity). 
A representative measurement of the compressive force as a function of time during 
injection is given in Fig. 4, which showed that nanosphere-based gels can be easily 
extruded using syringes with < 10 N compression force until the plunger reached the 
nozzle as evidenced by a sharp increase of the injection force. Additionally, 
homogeneous cohesive gel-threads were formed upon injection of nanosphere-
based gels from the syringe (Fig. 4B right), which still retained their noodle-like shape 
after injection into water (Fig. 4D). In contrast, upon injection of microsphere-based 
gels the compressive force gradually increased during 80 seconds, followed by a 
rapid force increase form <10 N to >80 N within ~50 s, at which point the plunger of 
syringe started to deform due to the high compression force. This so-called filter-
pressing phenomenon[40] involves expulsion of the water phase from the tightly 
packed microspheres and stresses that microsphere-based gels cannot be 
completely extruded from syringes as reflected by the remaining presence of 
microspheres in the syringe after completion of the compression test (Fig. 4B left). 
Furthermore, the microsphere-based gels disintegrated immediately after being 
injected into deionized water. 
 
3.3. In vitro degradation 
Degradation profiles of micro- versus nano-structured colloidal gelatin gels are given 
in Fig. 5 which reveals linear degradation profiles for both micro- and nanospheres. 
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3.3. In vitro degradation 
Degradation profiles of micro- versus nano-structured colloidal gelatin gels are given 
in Fig. 5 which reveals linear degradation profiles for both micro- and nanospheres. 
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Gelatin nanospheres showed much faster degradation, with more than 70% of gelatin 
degradation after 4 weeks, as opposed to <12% of gelatin degradation for 
microspheres. Moreover, GelB degraded faster than GelA with ~12% of GelB 
microspheres degraded after 4 weeks as opposed to 3% degradation for GelA 
microspheres. These differences between the two types of gelatin were not observed 
for nanospheres made of GelA and GelB. Furthermore, no significant difference in 
cumulative degradation of similarly (GelA or GelB) or oppositely charged (GelA+B) 
micro- and nanosphere-based gels was detected during the enzymatic degradation 
of gelatin. 
 
Figure 5. Cumulative in vitro degradation profiles of colloidal gels made of similarly (GelA or 
GelB) or oppositely (GelA+B) charged micro- (MS) or nanospheres (NS), which were 
incubated in collagenase-containing PBS to induce enzymatic degradation of gelatin. 
SEM images provided additional visual information on the process of enzymatic 
degradation of gelatin micro- and nanospheres (Fig. 6). Degradation of GelA and 
GelB microspheres after 2 weeks was hardly visible, which confirmed the slow 
degradation rate of gelatin microspheres as measured by means of the BCA assay. 
Microsphere degradation became noticeable after 4 weeks only, with obvious surface 
erosion for both GelA and GelB microspheres (Fig. 6 I and J). In contrast, obvious 
morphological changes were observed for nanospheres after 1 week, since both 
GelA and GelB nanospheres started to fuse together with the neighboring particles 
and form an interconnected structure (Fig. 6C and D). These integral constructs also 
experienced a surface erosion process, as evidenced by the loss of sphericity of 
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GelB nanospheres after 2 week incubation (Fig. 6H). Especially, continuous 
degradation of GelB nanosphere-based gels resulted into loss of the nano-structure 
and the formation of irregularly-shaped integral constructs (Fig. 6L).  
 
Figure 6. Representative SEM images of GelA or GelB micro- (MS) and nanospheres (NS) 
after 1 (A-D), 2 (E-H) and 4 (I-L) weeks of in vitro degradation. Scale bar for images of 
microspheres is 10µm, for nanospheres 1µm. 
 
Figure 7. Cumulative BMP-2 release from colloidal gels made of similarly (GelA or GelB) or 
oppositely (GelA+B) charged micro- (MS) or nanosphere-based (NS). 
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3.4. In vitro release of osteogenic proteins 
The kinetics of the release of osteogenic proteins from gelatin micro- and 
nanospheres were monitored by loading radiolabeled BMP-2 and ALP to colloidal 
gels of various composition (GelA, GelB or GelA+B). The BMP-2 release patterns are 
given in Fig. 7, which revealed considerably different release profiles for gelatin 
micro- and nanosphere-based colloidal gels. Overall, BMP-2 release was 
considerably faster for nanosphere- than for microsphere-based gels, with ~90% of 
BMP-2 release for nano-structured gels after 4 weeks, as opposed to 60-65% release 
for micro-structured gels. The release profiles from microspheres consisted of a 
moderate 30-35% burst release after 24 hrs followed by a plateau release phase with 
a relatively slow release rate. On the contrary, BMP-2 release from nanosphere-
based gels displayed nearly zero-order release kinetics after the initial burst release 
of 25-27%. Moreover, the overall BMP-2 release from microsphere-based gels 
decreased from GelA > GelB > GelA+B, while the differences in BMP-2 release from 
colloidal gels made of similarly (GelA or GelB) or oppositely charged (GelA+B) 
nanospheres were negligible. 
 
Figure 8. Cumulative ALP release from colloidal gels made of similarly (GelA or GelB) or 
oppositely (GelA+B) charged micro- (MS) or nanosphere-based (NS). 
We further tested the release of a much larger osteogenic protein ALP from gelatin 
micro- and nanospheres. As shown in Fig. 8, ALP release followed a completely 
different pattern compared to BMP-2 characterized by a much more pronounced 
burst release (~70% ALP) for both micro- and nano-structured gelatin gels. It is 
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noteworthy that the size of gelatin spheres and gelatin composition in colloidal gels 
had much less influence on ALP release in comparison to BMP-2 release.  
 
4. Discussion 
The goal of this study was to investigate the viscoelastic and biological properties of 
colloidal gelatin gels made of micro- or nanospheres. Comparisons were performed 
between micro or nano-structured colloidal gelatin gels and between colloidal gels 
made of similarly (GelA and GelB) or oppositely charged (GelA+B) gelatin spheres.  
The viscoelasticity and injectability of micro- and nanosphere-based colloidal gels 
were studied using rheology and injection tests. Overall, colloidal gels based on 
nanospheres exhibited properties superior to microsphere-based gels in terms of gel 
elasticity, injectability, gel integrity, and self-healing properties after network 
destruction. This can be explained by three phenomena. First, the exceptionally small 
particle size and corresponding large surface area of nanospheres allow for an 
increased number of connections with neighboring particles and the formation of a 
densely packed particulate network, thereby increasing the number and strength of 
interparticle bonds based on hydrophobic and/or electrostatic interaction forces. 
Second, the formation of electrostatic interactions between oppositely charged 
nanospheres further stabilized the colloidal gels, as evidenced by the considerably 
higher G’ values observed for GelA+B gels compared to gels made of either GelA or 
GelB nanospheres (Fig. 2A). On the contrary, electrostatic interactions between GelA 
and GelB microspheres were negligible, as suggested by the absence of significant 
difference in G’ between oppositely and similarly charged microsphere-based gels. 
This difference can be explained by the Derjaguin-Landau-Verwey-Overbeek (DLVO) 
theory which describes that the screened Coulombic interaction potential[33, 41] 
dramatically decreases with increasing particle size, thus resulting in insufficient 
interparticle forces to induce self-assembly of microspheres at diluted conditions and 
formation of elastic gel networks at higher solid content. Last, the deformable nature 
of water-swollen gelatin spheres further increased the resistance to shear 
deformation of the colloidal gels owing to the increased intimate contact between the 
gelatin nanospheres[7]. Similarly charged GelA nanosphere-based gels were more 
elastic than gels made of GelB nanospheres which can be attributed to the higher 
Bloom number and corresponding average molecular weight as well as stiffness of 
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GelA than GelB[24], as well as the larger particles size and lower ζ-potential value of 
GelA vs. GelB nanospheres (Table 1), which reduced the repulsive electrostatic 
forces between similarly charged particles. 
A critical concern with respect to injecting particle-based colloidal gels into target 
tissues is related to dislocation of particles by external mechanical deformation, most 
likely due to the lack of structural integrity resulting from weak interparticle forces[7, 14]. 
Previous studies on the use of gelatin microspheres for growth factor delivery in 
regenerative medicine showed positive in vitro and in vivo results[17, 18], but the 
possibility of dislocation of particulate building blocks from the target tissue was not 
addressed. Therefore, in the present study, the injectability of colloidal gelatin gels 
consisting of oppositely charged gelatin spheres was studied in more detail by 
investigating the retention of structural integrity after injection. Rapid recovery of gel 
strength after network destruction was observed in nanosphere-based gels, which 
was caused by the fast and reversible re-establishment of the non-covalent 
electrostatic and hydrophobic interactions between oppositely charged nanospheres 
as well as rapid re-arrangement of nanosphere packing upon gel equilibration[10, 11, 42]. 
The physical crosslinking mechanism of nano-structured colloidal gelatin gels allowed 
for the formation of homogeneous gel threads upon injection from conventional 
medical syringes, which retained their structural integrity after injection into deionized 
water (Fig. 4). In contrast, microsphere-based gels hardly recovered after shearing, 
confirming the negligible cohesion between cationic and ionic gelatin microspheres 
owing to their much larger particle size and lower specific surface area. The lack of 
sufficiently attractive interactions between microspheres led to the loss of gel integrity 
and rapid disintegration and dislocation of microspheres after injection into water (Fig. 
4). Additionally, the injection process of microsphere-based gels showed a filter-
pressing effect due to the high flowability of the liquid phase through the pores 
formed by the tightly packed microsphere network[43], which was not observed for 
nano-structured gels due to the nano-sized pores that reduced free flow of liquid. 
These results stress that colloidal gels made of gelatin nanospheres are much more 
suitable for use as injectable formulation in regenerative medicine than gels made of 
gelatin microspheres. 
The in vitro degradation of the colloidal gelatin gels revealed more than 10-times 
faster degradation profiles for nanosphere-based gels than microspheres. Moreover, 
both gelatin micro- and nanospheres underwent a surface-erosion process, probably 
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resulting from the limited permeability of enzymes to the interior of gelatin spheres. 
Bearing this in mind, the faster degradation of nanospheres can be explained by the 
considerably large specific surface area available for enzymatic degradation. Aside 
from particle size, the types of gelatin also influenced the degradation profiles of the 
particle-based gels. GelA spheres showed more resistance against enzymatic 
degradation than GelB spheres, primarily resulting from the higher Bloom number of 
GelA vs. GelB[24]. Moreover, the mixtures of oppositely charged gelatin spheres 
(GelA+B) did not improve the colloidal stability compared to gels made of similarly 
charged spheres (GelA or GelB), which indicated that the physically crosslinked 
particle-based network based on strong interparticle forces did not increase the 
resistance to enzymatic degradation.  
 
Figure 9. Correlation between degradation of and BMP-2 release from colloidal gels made of 
oppositely charged nano- (A) or microspheres (B). 
A particular advantage of gelatin micro- and nanospheres for controlled release of 
biomolecules is their capacity to control release kinetics by fine-tuning the 
degradability of gelatin carriers[26]. Here, we also found a strong correlation between 
the release profiles of BMP-2 from the spherical gelatin carriers and the 
corresponding degradation profiles of the gelatin carriers. For nanosphere-based 
gels, BMP-2 release exhibited nearly zero-order kinetics excluding the burst release 
phase, which revealed a good correlation with the degradation profiles of 
nanosphere-based gels, as exemplified by the identical slopes of the degradation 
and release profiles (Fig. 9A). The correlation between BMP-2 release profiles and 
gelatin degradation profiles for microspheres was less evident since protein release 
proceeded at a faster rate than gelatin degradation (Fig. 9B). Summarizing, BMP-2 
release from nanosphere-based gels followed a degradation-controlled mechanism, 
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whereas release from microsphere-based colloidal gels was modulated by a 
combination of gelatin degradation and biomolecule diffusion[44-46]. Due to the poor 
structural integrity, microsphere-based gels behaved similar to individual particles, 
from which proteins released by diffusion and gradual degradation of the carriers. On 
the contrary, nanosphere-based gels showed properties more similar to integral 
scaffolds, because of the strong interparticle forces that can entrap proteins in the 
nanopores between tightly packed nanospheres after biomolecules diffusion from 
nanospheres, thus acting as a buffer against free biomolecule diffusion[47]. On the 
other hand, ALP showed substantially different release kinetics compared to BMP-2 
release, which followed a desorption-controlled manner consisting of a high burst 
release phase, followed by very limited protein release[48]. This is most likely related 
to the much larger size of ALP (~160 kDa) proteins compared to BMP-2 (13 kDa), 
which exceeds the mesh size of gelatin hydrogels[36] and inhibits penetration of ALP 
into the interior of gelatin spheres to form polyion complexes with gelatin. The burst 
release of ALP during the initial period, irrespective of the particle size of gelatin 
spheres and types of gelatin, can be attributed to a loss of unbound or surface-
adsorbed ALP molecules. These observations stress that the colloidal gelatin gels as 
tested in the current study are not suitable for sustained delivery of large therapeutic 
proteins such as ALP due to a lack of binding to gelatin nano- or microspheres.  
In summary, the current study has shown that the use of gelatin nanospheres has 
three main advantages with respect to drug delivery. First, the use of gelatin 
nanospheres instead of microspheres resulted into reduced burst release due to the 
higher specific surface area of nanospheres, thus facilitating stronger binding of e.g. 
growth factors to oppositely charged gelatin nanospheres by polyion complexation. 
Second, the stronger interparticle forces between nanospheres as compared to 
microspheres resulted into colloidal gels with improved cohesion and confinement to 
the target site of application, thereby reducing the possibility of dislocation of spheres 
and corresponding leakage of growth factors. Third, the correlation between 
degradation and BMP-2 release was stronger for nanospheres compared to 
microspheres, which suggests that the control over drug release can be higher for 
nanospheres than microspheres. In addition, it was shown in vitro that degradation 
rates and corresponding drug release profiles of gelatin spheres strongly depended 
on the diameter of the micro- vs. nanospheres rather than the type of gelatin. 
Therefore, the optimal particle size for drug delivery from gelatin spheres still needs 
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to be established for specific clinical indications that require either short-term or long-
term release. 
 
5. Conclusions 
Colloidal gels made of gelatin nanospheres displayed a superior performance over 
microsphere-based gels in terms of gel elasticity, injectability, self-healing capacity 
after network destruction, and capacity for sustained protein release. BMP-2 was 
released in a sustained manner from nano-structured colloidal gelatin gels at rates 
that strongly correlated with the degradation rate of the gelatin nanospheres, 
confirming that release kinetics of biomolecules can be controlled by fine-tuning the 
degradability of gelatin nanospheres. In contrast, microsphere-based gels exhibited a 
much lower gel strength, poor injectability and capacity for self-healing after 
destructive shearing, resulting from insufficiently strong interactions between gelatin 
microspheres. Regarding BMP-2 release, both micro- and nano-structured colloidal 
gels were shown to be suitable for controlled and sustained release of BMP-2. Since 
sphere degradation and delivery rate of BMP-2 were found to be strongly dependent 
on the diameter of the gelatin spheres, the optimal particle size for drug delivery 
needs to be established for specific clinical indications that require either short-term 
or long-term release. In general, colloidal gels made of gelatin nanospheres have 
great potential for use as injectable formulation for sustained protein delivery. 
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Supplemental data 
 
Figure S1. Oscillatory time (A), frequency (B), strain (C, D) sweep of GelA+B micro- (MS) 
and nanosphere-based gels (NS) with different solid content (10 and 20 w/v% solid content). 
(A) Storage modulus G’ (dense symbols) and loss modulus G” (open symbols) were 
measured with 1% strain and 1Hz frequency. Frequency sweep (B) was performed at 1% 
strain with increasing frequency, and strain sweep (C, D) was performed at 1Hz frequency 
with increasing strain. 
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1. Introduction 
During the process of bone regeneration, a multitude of morphogenetic signaling 
factors regulate cellular behavior and ultimately tissue response. Growth factors (GFs) 
are presented to cells under strong spatial and temporal control, which stresses the 
relevance of spatiotemporally controlled delivery of multiple factors for bone tissue 
regeneration. The development of biomaterials that are capable of such 
spatiotemporal control over delivery and bioactivity of multiple GFs is considered as 
one of the most challenging topics in regenerative medicine[1-4]. A recent study on the 
clinical efficacy of GF delivery emphasized that serious clinical complications may 
arise from poorly controlled delivery of the osteogenic growth factor bone 
morphogenetic protein-2 (BMP-2) from a simple collagen sponge[5]. The poor 
performance of the collagen sponge necessitated (over)dosing of BMP-2 resulting 
into bone tissue overgrowth, ectopic bone formation, retrograde ejaculation, airway 
obstruction, inflammation and even carcinogenicity. The disappointing performance 
of conventional carrier materials stresses the need for a novel generation of carrier 
materials with improved control over delivery of GFs. 
Compared to other carrier systems such as ceramics and non-hydrated polymers[4, 6], 
hydrogels are ideal candidates since they are generally biocompatible, biodegradable, 
and in most cases, injectable[7-10]. In addition, polymeric hydrogels can act as 
reservoir for sustained release of therapeutic and signaling agents. Nevertheless, 
current hydrogel-based carrier materials exhibit a rather poor ability to present 
multiple signaling molecules at programmed time-points and release rates. Colloidal 
gels, on the other hand, have recently emerged as a promising “bottom-up” strategy 
for design and fabrication of multifunctional scaffolds with strong capacity for 
programmed delivery of biomolecules[11-21]. Colloidal gels typically employ polymer 
micro- and nanoparticles as building blocks to assemble into cohesive macroscopic 
scaffolds. Due to the use of small building blocks, colloidal gels possess several 
advantages over conventional monolithic hydrogels including i) enhanced control 
over the properties of macroscopic scaffolds by fine-tuning the characteristics of sub-
populations of particulate building blocks[11-13], ii) injectability/moldability allowing for 
optimal filling of irregularly shaped defects using minimally invasive approaches[15, 17, 
22], iii) in situ gel formation without using the potentially cytotoxic gelling/crosslinking 
agents to trigger gelation[11-13], iv) the ease of incorporation of therapeutic agents[16, 
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23], and v) the high responsiveness to external stimuli such as pH and temperature[11, 
13]. 
Our laboratory recently developed colloidal gels made of oppositely charged gelatin 
nanospheres which were elastic and self-healing after gel network destruction due to 
reversible non-covalent cohesive interactions (i.e. electrostatic and hydrophobic 
interactions) between the nanospheres[15]. More importantly, these colloidal gelatin 
gels were shown to be suitable carriers for controlled and sustained delivery of GFs 
by fine-tuning the crosslinking density of gelatin nanospheres[23]. 
BMP-2 is the most potent growth factor for bone regeneration by stimulating the 
migration of mesenchymal stem cells and their differentiation into osteoblasts[24-26]. In 
addition to osteogenic GFs, angiogenic growth factors are also necessary since neo-
vascularization at early stages of wound healing is necessary to allow for transport of 
mesenchymal stem cells and supply of oxygen and nutrients[27, 28]. Basic fibroblast 
growth factor (bFGF) is a well-known angiogenic factor which also exerts stimulatory 
effects on migration and proliferation of various types of cells such as vascular cells 
and osteoblasts. Basic FGF has therefore been recognized as an important GF in the 
process of bone fracture healing[29-32]. Enhanced bone regeneration was reported for 
combined treatment of BMP-2 and bFGF in comparison to the single use of either 
BMP-2 or bFGF[33-37]. However, in the majority of the studies dealing with combined 
delivery of BMP-2 and bFGF, the release kinetics of both GFs has not been studied 
in detail, thereby neglecting the fact that GFs are expressed sequentially during bone 
healing[28]. In addition, since GFs were delivered using simple strategies such as 
bolus administration or surface-adsorption of GF onto carriers, the control over 
release was generally low as characterized by e.g. burst release effects[33-37]. 
Therefore, the current study aimed to improve the control over dual delivery of both 
osteogenic and angiogenic growth factors by exploiting the inherent capacity of 
colloidal gels for programmed drug delivery. The particulate nature of colloidal gels is 
highly suitable for delivery of multiple biomolecules at mutually independent release 
rates, since degradation kinetics of sub-populations of particulate building blocks can 
be controlled to desire. Surprisingly, however, dual release from a single colloidal gel 
has never been reported before in vitro or in vivo. We hypothesized that i) release 
kinetics of BMP-2 and bFGF could be controlled independently by incorporating 
separate GFs into sub-populations of gelatin nanospheres of different crosslinking 
density and type of gelatin (Fig. 1A), and ii) dual delivery of BMP-2 and bFGF would 
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has never been reported before in vitro or in vivo. We hypothesized that i) release 
kinetics of BMP-2 and bFGF could be controlled independently by incorporating 
separate GFs into sub-populations of gelatin nanospheres of different crosslinking 
density and type of gelatin (Fig. 1A), and ii) dual delivery of BMP-2 and bFGF would 
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induce synergistic effects on bone regeneration by fast delivery of bFGF (to induce 
angiogenesis and proliferation of osteoprogenitor cells to expand the pool of 
osteoblasts) and slow yet sustained release of BMP-2 (to ensure long-term 
stimulation of osteogenesis). 
To prove our hypothesis, we first investigated the kinetics of both single delivery 
(either BMP-2 or bFGF) as well as dual delivery (both BMP-2 and bFGF) from 
colloidal gels composed of nanospheres of different crosslinking density and type of 
gelatin by using radiolabeled GFs. Second, the effects of either single or dual delivery 
of BMP-2 and bFGF on bone regeneration were also tested in vivo using an 
implantation model rat femoral condyles. 
 
2. Materials and methods 
2.1. Materials 
Gelatin A (GelA, from porcine skin, 300 Bloom, isoelectric point (IEP) ~9) and gelatin 
B (GelB from bovine skin, 225 Bloom, IEP ~5) were purchased from Sigma-Aldrich. 
Glutaraldehyde (GA, 25 wt% solution in water) was commercially available from 
Acros Organics. Recombinant human Bone Morphogenetic Protein-2 (BMP-2, 
carrier-free, catalogue number 355BM/CF, molecular mass 13 kDa, isoelectric point 
(IEP) 8.5) and Recombinant human basic Fibroblast Growth Factor (bFGF, 146 aa, 
carrier-free, catalogue number 233FB/CF, molecular mass 16 kDa, IEP 9.6) were 
supplied by R&D Systems. All other materials were purchased from Sigma-Aldrich. 
 
2.2. Preparation and characterization of gelatin nanospheres 
Gelatin nanospheres were prepared using a two-step desolvation method as 
reported previously[15]. Briefly, acetone (100 ml) was added to 100 ml gelatin solution 
(5 w/v%) to precipitate high molecular weight gelatin, after which the supernatant was 
removed, and gelatin was re-dissolved in water at 50 °C. After adjusting the pH to 2.5, 
300 ml acetone was added dropwise (~2 ml/min) into the vigorously stirred (1,000 
rpm) gelatin solution to form gelatin nanospheres. Subsequently, GA was added 
(room temperature) to stabilize gelatin particles with a low or high GA crosslinking 
degree (defined as the molar ratios of GA relative to [NH2]gelatin of 1 or 4, 
respectively)[15]. After crosslinking for 16 h, glycine solution (100 mM) was added to 
the nanosphere suspension to block unreacted aldehyde groups. The suspension 
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was then subjected to three cycles of centrifugation (16,100 g for 5 min) and re-
suspension in deionized water by vortexing, after which the pH of nanosphere 
suspension was adjusted to pH 7.0. After freeze-drying for 24 hr, nanospheres were 
stored at 4 °C until further use. 
Dynamic light scattering (DLS, Zetasizer Nano-S, Malvern Instruments Ltd.) was 
used to measure the particle size of gelatin nanospheres. ζ-potential of gelatin 
nanospheres was measured by laser doppler electrophoresis using a Zetasizer 
Nano-Z (Malvern Instruments Ltd.) by dispersing particles in HEPES buffer (5 mM, 
pH 7.0). Water content of crosslinked nanospheres was measured according to a 
method previously described by Holland et al. by comparing the weight of gelatin 
spheres before and after complete swelling of gelatin spheres in deionized water[38]. 
The GA crosslinking density of gelatin nanospheres was quantified by measuring the 
residual amount of free amine groups in crosslinked gelatin using the 2,4,6-
trinitrobenzene sulfonic acid (TNBS) assay, which was described in detail 
previously[39]. All measurements were performed in triplicate. 
 
2.3. Preparation and rheological characterization of colloidal gelatin gels 
Lyophilized gelatin nanospheres were mixed with aqueous solution (1mM NaCl, 
pH7.0) with or without soluble GF to obtain homogeneous gels with a solid content 
of 20 w/v%, which were afterwards stored at 4 °C ovrnight to allow for complete 
swelling of gelatin nanospheres. All colloidal gels consisted of equal amounts of 
cationic (gelA) and anionic (GelB) nanospheres.  
The viscoelastic properties of colloidal gelatin gels were characterized using a 
rheometer (AR2000ex, TA Instruments). All measurements were performed within 
the linear viscoelastic region using a flat steel plate geometry (20 mm diameter) at 
25 °C. The self-healing behavior of colloidal gelatin gels after network destruction 
was evaluated according to a method adapted from previous studies[15, 40] which 
mimics the clinical injection procedure (i.e. gel destruction by high shear forces 
upon extrusion through narrow syringes). Briefly, viscoelastic properties (G’ and 
G’’) of the colloidal gels (20 w/v% solid content) were monitored in an oscillatory 
time sweep (5 min, 1 % strain, 1 Hz frequency) before and after disruption of the 
colloidal gel network using a highly destructive external shear (1000 % strain, 1 
min, 1 Hz frequency).This gel destruction-recovery procedure was performed 
three times to study the effect of repeated gel network destruction.  
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2.4. In vitro degradation 
The degradability of colloidal gels made of GelA or GelB nanospheres of low or high 
crosslinking density was evaluated in vitro using a method reported previously[23]. To 
this end, gels were incubated in phosphate buffered saline (PBS) containing 
collagenase 1A, and total protein release was measured in the supernatant using the 
bicinchoninic acid (BCA) assay at various time points. Briefly, 5 mg gelatin 
nanospheres were mixed with 25 µl 1 mM NaCl solution (pH 7.0) in 2 ml Eppendorf® 
tubes to obtain homogeneous colloidal gels (20 w/v% solid content), which were 
subsequently stored at 4 °C overnight to allow for complete swelling of gelatin. 1 ml 
of PBS containing 400 ng/ml collagenase 1A and 0.001 w/v% sodium azide was then 
added into the tube which was thereafter incubated at 37 °C on a rotating plate. At 
each time point, 0.9 ml of supernatant was collected for the BCA assay after 
centrifugation (2767 g, 5 min) to separate gelatin particles, and the same volume of 
fresh medium were added afterwards. 
 
Figure 1. Schematic (A) and experimental (B) representation of the preparation of dual GF-
loaded colloidal gels (20 w/v% solid content) made of oppositely charged gelatin 
nanospheres (NSs) using a twin-syringe. 
2.5. In vitro growth factor release 
2.5.1. Radioiodination of growth factors 
BMP-2 and bFGF were labeled with 125I and 131I, respectively, according to the 
iodogen method[41]. Brieﬂy, 25 µg of BMP-2 (75 µl, 0.337 mg/ml) or 5 µl bFGF (1 
mg/ml) was pipetted into a 1.5 ml Eppendorf® vial coated with 100 μg iodogen 
together with 10 μl of 125I or 131I (radioactivity = 1000 µCi, Perkin-Elmer, Boston, 
MA). The final volume was adjusted to 100 μl with 0.5 M phosphate buffer, pH 7.0. 
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The tube was then incubated at room temperature for 10 min to allow for 
completion of the reaction. Subsequently, 100 μl of saturated tyrosine solution in 
PBS was added to react with the nonincorporated 125I. The reaction mixture was 
then eluted with 0.5% BSA in 1 mM NaCl (pH 7.0) solution on a prerinsed 
disposable Sephadex G25M column (PD-10; Pharmacia, Uppsala, Sweden). The 
reaction mixture was on a prerinsed disposable Sephadex G25M column (PD-10; 
Pharmacia, Uppsala, Sweden) that was eluted eluted with 0.5% BSA in 1 mM 
NaCl (pH 7.0) solution, and 500 μl fractions were collected. The fraction with the 
highest radioactivity was used for further studies. The radiochemical purity of the 
125I- or 131I-labeled proteins was determined by instant thin layer chromatography 
(ITLC) on Gelman ITLC-SG strips (Gelman Laboratories, Ann Arbor, MI, USA) 
with 0.1 M citrate (pH 5.0) as the mobile phase. The radiochemical purity of 125I-
BMP-2 and 131I-bFGF was 98.5% and 94.7%, respectively. The solutions 
containing the radiolabeled proteins were further diluted using 1 mM NaCl solution 
to a concentration of 24 (for dual GF loading) or 12 µg/ml (for single GF loading) 
for further use. 
 
2.5.2. Growth factor loading 
Radiolabeled BMP-2 and bFGF were loaded to gelatin nanospheres via diffusional 
loading by directly mixing lyophilized gelatin spheres with GF-containing aqueous 
solutions. To ensure complete sorption of GF by gelatin carriers, volumes of GF 
containing solutions were less than required for complete swelling of gelatin 
nanospheres. Thus, for colloidal gels made of similarly or oppositely charged 
gelatin nanospheres, a solid content of 20 w/v% was used.  
Single GF loading 
For single GF-loaded gels, a dose of 60 ng GF per mg of gelatin nanospheres was 
used. Briefly, 5 mg of GelA or GelB nanospheres were mixed in a 2 ml Eppendorf® 
tube with 25 µl of aqueous solutions containing 12 µg/ml 125I-labeled BMP-2 or 
131I-labeled bFGF, thus obtaining GF-loaded colloidal gels with a solid content of 
20 w/v% and a total weight of around 30mg after complete swelling. 
Dual GF loading 
For dual GF-loaded gels, a dose of 60 ng of both BMP-2 and bFGF per mg gelatin 
nanospheres was used. A twin-syringe (Twin-Syringe Biomaterials Delivery 
system (M-system), Medmix, Switzerland) was utilized to mix 125I-BMP-2 loaded 
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GelB nanospheres with 131I-bFGF loaded GelA nanospheres(Fig. 1B). Briefly, 24 
µg/ml of BMP-2 or bFGF solution was mixed with GelA or GelB nanospheres, 
respectively, in the separate chambers of the twin-syringe, followed by mixing of 
both nanosphere populations by extrusion. The resulting colloidal gels (solid 
content 20 w/v%) containing both GFs were collected in 2 ml Eppendorf® tubes to 
obtain a total sample weight of 30 mg of the gels (similar to the samples of single 
GF-loaded gels).  
All samples were stored at 4 °C overnight to allow for complete sorption of GFs, 
after which 1 ml PBS containing 400 ng/ml collagenase 1A and 0.001 w/v% 
sodium azide was added to the tube followed by incubation at 37 °C on a rotating 
plate (70 rpm). At each time point, 0.9 ml of supernatant was refreshed with the 
same volume of medium after centrifugation (2767 g, 5min) to cause 
sedimentation of the colloidal gelatin gels. The release of BMP-2 and bFGF at 
each time point was monitored by measuring the residual γ-irradiation from the 
gelatin samples using a gamma counter after refreshing the supernatant media. 
Consequently, the cumulative release of BMP-2 and/or bFGF was determined by 
normalizing radioactivity at each time point relative to the initial radioactivity of 
each sample, and by compensating for the natural decay of 125I and 131I by 
recording the radioactivity of radiolabeled growth factors that were not loaded onto 
gelatin nanospheres. 
Table 1. Experimental groups as tested in vivo. 
Groups Colloidal gels  Dosing and loading of GF 
Empty defect -  -  
Gels GelA+GelB NS -  
Gels + BMP-2 GelA+GelB NS 2µg BMP-2 (loaded by GelB NS) 
Gels + bFGF GelA+GelB NS 2µg bFGF (loaded by GelA NS) 
Gels + 2GF GelA+GelB NS 2µg BMP-2 (loaded by GelB) + 
2µg bFGF (loaded by GelA NS) 
2.6. In vivo study 
2.6.1. Surgical procedure 
20 skeletally mature male 12 weeks old Sprague Dawley rats were used as 
experimental animals. The protocol was approved by the Animal Ethical Committee 
of the Sichuan University and Chinese national guidelines for the care and use of 
laboratory animals were applied. The anesthesia for all the animals was induced by 
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an intravenous administration of ketamine hydrochloride (20 mg/kg) and xylazine (5 
mg/kg). To reduce the peri-operative infection risk, the rats received antibiotic 
prophylaxis (Baytril®, 2.5% (Enrofloxacin), 10 mg/kg). After exposure of the distal 
femoral condyle, a defect with the size of 3 mm in diameter and 3 mm in depth was 
created. Thereafter, the defects were thoroughly irrigated and packed with sterile 
cotton gaze to stop bleeding. Surgery was performed in both legs of the rats and one 
defect was created in each condyle. The defects were either left empty or filled with 
either bare or GF-loaded colloidal gelatin gels by direct injection using twin-syringes 
in a randomized manner (n=8). Five experimental groups were studied for the animal 
experiment, as shown in Table 1. Colloidal gelatin gels were composed of bFGF 
loaded GelA nanospheres of low crosslinking density and BMP-2 loaded 
nanospheres of high crosslinking density, to induce slow and high release rates for 
bFGF and BMP-2, respectively. A dose of 2 µg of BMP-2 and/or bFGF per defect 
was used (94 ng/ml in concentration) as an intermediate between over- and 
underdosing as reported in previous studies on delivery of BMP-2 and/or bFGF[5, 33, 34, 
42-45]. The lyophilized gelatin nanospheres were sterilized using ethylene oxide. 
Colloidal gelatin gels loaded with one or two GFs were both injected using twin-
syringes as described above (Section 2.5.2). After injection, the superfluous gel was 
removed and soft tissues were closed layer-by-layer using resorbable sutures. After 4 
weeks of implantation, all rats were sacrificed using an overdose of anesthesia and 
the femoral condyles were harvested for histological evaluation and microCT analysis. 
 
2.6.2. Histological evaluation 
After harvesting of the femoral condyles and removal of surrounding soft tissues, the 
specimens were fixed in 10 % neutral buffered formalin solution for 2 days and 
dehydrated in graded ethanol solution from 70 to 100%, and embedded in methyl 
methacrylate (MMA). After polymerization, at least three 10 µm sagittal cross 
sections of the condylar part (parallel to the longitudinal axis of the defect) were 
prepared using a modified sawing microtome technique[46]. Sections were stained 
with methylene blue/basic fuchsin and examined with a light microscope (Leica 
Microsystems AG, Wetzlar, Germany). 
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2.6.3. MicroCT analysis 
The harvested femoral condyles were scanned using microCT (SkyScan 1072 X-ray 
micro-tomograph, TomoNT version 3N.5, SkyScan®, Belgium). The X-ray source was 
set to 100 kV, the current to 96 µA and the resolution was 11.1 µm pixel. Cone beam 
reconstruction was performed and the data were analyzed by CT-Analyzer (version 
1.4, SkyScan). 3D reconstruction images of the explanted femoral condyles were 
created using CT-Vox (SkyScan). A cylindrical volume of interest (VOI) with a 
diameter of 3 mm and a length of 2 mm was set based on the interruption of 
epiphyseal growth plates and the distinction between original and newly formed bone 
tissues. The volume of newly formed bone (BV) was expressed relative to the total 
volume (TV) within the VOI. 
 
2.7. Statistics 
All measurements were calculated as average ± standard deviation. The statistical 
analyses were performed using GraphPad InStat software. Differences among 
groups were determined by one-way Analysis of Variance (ANOVA) with a Tukey 
(multiple comparisons) post test, and a value of p < 0.05 was considered as 
significantly different. 
 
3. Results 
3.1. Characterization of gelatin nanospheres 
As shown in Table 2, the sizes of the nanospheres in swollen state ranged between 
250-450 nm. GelA nanospheres were larger than GelB due to the higher Bloom 
number and corresponding molecular weight of GelA[47]. The size of nanospheres 
decreased with increasing crosslinking degree, which can be attributed to a 
contraction of the polymer network of gelatin after extensive crosslinking. Additionally, 
the crosslinking degree also affected the ζ-potential of gelatin nanospheres. 
Positively (GelA) and negatively (GelB) charged nanospheres were obtained at low 
crosslinking density (GA/NH2=1), whereas both GelA and GelB nanospheres became 
negatively charged at high crosslinking density (GA/NH2=4). This can be explained 
by excessive consumption of positively charged amine groups (-NH2) by the 
crosslinker GA at high crosslinking density, resulting into loss of positive charge for 
GelA nanospheres. Moreover, the water content decreased from 87-89% of GelA and 
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GelB nanospheres at low crosslinking degree to approximately 83% at high 
crosslinking degree for both GelA and GelB nanospheres. Furthermore, similar 
consumption of available NH2 groups (~40%) was observed for both GelA and GelB 
nanospheres at a GA/NH2 molar ratio of 1, whereas the amount of amine 
consumption was different for GelA nanospheres (90%) as compared to GelB 
nanospheres (75%) at a GA/NH2 molar ratio of 4.  
Since positively charged nanospheres could only be prepared using GelA 
nanospheres of low GA crosslinking density (GelA-low), they were selected for 
further experiments. 
Table 2. Characteristics of GelA and GelB nanospheres of different crosslinking density. 
Crosslinking 
density 
molar 
ratio of 
GA/NH2 
Parameters  GelA NS GelB NS 
Low 
 
1 
 
Size (swollen state) 430±4 nm 263±5 nm 
Zeta potential +9.3±0.3 mV -20.0±0.4 mV 
Water content 89.2±0.4 % 87.1±1.0 % 
Measured 
crosslinking density 
41.0±2.7 % 44.9±5.9 % 
High 4 Size (swollen state) 347±10 nm 247±2 nm 
Zeta potential  -9.8±0.1 mV -19.4±0.8 mV 
Water content 83.3±1.0 % 83.2±0.7 % 
Measured 
crosslinking density 
90.2±2.2 % 75.6±0.8 % 
3.2. Rheological characterization of colloidal gels 
Fig. 2 showed the representative viscoelastic properties of colloidal gels (20 w/v% 
solid content) made of oppositely charged GelA and GelB nanospheres. The colloidal 
gels displayed storage moduli (G’) of ~14 kPa which were substantially higher than 
loss moduli (G”) in region I (corresponding to tan (delta) values of about 0.03), 
indicating the formation of highly elastic, solid-like materials. In region II, the elastic 
gel networks were severely destructed by applying a high shear strain (1000% for 1 
min), resulting into the transformation from elastic to liquid-like behavior (G’ < G”). 
Upon removal of the external shear force after severe gel network destruction (region 
III), the elasticity of the gels recovered instantaneously since more than 60% of the 
initial gel elasticity recovered within 5 min. Moreover, this so-called self-healing 
behavior was observed repeatedly after three repetitive cycles of gel destruction, 
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which confirmed that reversible interactions (electrostatic and hydrophobic 
interactions) between the nanospheres were responsible for gel formation[15]. 
 
Figure 2. Rheological characterization of self-healing behavior of colloidal gelatin gels (20 
w/v% solid content) consisting of oppositely charged GelA-low and GelB-high nanospheres 
after repeated (3×) network destruction by monitoring storage moduli G’ (square) and loss 
moduli G” (circle) as a function of time. Regions I, II and III correspond to the initial gel prior 
to repeated destruction, gel destruction, and gel recovery, respectively.  
 
Figure 3. In vitro degradation of GelA or GelB nanospheres (20 w/v% solid content) of low 
(GelA-low and GelB-low) or high crosslinking density(GelA-high and GelB-high) upon 
incubation in collagenase-containing PBS. 
3.3 In vitro degradation of GelA or GelB nanospheres 
Degradation rates of GelA or GelB nanosphere building blocks for of low or high 
crosslinking density are depicted in Figure 3. Gelatin nanospheres of low crosslinking 
density degraded considerably faster than nanospheres of low crosslinking since 
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more than 80% of poorly crosslinked nanospheres were degraded after 4 weeks as 
opposed to 10-20 % gelatin degradation for nanospheres of high crosslinking density. 
The degradation of gelatin nanospheres of low crosslinking density showed a 
biphasic profile consisting of a slow initial degradation within the first three days, 
followed by a more rapid linear degradation phase. Degradation profiles of gelatin 
nanospheres of high crosslinking density were linear for the entire study period of 4 
weeks. Regarding the type of gelatin, GelB nanospheres degraded faster than GelA, 
as evidenced by a total degradation after 4 weeks of 24% and 10% for highly 
crosslinked GelB or GelA nanospheres, respectively. This phenomenon was 
attributed to the higher Bloom number (and corresponding molecular weight) and 
larger particle size for GelA nanospheres as well as the higher crosslinking efficiency 
for GelA nanospheres as confirmed by the TNBS assay (Table 2). 
 
3.4. In vitro release of BMP-2 and bFGF from colloidal gels 
Single GF release 
Burst release was limited for all experimental groups to remarkably low values of less 
than 5%. The cumulative BMP-2 release revealed a predominant effect of gelatin 
nanosphere crosslinking density on GF release kinetics, as reflected by a 
considerably faster BMP-2 release from colloidal gelatin gels of low vs. high 
crosslinking density (Fig. 4). Three phases could be discerned for the release of 
gelatin nanospheres of low crosslinking density; a relatively slow initial release during 
the first week, followed by a linear, faster release from 1 to 3 weeks followed by a 
third plateau phase where release rates leveled off due to completion of BMP-2 (Fig. 
4A). BMP-2 release from gelatin nanospheres of high crosslinking density, on the 
other hand followed a more continuous and linear release profile without reaching the 
plateau phase. The BMP-2 release per time point (Fig. 4B) revealed that peak 
release rates were reached after 2 weeks of incubation for gelatin nanospheres of 
low crosslinking density, whereas BMP-2 release from highly crosslinked 
nanospheres displayed continuously increasing release rates for the entire study 
period. BMP-2 release was faster from GelB vs. GelA nanospheres (especially for 
gelatin nanospheres of high crosslinking density), which was in line with the faster 
degradation rates as observed for GelB nanospheres vs. GelA nanospheres (Fig. 3). 
The release kinetics of bFGF (Fig. 5) revealed a trend similar to BMP-2 release (Fig. 
4), except for a higher burst release of bFGF (approximately 15%) in comparison to 
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the low burst release values of BMP-2 (less than 5 %). Similarly, the influence of 
crosslinking density of gelatin nanospheres on bFGF release was more pronounced 
than the effect of the type of gelatin. 
 
Figure 4. Cumulative BMP-2 release (A) and BMP-2 release per time point (B) from GelA or 
GelB nanospheres (20 w/v% solid content) of low (GelA-low and GelB-low) or high 
crosslinking density (GelA-high and GelB-high). 
 
Figure 5. Cumulative bFGF release (A) and bFGF release per time point (B) from GelA or 
GelB nanospheres (20 w/v% solid content) of low (GelA-low and GelB-low) or high 
crosslinking density (GelA-high and GelB-high). 
Dual GF release 
Two selected combinations of nanosphere sub-populations were investigated with 
respect to their capacity for dual GF release, i.e. (1) GelA-low and GelB-high 
nanospheres (Fig. 6A, B) as well as (2) GelA-low and GelB-low nanospheres (Fig. 6C, 
D). By loading bFGF and BMP-2 to GelA-low nanospheres and GelB-high 
nanospheres, respectively, significantly higher release rates were obtained for 
angiogenic GF (bFGF) vs. osteogenic GF (BMP-2) (Fig. 6A). In total, over 70 % of 
bFGF release was observed as opposed to 37% BMP-2 release after 4 weeks of 
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incubation (Fig. 6A). Both BMP-2 and bFGF release exhibited release profiles 
comparable to single GF release systems, but dual delivery systems revealed 
significantly lower amounts of burst and total release than single-GF release systems. 
The profiles of dual GF release per time point clearly confirmed the different release 
rates of bFGF and BMP-2, i.e., bFGF was released at faster rates than BMP-2 and 
reached a peak rate at week 2, whereas release rates of BMP-2 increased 
continuously for the entire study period of weeks. (Fig. 6B). 
 
Figure 6. Cumulative dual release (A, C) of BMP-2 and bFGF as well as GF release per time 
point (B, D) from colloidal gels (20 w/v% solid content) made of oppositely charged gelatin 
nanospheres. Two combinations of nanosphere sub-populations were tested for dual-GF 
release study, i.e. (1) GelA-low and GelB-high nanospheres (A, B), or (2) GelA-low and 
GelB-low nanospheres (C, D). BMP-2 and bFGF were loaded onto GelB and GelA 
nanospheres, respectively, which were subsequently mixed to form homogeneous colloidal 
gels using a twin-syringe. 
On the other hand, colloidal gels composed of GelA-low and GelB-low nanospheres, 
which were loaded with bFGF and BMP-2 respectively, resulted into equally fast 
release kinetics for both GFs (Fig. 6C). The release of both bFGF and BMP-2 
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crosslinking density of gelatin nanospheres on bFGF release was more pronounced 
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which were loaded with bFGF and BMP-2 respectively, resulted into equally fast 
release kinetics for both GFs (Fig. 6C). The release of both bFGF and BMP-2 
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displayed a linear profile that reached plateau values at 4 weeks due to the 
completion of GF release. The GF release per time point indicated a comparable 
release rate of bFGF and BMP-2, which reached peak rates between 2-3 weeks 
post-incubation (Fig. 6D). 
 
Figure 7. Histological (A-J) and microCT (a-e) analyses of the explants 4 weeks after 
implantation. (A-J) Histological sections of the rat femoral condyle defects at low (left column) 
and high (middle column) magnifications. The circular region of interest (ROI) at the defect 
site was schematically depicted in yellow (diameter of 3mm). NB = new bone, FI = fibrous 
tissue invasion, BV = blood vessel-like structure, and the arrow indicates remnants of 
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colloidal gels. (a-e) 3D reconstructions of the explanted femoral condyles after microCT 
analysis. Cylinder-shaped defects are depicted in red. Each defect was sectioned in the 
middle of the defect along the longitudinal axis. 
3.5 In vivo study 
One rat was euthanized during the surgery due to an overdose of anesthesia, 
resulting into the loss of one sample in empty control as well as bFGF-loaded gel. 
The remaining animals experienced an uneventful recovery from the surgical 
procedure. At implant retrieval, no clinical signs of inflammatory or adverse tissue 
reaction were observed upon retrieval of the femoral condyles. 
Light microscopical analysis of the histological sections revealed significantly different 
amounts of new bone formation for the various experimental groups. For most of the 
specimens, the exact original margins of the drilled defects were not clearly 
recognizable anymore due to extensive bone ingrowth. Still, the approximate location 
of the implants was still traceable based on the original size of the defect, the 
interruption of epiphyseal growth plates, and the separation between old and newly 
formed bone tissues. The empty control defects were almost completely filled with 
newly formed bone after 4 weeks (Fig. 7A and B). The defects filled with bare GF-
free colloidal gelatin gels revealed active bone ingrowth originating from the 
peripheral bone surrounding the central areas of the defect that were occasionally 
filled with fibrous tissue as shown in Fig. 7C and D, indicating that colloidal gelatin 
gels degraded after 4 weeks of implantation. 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Amount of new bone formation (BV) 
relative to the total volume within the defect 
area after 4 weeks of implantation.  
For BMP-2-loaded colloidal gels, extensive bone regeneration was observed 
characterized by osteocyte-populated woven bone that completely bridged the 
original defect area after 4 weeks (Fig. 7E). Also, mature trabecular-like bone was 
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visible as characterized by the presence of an open porous structure comprising 
bone marrow and blood vessel-like structures (Fig. 7F). Extensive bone formation 
was also observed for the defects filled with bFGF-loaded colloidal gels, where newly 
formed bone grew into the central area of the defect with an irregular porous 
structure (Fig. 7G and H). In addition, remnants of the colloidal gelatin gels were 
sporadically observed in the vicinity of newly formed bone, corresponding to 
incomplete degradation of the implant after 4 weeks of implantation (Fig. 7H). In 
contrast, the extent of bone regeneration was reduced in the defects treated with gels 
loaded with both BMP-2 and bFGF, as evidenced by a minimal amount of new bone 
formation and extensive invasion of fibrous tissue into the defect area (Fig. 7I and J).  
Fig. 7a-e shows representative 3D reconstructions of the femoral condyles as 
created using microCT analysis of the explants, the results of which were in line with 
the histological observations. Empty control defects, unloaded gels and gels loaded 
with either BMP-2 or bFGF revealed extensive bone regeneration within the defect 
sites as evidenced by the comparable grayscales for treated defects and surrounding 
original bone tissue (Fig. 7a-d). In contrast, dark-colored defect areas and thus 
reduced hard tissue formation was observed for defects treated with gels containing 
both BMP-2 and bFGF (Fig. 7e), confirming the inhibitory effect of combined delivery 
of BMP-2 and bFGF on osteogenesis under the current experimental conditions. 
Quantification of the microCT analyses (Fig. 8) confirmed the observations made 
using qualitative histology. BMP-2-loaded gels revealed significantly higher volumes 
of newly formed bone within the defect area than the other experimental groups (Fig. 
8). On the contrary, the combined delivery of BMP-2 and bFGF resulted into 
significantly lower bone formation than the other experimental groups. No significant 
difference in new bone formation was found between the empty control defects, GF-
free gels and bFGF-loaded gels.  
 
4. Discussion 
Since the handling properties of injectable materials are superior to the pre-shaped 
collagen sponges that are currently used for clinical delivery of BMP-2[5], extensive 
research efforts are dedicated to develop injectable gels and putties as carrier for 
local GF delivery[48]. Rheological characterization of colloidal gelatin gels confirmed 
that the gel networks were able to recover from repeated and severe network 
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destruction by application of destructive shear forces, which makes the gel suitable 
for minimally invasive application. This self-healing behavior - which can be attributed 
the non-covalent, reversible nature of the interactions between gelatin nanospheres - 
endows colloidal gelatin gels with the capacity to withstand high shear forces that are 
exerted on the gels during gel extrusion through small orifices of medical syringes. It 
should be emphasized that the charge ratio between gelatin nanospheres was not 
equal at low crosslinking density (+9.3 mV for GelA and -20.0 mV for GelB), whereas 
charges were similar at high crosslinking density (-9.8 mV for GelA and -19.4 for 
GelB). Still, gels of remarkable integrity were formed for all experimental groups, 
stressing the fact that attractive hydrophobic forces dominate repulsive electrostatic 
interactions at high solid gelatin content. 
Retention of GFs to carrier materials is crucial to ensure prolonged therapeutic 
efficacy of growth factor delivery and avoid premature loss of GFs. In that respect, 
the remarkably low burst release values as observed in the current study is an 
advantage of nanostructured colloidal gels compared to systems that displayed 
higher burst release values for BMP-2 or bFGF[49, 50], despite the fact that GFs were 
incorporated into the nanospheres by simple diffusional post-loading.  
After the small burst release phase, the subsequent sustained release phase could 
be controlled by fine-tuning the degradability of the gelatin nanospheres. This 
corresponds with previous studies which also demonstrated that GF release from 
gelatin carriers such as microspheres or sponges is mainly controlled by the 
enzymatic degradability of the respective gelatin carriers[49, 51]. Fig. 9A shows the 
strong correlation between degradability of and cumulative BMP-2 release from GelA 
and GelB nanospheres of low crosslinking density, whereas GF release rates from 
gelatin nanospheres of high crosslinking density exceeded degradation rates of the 
nanospheres (Fig. 9B), indicating that the GF release from the gels of high 
crosslinking density was also modulated by free diffusion of GFs in addition to 
enzymatic degradation of the gelatin carriers[4, 52, 53]. 
The main goal of the current study was to combine fast delivery of bFGF with more 
sustained delivery of BMP-2 from an injectable, colloidal gelatin gel carrier for early 
and sustained stimulation of angio- and osteogenesis, respectively. Our in vitro 
results confirm that colloidal gels are indeed very suitable to this end, since these 
particulate but cohesive gel networks allow for orthogonal control over release rates 
of both GFs by controlling the degradability of nanosphere sub-populations using 
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parameters such as the crosslinking density and/or type of gelatin. By loading bFGF 
onto rapidly degraded GelA-low nanospheres and BMP-2 to GelB-high nanospheres 
of lower degradability, fast release of bFGF was combined with slow release of BMP-
2 (Fig. 6A). It is noticeable that the burst and total GF release values for gels 
containing dual GFs (Fig. 6A) were lower than values observed for gels loaded with 
single GFs (Figs. 4A and 5A for BMP-2 and bFGF, respectively). It was shown 
previously that mixing of oppositely charged gelatin nanospheres (GelA+B) did not 
result into enhanced colloidal stability (i.e. reduced enzymatic degradation and 
corresponding growth factor release rates) compared to gels made of similarly 
charged nanospheres (GelA or GelB)[23]. This indicated that electrostatic interactions 
were not responsible for the different release profiles observed between single and 
dual GF-loaded colloidal gels. A more likely explanation for the lower burst and total 
GF release values as observed for dual GF release systems (gels made of GelA-low 
and GelB-high nanospheres (Fig. 6A)) vs. single GF release systems (gels made of 
either GelA or GelB nanospheres (Figs. 4A and 5A)) was related to the differences in 
preparation of single or dual GF-loaded gels; twin-syringes were used for preparation 
of gels containing both bFGF and BMP-2 in contrast to gels loaded with one GF only, 
which might have resulted into compaction of the colloidal gels, thereby decreasing 
the accessibility of proteolytic enzymes into the interior of tightly packed colloidal gels. 
Moreover, it was observed that the crosslinking degree of GelB nanospheres affected 
the release rate of bFGF from GelA nanospheres of low crosslinking density, as 
evidenced by the significantly lower total bFGF release from GelA-low nanospheres 
upon combining with GelB-high nanospheres (73±1%) rather than with GelB-low 
nanospheres (94±3%) (Fig. 6A and C). This effect might be caused by the reduced 
penetration of collagenase into the particulate network of colloidal gels comprising 
GelB-high nanospheres (which exhibited strong resistance to enzymatic degradation), 
thereby reducing the overall degradation rate of the entire colloidal gel and 
corresponding release of BMP-2 and bFGF from GelB and GelA nanospheres, 
respectively. 
Besides the rate of GF delivery, GF dosing is of particular importance as well due to 
the dose-dependent effect of GF delivery. It has been pointed out that a high dose of 
BMP-2 (> 150 μg)[5, 42, 43] or bFGF (≥ 10 μg)[33, 34, 44, 45] can result into detrimental side 
effects (e.g. cyst-like bone formation, ectopic bone formation, soft tissue swelling, 
inflammation and even carcinogenicity) or inhibition of osteogenesis (with respect to 
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bFGF delivery), whereas GF doses below 1.5 µg are often not sufficient to induce a 
therapeutic effect[42]. Therefore, an intermediate dose of 2 μg of BMP-2 and bFGF 
per defect was selected in the current study. 
Colloidal gels have not been used before to release multiple biomolecules at mutually 
independent release rates as shown in the current study. Moreover, the bone 
response of colloidal gels has never been quantified in vivo, which emphasized the 
novelty of the results presented in the current study. Generally, the in vivo study 
confirmed the biocompatibility and biodegradability of the gelatin nanosphere-based 
colloidal gels as well as the efficacy of GF-delivery from colloidal gelatin gels on the 
process of bone healing. No adverse effects of the unloaded colloidal gelatin gels on 
the natural process of bone healing were observed, and the amounts of bone 
formation in defects filled with unloaded colloidal gelatin gels were comparable to the 
empty defects.  
 
Figure 9. Correlation between in vitro degradation of and BMP-2 release from colloidal 
gelatin gels (20 w/v% solid content) made of GelA (square) or GelB (circle) nanospheres of 
low (A) or high (B) crosslinking density.  
Regarding to GF-loaded gels, the amount of new bone formation was highest for 
BMP-2 loaded gels and lowest for gels loaded with both BMP-2 and bFGF, while 
bFGF-loaded gels displayed an intermediate behavior characterized by amounts of 
bone comparable to empty control defects and unloaded colloidal gelatin gels 
(Fig.8A). It can be concluded that single delivery of BMP-2 accelerated bone 
regeneration compared to the natural rate of bone healing in empty defects, whereas 
single delivery of bFGF did not affect the physiological rate of bone regeneration in 
the current experimental conditions. In literature, conflicting results have been 
reported on the efficacy of bFGF on bone regeneration[36, 54, 55]. Generally, these 
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studies observed that the osteogenic potential of bFGF delivery was both dose-
dependent[41] and differentiation stage-specific[56]. For instance, relatively high doses 
of bFGF (1 µg of bFGF delivered by collagen sponges) were shown to result into 
inhibitory effects on bone formation in a rat mandibular defect model[55]. Moreover, 
Debiais et al. showed that bFGF treatment (0.1-100 ng/ml, 2-5 days) reduced the 
expression of osteoblast markers in less mature cells whereas it induced osteocalcin 
production and matrix mineralization in more mature cells in vitro[56]. These studies 
suggest that the absence of a therapeutic effect of local bFGF delivery as observed 
in the current study could be related to the high bFGF dose (2 µg bFGF per defect, 
94 ng/ml in concentration) and/or a premature release of bFGF due to the fast 
degradation of weakly crosslinked, bFGF-loaded GelA nanospheres. 
Table 3. Overview of previous studies dealing with combined delivery of BMP-2 and bFGF 
for bone regeneration showing either stimulatory or inhibitory effects of combined BMP-2 and 
bFGF delivery on osteogenesis. 
Effect on 
osteogenesis 
GF dose per defect Delivery carrier In vitro/in vivo model Ref. 
BMP-2 bFGF  
Stimulatory 800 ng 100 ng Fibrous glass membrane Subcutaneous implantation in 
rats 
[33] 
2 µg 16-400 ng Collagen sponge Intramuscular implantation in 
rats 
[34] 
Not 
known 
25, 250 ng Polyglycolic acid/gelatin 
sponge 
Cranial defect in rats [35] 
5 µg 1-10 ng Collagen disc Subcutaneous implantation in 
mice 
[36] 
1 µg 10 ng Porous hydroxyapatite 
scaffold 
Cranial defect in rats [37] 
300 
ng/ml 
2.5 ng/ml Direct addition in culture 
media 
In vitro MSCs culture [29] 
100 
ng/ml 
10ng/ml Direct addition in culture 
media 
In vitro MSCs culture [57] 
50 
ng/ml 
2.5 ng/ml Direct addition in culture 
media 
In vitro MSCs culture [58] 
5 µg 12.5 µg Porous hydroxyapatite 
particles 
Intramuscular implantation in 
rabbits 
[59] 
Inhibitory  100 µg 100 µg Carrier-free injection Irradiated mandible model in 
rats 
[45] 
800 ng 10 µg Fibrous glass membrane Subcutaneous implantation in 
rats 
[33] 
2 µg 50 µg Collagen sponge Intramuscular implantation in 
rats 
[34] 
5 µg 100 ng-5 
µg 
Collagen disc Subcutaneous implantation in 
mice 
[36] 
600 ng 100ng Collagen sponge Bone harvest chamber in 
rabbits 
[60] 
Dual delivery of bFGF and BMP-2 obviously inhibited bone regeneration (Fig. 8). 
Previous studies dealing with combined delivery of BMP-2 and bFGF are 
contradictory with respect to their synergistic effect on osteogenesis (Table 3). 
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Interesting trends can be discerned from this overview, although these trends remain 
largely speculative in view of the different defect sizes, animal models, and growth 
factor carriers used. Generally, low doses of bFGF (in ng scale) in combination with 
higher doses of BMP-2 resulted into enhanced osteogenesis[29, 33-37, 57, 58], whereas 
higher doses of bFGF (in µg scale) in combination with lower or equal doses of BMP-
2 seemed to hamper bone formation[33, 34, 36, 45]. The exact biological mechanism 
behind this phenomenon remains unclear to date. However, Nakamura et al. 
provided indications that a high dose of bFGF stimulated intracellular inhibitors 
(Smad 6) of BMP-2 signaling, which could lead to diminished bone formation[36]. 
Another explanation states that overdosing of bFGF stimulates osteoclastogenesis, 
resulting into reduced bone density[36]. In that respect, the inhibitory effect of 
combined delivery of bFGF and BMP-2 (both at 2 µg per defect) might be caused by 
overdosing of bFGF relative to BMP-2. In addition to this dosing effect, however, 
bFGF release kinetics might also have influenced the process of bone regeneration. 
Since bFGF was shown to exhibit mitogenic activity and reduced the expression of 
osteoblast markers in less mature cells[56], rapid release of bFGF at the early stage of 
bone healing could have reduced the osteogenic potential of osteoprogenitor cells at 
the defect site, thereby resulting into reduced bone regeneration. These results seem 
to suggest that dosing and timing effects are important to obtain synergistic effects 
after co-delivery of BMP-2 and bFGF, but additional studies are necessary to draw 
unambiguous conclusions on the biological interaction between BMP-2 and bFGF. 
 
5. Conclusions 
This study provides in vitro and in vivo evidence that injectable nanosphere-based 
colloidal gelatin gels are highly suitable for controlled delivery of multiple growth 
factors. The in vitro results confirmed that the delivery kinetics of BMP-2 and/or 
bFGF are more dependent on the degree of crosslinking than on the type of 
gelatin. Sequential release characterized by rapid release of angiogenic bFGF 
and more sustained release of osteogenic BMP-2 was obtained by loading bFGF 
onto cationic nanospheres of low crosslinking density and BMP-2 onto anionic 
nanospheres of high crosslinking density. The in vivo study demonstrated the 
biocompatibility and biodegradability of bare colloidal gelatin gels, and did not 
show any adverse effects on the process of bone healing after 4 week of 
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implantation. An obvious stimulatory effect on bone regeneration was observed for 
the colloidal gel loaded with BMP-2, whereas bFGF-loaded colloidal gelatin gels 
did not influence the rate of bone regeneration. In contrast, the combined delivery 
of BMP-2 and bFGF resulted into an inhibitory effect on osteogenesis under the 
current experimental conditions. Summarizing, nanosphere-based colloidal gelatin 
gels were shown to have a strong capacity for for programmed delivery of multiple 
biomoleucles for tissue regeneration. 
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1. Introduction  
Regeneration of large segmental bone defects is one of the most challenging topics 
in trauma and orthopedic surgery[1]. Despite availability of several bone substitute 
materials to graft bone defects[2], autologous bone is still the clinical gold standard[3]. 
Nevertheless, well-known drawbacks of autografts (e.g. limited amounts, second 
surgical site and donor site morbidity[4]) provide continuous incentive for development 
of new bone substitute materials. Bone substitute materials to regenerate bone in 
large segmental defects that provide sufficient mechanical support as well as 
biological cues to enhance bone regeneration are not yet available[5, 6]. 
Bone regeneration is a cascade of events strongly regulated by spatial and temporal 
action of angiogenic and osteogenic growth factors (GFs)[7]. Angiogenic GFs such as 
vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) 
are expressed during early stages of bone healing[7, 8]. In contrast, osteogenic GFs 
such as bone morphogenetic factor-2 (BMP-2) are expressed for the entire duration 
of bone healing[7, 9]. Mimicking the spatiotemporally presentation of GFs by controlled 
delivery from a carrier material is considered a powerful tool to stimulate bone 
regeneration[10]. Conventional carrier materials (e.g. collagen sponges) revealed a 
poor capacity to control GF delivery, and therefore require a high dose of GF to reach 
a therapeutic effect. However, high doses of GF, especially in the case of BMP-2, 
resulted in serious side effects including bone tissue overgrowth, ectopic bone 
formation, inflammation and even carcinogenicity[11]. These results underline the 
need for new carrier materials that are capable of delivering multiple GFs in a time 
and dose-dependent manner[9]. 
Colloidal gels have emerged as a new generation of carrier materials with improved 
controllability over GF release[12-15]. Colloidal gels typically employ polymer micro- 
and nanoparticles as building blocks to assemble into cohesive macroscopic gels. 
Due to use of small building blocks, gels are injectable and capable of controlled 
release of multiple bioactive molecules[16-19]. Wang et al[18], recently developed a 
nanostructured colloidal gels made of oppositely charged gelatin nanospheres that 
showed shear-thinning and self-healing behavior due to reversible non-covalent 
cohesive interactions (i.e. electrostatic and hydrophobic) between nanospheres. 
More importantly, this nanostructured colloidal gelatin gel was shown to be a suitable 
carrier for time- and dose-dependent delivery of multiple GFs. Fast release of bFGF 
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and more sustained release of BMP-2 could be acquired by fine-tuning crosslinking 
density of gelatin nanospheres[20], and the gelatin gels were found to degradate in 
four weeks time[20, 21]. However, BMP-2 and bFGF release from these nanostructured 
colloidal gelatin gels has resulted in an inhibitory effect on in vivo osteogenesis in a 
rat femoral condyle defect model. Inhibitory[22-26] as well as stimulatory[22, 25, 27-32] 
effects are both described in literature, and point out that inhibitory effects are caused 
when using comparable doses of bFGF and BMP-2. 
The aim of this study is to stimulate bone regeneration using the above-mentioned 
nanostructured colloidal gelatin gels with a low dose of bFGF compared to the dose 
of BMP-2 (dose ratio BMP-2/bFGF of 5:1) in a large critical-sized segmental bone 
defect in a rat femur. In order to provide mechanical support for this large bone defect, 
gels were incorporated into porous titanium scaffolds. Titanium scaffolds have been 
shown to provide direct mechanical support in the early phase after implantation 
while the porous structure facilitated bone formation (osteoconduction) over time[33], 
thereby showing potential as a bone substitute material suitable for grafting large 
weight-baring bone defects[33]. Combining porous titanium scaffolds with colloid 
gelatin gels combines the mechanical strength of titanium with GF-delivery capacities 
of colloidal gels, thereby overcoming poor mechanical strength of the gels as well as 
bioinertness of the titanium. We hypothesize that porous titanium scaffolds with BMP-
2/bFGF gels result in more bone regeneration in segmental cortical bone defects in 
rats femurs compared to BMP-2 gels, bFGF gels, and unloaded gels. To test this 
hypothesis, the effects of these gels on in vivo bone regeneration were evaluated 
using in vivo and ex vivo micro-CT, histology, and three-point bending tests. 
 
2. Materials and methods  
2.1. Materials 
Gelatin A (GelA, from porcine skin, 300 Bloom, isoelectric point (IEP) ~9) and gelatin 
B (GelB from bovine skin, 225 Bloom, IEP ~5) were purchased from Sigma-Aldrich. 
Glutaraldehyde (GA, 25 wt% solution in water) was commercially available from 
Acros Organics. Recombinant human Bone Morphogenetic Protein-2 (BMP-2, 
molecular mass 26 kDa (dimer), IEP 7) was purchased from Shanghai Rebone 
Biomaterials Co., China, and recombinant human basic Fibroblast Growth Factor 
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showed shear-thinning and self-healing behavior due to reversible non-covalent 
cohesive interactions (i.e. electrostatic and hydrophobic) between nanospheres. 
More importantly, this nanostructured colloidal gelatin gel was shown to be a suitable 
carrier for time- and dose-dependent delivery of multiple GFs. Fast release of bFGF 
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and more sustained release of BMP-2 could be acquired by fine-tuning crosslinking 
density of gelatin nanospheres[20], and the gelatin gels were found to degradate in 
four weeks time[20, 21]. However, BMP-2 and bFGF release from these nanostructured 
colloidal gelatin gels has resulted in an inhibitory effect on in vivo osteogenesis in a 
rat femoral condyle defect model. Inhibitory[22-26] as well as stimulatory[22, 25, 27-32] 
effects are both described in literature, and point out that inhibitory effects are caused 
when using comparable doses of bFGF and BMP-2. 
The aim of this study is to stimulate bone regeneration using the above-mentioned 
nanostructured colloidal gelatin gels with a low dose of bFGF compared to the dose 
of BMP-2 (dose ratio BMP-2/bFGF of 5:1) in a large critical-sized segmental bone 
defect in a rat femur. In order to provide mechanical support for this large bone defect, 
gels were incorporated into porous titanium scaffolds. Titanium scaffolds have been 
shown to provide direct mechanical support in the early phase after implantation 
while the porous structure facilitated bone formation (osteoconduction) over time[33], 
thereby showing potential as a bone substitute material suitable for grafting large 
weight-baring bone defects[33]. Combining porous titanium scaffolds with colloid 
gelatin gels combines the mechanical strength of titanium with GF-delivery capacities 
of colloidal gels, thereby overcoming poor mechanical strength of the gels as well as 
bioinertness of the titanium. We hypothesize that porous titanium scaffolds with BMP-
2/bFGF gels result in more bone regeneration in segmental cortical bone defects in 
rats femurs compared to BMP-2 gels, bFGF gels, and unloaded gels. To test this 
hypothesis, the effects of these gels on in vivo bone regeneration were evaluated 
using in vivo and ex vivo micro-CT, histology, and three-point bending tests. 
 
2. Materials and methods  
2.1. Materials 
Gelatin A (GelA, from porcine skin, 300 Bloom, isoelectric point (IEP) ~9) and gelatin 
B (GelB from bovine skin, 225 Bloom, IEP ~5) were purchased from Sigma-Aldrich. 
Glutaraldehyde (GA, 25 wt% solution in water) was commercially available from 
Acros Organics. Recombinant human Bone Morphogenetic Protein-2 (BMP-2, 
molecular mass 26 kDa (dimer), IEP 7) was purchased from Shanghai Rebone 
Biomaterials Co., China, and recombinant human basic Fibroblast Growth Factor 
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(bFGF, 146 aa, catalogue number 233FB/CF, molecular mass 16 kDa, IEP 9.6) were 
supplied by R&D Systems. 
Table 1. Characteristics of GelA and GelB nanospheres (NS) used for the preparation of 
colloidal gelatin gels. 
Characteristics GelA NS GelB NS 
Crosslinking density low  
(GA/NH2 = 1) 
high  
(GA/NH2 = 4) 
Particle size (swollen state) 430±4 nm 247±2 nm 
Zeta-potential +9.3±0.3 mV -20.0±0.4 mV 
Table 2. Preparation of (GF-loaded) colloidal gelatin gels. 
Gel GelA  Gel B 
Unloaded - - 
bFGF 22 µg/ml bFGF - 
BMP-2 - 110 µg/ml BMP-2 
BMP-2/bFGF 22 µg/ml bFGF 110 µg/ml BMP-2 
2.2. Preparation and characterization of (GF-loaded) colloidal gelatin gels 
Colloidal gelatin gels made of oppositely charged gelatin nanospheres were prepared 
using a previously reported method[18, 21], in which gelatin nanospheres were 
obtained using a desolvation method followed by crosslinking using GA. A low and 
high crosslinking density (defined as the molar ratios of GA relative to[NH2]gelatin) of 
one or four was applied to GelA and GelB nanospheres, respectively. That resulted in 
positively charged GelA and negatively charged GelB nanospheres[20]. The particles 
size and ζ-potential of gelatin nanospheres were measured using dynamic light 
scattering (DLS, Zetasizer Nano-Z, Malvern Instruments Ltd.) (Table 1). 
Lyophilized GelA or GelB nanospheres were mixed with aqueous 1mM NaCl 
solutions (pH 7) in two separate 1ml BD® Luer-lokTM syringes. A homogeneous gel 
was then obtained by repeated extrusion (20x) from the GelA-containing syringe to 
GelB-containing syringe (and vice versa) while being connected by a Luer-lokTM 
connector. BMP-2/bFGF gels were made by mixing GelA nanospheres with NaCl 
solution containing 22 µg/ml bFGF and GelB nanospheres with NaCl solution 
containing 110 µg/ml BMP-2. BMP-2, bFGF or unloaded gels were obtained by 
mixing GelA, GelB or both with 1mM NaCl solution only (Table 2). The gels (solid 
content of 20 w/v%) were stored at 4 °C overnight to allow for complete swelling of 
gelatin nanospheres, thus facilitating complete GF absorption into the swollen gelatin 
network. 
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The viscoelastic properties of colloidal gelatin gels were characterized using a 
rheometer (AR2000ex, TA Instruments). All measurements were performed within 
the linear viscoelastic region using a flat steel plate geometry (20 mm diameter) at 
25 °C. The shear-thinning and self-healing behavior of gels was evaluated according 
to a method adapted from previous studies[34-36] that mimics the clinical injection 
procedure (i.e. gel destruction by increasing shear forces upon extrusion through 
narrow syringes). Briefly, gels were gradually destroyed by applying an oscillatory 
strain sweep with shear strain increasing from 0.1% to 1000% (1 Hz frequency), 
meanwhile the viscoelastic properties (G’ and G’’) of the gels were monitored. 
Thereafter, an oscillatory time sweep (5 min, 1 % strain, 1 Hz frequency) was 
instantaneously applied to the gels, and gel recovery was recorded. 
Table 3. Structural and mechanical properties of porous titanium scaffolds. 
Titanium scaffold Characteristics 
Titanium thickness 120 µm  
Pore size 490 µm 
Porosity 88 % 
Pore volume 55 mm3 
Compression strength 14 MPa 
Young’s modulus 0.4 GPa 
2.3. Incorporation of GF-loaded colloidal gelatin gels into porous titanium 
scaffolds 
Porous titanium scaffolds were produced from Ti6Al4V using selective laser melting 
(SLM) as previously described[33]. The scaffolds were produced in the shape of the 6 
mm femur bone segment (as previously determined on intact rat femora using micro-
CT) to be replaced during the animal experiment (Fig. 1A, see section 2.4). Titanium 
struts were 120 µm thick and the pore size was 240-730 µm, resulting in a fully 
interconnected structure with a porosity of 88% and 55 mm3 pore volume per scaffold. 
Compression strength and Young’s modulus are given in Table 3. All scaffolds 
underwent an acid-alkali-heat treatment[37] consisting of (1) immersion in a 5 M 
aqueous NaOH solution at 60 ºC for 24 h, (2) immersion in ultrapure water at 40 ºC 
for 24 h, (3) immersion in 0.5 mM HCl solution at 40 ºC for 24 h, (4) immersion in 
ultrapure water at 40 ºC for 24 h, (5) heating to 600 ºC at a rate of 5 ºC/min in an 
electric furnace in ambient air pressure, holding the temperature at 600 ºC for 1 h, 
and subsequent natural cooling in the furnace. 
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Porous titanium scaffolds were produced from Ti6Al4V using selective laser melting 
(SLM) as previously described[33]. The scaffolds were produced in the shape of the 6 
mm femur bone segment (as previously determined on intact rat femora using micro-
CT) to be replaced during the animal experiment (Fig. 1A, see section 2.4). Titanium 
struts were 120 µm thick and the pore size was 240-730 µm, resulting in a fully 
interconnected structure with a porosity of 88% and 55 mm3 pore volume per scaffold. 
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underwent an acid-alkali-heat treatment[37] consisting of (1) immersion in a 5 M 
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and subsequent natural cooling in the furnace. 
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The abovementioned gels were loaded into porous titanium scaffolds using a custom-
made gel chamber that could be directly connected to the Luer-lokTM syringes 
containing the gels. Injection of an excess of the gel into the chamber containing a 
scaffold resulted in complete filling of the porous space. Gel-titanium scaffolds were 
stored at 4 °C until implantation. Prior to implantation, the scaffolds were taken out of 
the gel chamber, and superfluous gel around the scaffold was removed (Fig. 1B). 
Complete filling of the porous space (55 mm3) resulted in a total dose of 3 µg BMP-2 
and/or 0.6 µg bFGF. Filling efficacy of the gels in the scaffolds was visualized by 
means of micro-CT and scanning electron microscopy (SEM). The gel was visualized 
on micro-CT using a 30% ioxaglate saline solution (Hexabrix 320®, Mallinckrodt, 
Hazelwood, MO, USA) as a contrast agent to prepare the gel. Subsequently the gel-
titanium scaffold was scanned with a SkyScan 1176 micro-CT scanner (Bruker micro-
CT N.V., Kontich, Belgium). 
 
2.4. Animal experiment 
Forty skeletally mature male Wistar rats were used as experimental animals. The 
Animal Ethics Committee of the Erasmus University approved the study and Dutch 
guidelines for the care and use of laboratory animals were applied. All operations 
were performed aseptically under general anesthesia (1-3.5 % isoflurane). To reduce 
perioperative infection risk, all rats received antibiotic prophylaxis (enrofloxacin, 5 
mg/kg body weight). The right femur was exposed through a lateral incision of the 
skin and division of the underlying fascia. A 23 mm long PEEK plate was fixated to 
the anterolateral plane of the femur using three proximal and three distal screws. The 
periostium was removed over approximately 8 mm of the mid-diaphyseal region 
before removal of the 6 mm long bone segment. The bone segment was removed 
with a tailor-made saw guide and a wire saw and a porous titanium scaffold 
containing gel was press-fitted into the defect. Colloidal gelatin gels made (Table 2) 
were studied in four experimental groups consisting of ten rats each The fascia and 
skin were sutured in layers using Vicryl 5-0. Prophylactic pain medication 
(buprenorphine, 0.05 mg/kg body weight) was administered twice a day for the first 
three days after surgery. 
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2. 5. In vivo and ex vivo micro-CT evaluation 
Immediately following implantation surgery as described above (section 2.4), while 
the rats were still under general anesthesia (1-3.5 % isoflurane), a baseline in vivo 
micro-CT scan was acquired (SkyScan 1176 scanner, Bruker micro-CT N.V., Kontich, 
Belgium). A 35 µm-resolution protocol was used at 90 kV, 278 µA current, 0.1 mm Cu 
filter, and 0.5 degree rotation step, resulting in a 7 minute scan. In vivo scans were 
repeated after four, eight, and twelve weeks. For the final ex vivo scan (after the 
sacrifice the animals), an 18 µm-resolution protocol was used at 90 kV, 278 µA 
current, 0.1 mm Cu filter, and 0.2 degree rotation step (1 h scan). The CT images 
were reconstructed using volumetric reconstruction software NRecon version 1.5 
(Bruker micro-CT N.V., Kontich, Belgium). 
Bone formation was expressed as bone volume (BV) and measured at four specific 
regions: 1) total BV: total volume of bone formed within the 6 mm defect area; 2) 
outer BV: bone formed outside the porous titanium scaffolds; 3) porous BV: bone 
formed inside the porous space of the titanium scaffolds; and 4) inner BV: bone 
formed in the medullary canal of the scaffold. The BV of each specific region was 
measured after capturing the specific region as a corresponding volume of interest 
(VOI) on the scans using a custom-made algorithm within the software CTAnalyser 
version 1.11 (Bruker micro-CT N.V., Kontich, Belgium). After selection of the specific 
VOI, the porous titanium scaffold was subtracted from the images using a global 
threshold. An additional eroding step was performed to remove an adjacent 35 µm 
layer in order to exclude the metal artifacts at the interface that may interfere with the 
BV measurement. BV was then determined after applying a global threshold that was 
determined based on visual inspection and was kept constant for all micro-CT scans. 
Finally, the extent of bone bridging was measured on the ex vivo scans with 
DataViewer 1.4 (Bruker micro-CT N.V., Kontich, Belgium). 
 
2.6. Histology 
Histology was performed to study both the bone-titanium interface and bone 
morphology. Five femurs of each group were processed for histology. After 
harvesting of the femurs and removal of surrounding soft tissues, the specimens 
were fixed in 10 % neutral buffered formalin solution for two days, dehydrated in 
graded ethanol solutions (70 to 100%), and finally embedded in methyl methacrylate 
(MMA). Sections of ~20 µm thickness were obtained using a diamond saw (Leica 
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SP1600, Rijswijk, The Netherlands) and stained with basic fuchsin 0.3% solution and 
methylene blue 1% solution. Newly formed bone stains red with basic fuchsin and 
fibrous tissue stains blue with methylene blue. 
 
2.7. Mechanical evaluation 
Final strength of the treated femurs was measured using three-point bending tests 
conducted on five femurs from each experimental group. After harvesting of the 
femurs, the soft tissues and PEEK plate were carefully removed. Specimens were 
kept in 10 % neutral buffered formalin solution for the first two days followed by 
phosphate buffered saline. Bending tests were carried out using a Zwick test 
machine (Zwick GmbH, Germany) as follows: first, femurs were fixed at proximal and 
distal side using two holding plates that were secured with screws. The fixated femur 
was supported by two supports (15 mm width) and a downward force was applied by 
a denter (3 mm width) to the middle of the porous titanium scaffold. Bending tests 
were performed at a displacement rate of 2 mm/min until peak load was reached. 
Force-displacement curves were recorded and used to determine the maximum force. 
 
2.8. Statistics 
Statistical analyses were performed using SPSS Statistics 20.0 (SPSS Inc, Chicago, 
US). Data is presented as means with standard deviation. One-way Analysis of 
Variation (ANOVA) and subsequent post-hoc pairwise comparisons with Bonferroni 
adjustment was used to analyze differences between groups. 
 
3. Results 
3.1. Gelatin nanosphere-based colloid gels 
Representative viscoelastic properties of colloidal gels (20 w/v% solid content) made 
of oppositely charged GelA and GelB nanospheres are shown in Fig. 2. An oscillatory 
strain sweep (region I) was performed by varying strain from 0.1 to 1000% (constant 
frequency of 1 Hz) and monitoring storage (G’) and loss moduli (G”). Within the linear 
viscoelastic region, storage moduli of ~12 kPa were observed which were 
substantially higher than loss moduli (corresponding to tan (delta) values of about 
0.03), indicating formation of highly elastic gels. Gel networks were destructed when 
applied shear strain exceeded 70%, which led to transformation from elastic to liquid-
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like behavior (G’ < G”). At a highly destructive strain of 1000% the external shear 
force was removed and storage and loss moduli of the gels were recorded as a 
function of time (region II) revealing that ~70% of the initial gel elasticity was 
recovered within 5 min. 
 
Figure 1. Photographs of porous titanium scaffolds in the shape of the 6 mm segment going 
to be replaced during the animal experiment before (A) and after (B) incorporation with 
colloidal gelatin gels. Micro-CT images of the perpendicular (C) and horizontal (D) cross-
sections of porous titanium scaffold (black) containing colloidal gelatin gels containing iodine-
based radiographic contrast agent ioxaglate (grey). Scale bar = 1 mm. 
 
Figure 2. Rheological characterization of self-healing behavior of colloidal gelatin gels (20 
w/v% solid content) by monitoring storage moduli G’ (square) and loss moduli G” (circle) as a 
function of time (region II: oscillatory time sweep with 1% strain and 1 Hz frequency) after 
network destruction by increasing strain from 0.1% to 1000% (region I: oscillatory strain 
sweep with 1 Hz frequency). 
Colloidal gelatin gels were easily incorporated into porous titanium scaffolds 
(Supplementary information Video 1) resulting in a homogeneous distribution of gels 
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throughout the interconnected porosity of the scaffolds as confirmed by micro-CT (Fig. 
1C and D). Scanning electron micrographs revealed the porous structure made of 
fused titanium particles as well as the surface morphology of titanium (Fig. 3A and B). 
The porous structure of the scaffolds was fully filled with nanostructured colloidal 
gelatin gels (Fig. 3C). As a consequence, original surface morphology of titanium was 
replaced by nanoparticulate morphology of colloidal gelatin gels consisting of 
nanoparticles ranging between 100-200 nm in diameter (Fig. 3D)[18]. 
 
Figure 3. Microscopic images of the porous titanium scaffolds before (A, B) and after (C, D) 
incorporation of the colloidal gelatin gels. Low (A, C) and high (B, D) magnification. 
3.2 In vivo evaluation 
3.2.1. Clinical evaluation 
All rats were able to tolerate weight-bearing activities immediately after surgery, and 
all implantation sites healed without complications. All animals remained healthy 
during the entire study period, except for one rat that received the BMP-2 group, 
which died due to anesthesia-related complications during the in vivo micro-CT scan 
made at four weeks.  
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Figure 4. Representative 3D micro-CT images of bone bridging the porous titanium scaffolds 
containing the unloaded gels (A), bFGF gels (B), BMP-2 gels (C) and BMP-2/bFGF gels (D) 
after twelve weeks implantation. Porous titanium scaffolds are shown in grey whereas bone 
appears in brown. 
 
Figure 5. Representative transversal micro-CT images of the porous titanium scaffolds 
containing the unloaded (A), bFGF (B), BMP-2 (C) and BMP-2/bFGF (D) gels after 12 weeks 
implantation. Porous titanium scaffolds and fixation screws appear in black whereas bone 
appears in dark grey. Scale bar = 1 mm. 
3.2.2. In vivo and ex vivo micro-CT evaluation 
In all groups, bone regeneration started at the proximal and distal bone adjacent to 
the defect and progressed towards the central area of the defect (Fig. 4). The defect 
was almost completely bridged (defined as a remaining gap <0.5 mm) in seven rats 
of the BMP-2/bFGF group, seven rats of the BMP-2 group, five rats of the bFGF 
group and one rat of the unloaded group. The average remaining gap distance was 
0.33±0.34 mm for the BMP-2/bFGF group, 0.51±0.74 mm for the BMP-2 group, 
0.83±0.53 mm for the bFGF group and 1.20±0.56 mm for the unloaded group. The 
2D images of cross-sections along the vertical axis of the femurs also confirmed 
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substantial bone ingrowth into pores and the inner medullary space originating from 
proximal and distal ends (Fig. 5). 
 
Figure 6. A) In vivo micro-CT quantification of total bone volume (BV) at four, eight twelve 
weeks after implantation. B) Ex vivo micro-CT quantification of total BV after twelve weeks of 
implantation. Total BV was defined as total volume of bone formed within the 6 mm defect 
area. Horizontal and vertical bars indicate statistically significant differences (p<0.05) 
between groups. 
Bone regeneration was quantified using in vivo micro-CT by measuring bone inside 
the defect (total BV) at different time points following implantation. All groups showed 
an increase at each time point, but there was significantly more bone regenerated in 
the defects that received the GF-loaded gels than those that received the unloaded 
gels after twelve weeks (Fig. 6). BMP-2 gels strongly enhanced bone formation 
during the first four weeks, and total BV was significantly more than unloaded gels at 
four weeks (Fig. 6A). Total BV continued to increase between four and eight weeks, 
and reached a plateau phase during the last four weeks (8-12 weeks). bFGF gels did 
not show a significant increase in total BV after four weeks, but between four and 
eight weeks total BV increased rapidly. Finally, bFGF gels resulted in 40.0±7.6 mm3 
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total BV, which was comparable to BMP-2 gels (42.9±18.9 mm3). BMP-2/bFGF gels 
continuously enhanced bone formation during the entire follow-up period, resulting in 
the highest average total BV at twelve weeks (49.6±8.6 mm3) (Fig. 6B). 
Bone formation was most profoundly enhanced outside the porous titanium scaffolds 
(outer BV) Porous titanium scaffolds with BMP-2/bFGF gels resulted in significantly 
more bone than those with BMP-2 gels, or bFGF gels (Fig. 7A). Bone ingrowth into 
the porous titanium scaffold (porous PV), however, was not significantly enhanced by 
the GF-loaded gels (Fig. 7B). Porous BV was 13.6±7.2 mm3 with BMP-2/bFGF gels, 
15.3±7.6 mm3 with BMP-2 gels, 14.4±4.2 mm3 with bFGF gels and 10.4±5.3 mm3 
with unloaded gels. bFGF-gels resulted in significantly more bone inside the porous 
titanium scaffold (inner BV) than BMP-2 gels. Inner BV was 6.1±0.8 mm3 with bFGF 
gels and 4.0±1.6 mm3 (p=0.033) with BMP-2 gels (Fig. 7C), respectively. The latter 
was comparable to BMP-2/bFGF gels (4.3±2.1 mm3) and unloaded gels (4.2±1.4 
mm3). 
 
Figure 7. Ex vivo micro-CT quantification of outer BV (A), porous BV (B) and inner BV (C) at 
twelve after weeks implantation. Outer BV was defined as bone formed outside the porous 
titanium scaffolds; porous BV: bone formed inside the porous space of the titanium scaffolds; 
and inner BV: bone formed in the medullary canal of the scaffold. Horizontal bars indicate 
statistical significant differences (p<0.05). 
3.2.3. Histological evaluation 
Light microscopy analysis of histological sections showed no distinct differences in 
terms of bone morphology, bone-titanium bonding or vascularisation between 
experimental groups (Fig. 8A-D). Area of newly formed bone, however, differed. 
Unloaded gels showed less bone (Fig 8A) than bFGF gels (Fig. 8B), BMP-2 gels (Fig. 
8C), and BMP-2/bFGF gels (Fig. 8D). Bone formation inside the porous space was 
mainly observed at distal and proximal sites of the scaffolds and resulted in direct 
bone-titanium contact (Fig. 8G). However, direct bone-titanium contact was not found 
throughout the entire bone-titanium interface. In some areas, bone-titanium interface 
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mainly observed at distal and proximal sites of the scaffolds and resulted in direct 
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throughout the entire bone-titanium interface. In some areas, bone-titanium interface 
Chapter 6 
 
148 
 
consisted of a cartilage-like zone (Fig.8E). Fibrous tissue infiltration was observed 
occasionally within areas inside pores devoid of newly formed bone and within the 
remaining gap of nearly completely bridged defects (Fig. 8F). No remnants of 
colloidal gelatin gels were detected after 12 weeks, and signs of foreign body 
reaction or inflammatory response were not observed. 
 
Figure 8. Representative transversal histological sections of the porous titanium scaffolds 
containing the unloaded (A), bFGF (B), BMP-2 (C) and BMP-2/bFGF (D) gels twelve weeks 
after implantation as well as high magnification views (E,F, and G) of the areas as depicted 
in figure D. Titanium appears in black whereas bone appears in purple. Scale bar = 1 mm. 
 
 
 
 
 
 
 
 
 
 
Figure 9. Fracture force that needed to break 
grafted femurs (treaded) and contralateral 
intract femurs (control) measured by three-
point bending test.  
 
3.2.4. Mechanical evaluation 
Five grafted femurs of each group and their contralateral intact femurs were 
subjected to three-point bending test up to the point of fracture. Fracture force was 
not significantly different, and in all groups the grafted femurs broke at approximately 
50% of the force required to break the intact contralateral femurs (Fig. 9) The 
observed fracture location, however, was different (Table 4). Femurs grafted with 
scaffolds containing unloaded gels broke at the bone-implant interface (2/5) or 
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through the porous titanium scaffolds (3/5). Similar fracture locations were observed 
for bFGF group. In contrast, the BMP-2 group consistently broke at the bone-implant 
interface (5/5) and the BMP-2/bFGF group fractured consistently (5/5) at the distal 
side through the host bone at a distance of 3 mm from the titanium-bone interface.  
 
4. Discussion 
Porous titanium scaffolds have recently received increasing attention due to their 
potential use as a bone substitute material that can function as an osteoconductive 
scaffold while providing direct mechanical support in large bone defects at weight-
baring sites[38]. Advanced production techniques, such as selective laser melting, 
allows for fine-tuning of design, microstructure and mechanical strength to meet 
specific requirements necessary for successful bone regeneration[33], However, 
porous titanium scaffolds remain bioinert and thereby lack the ability to provide 
biological cues to enhance bone regeneration. This lead to the hypothesis that 
incorporation of GF-loaded colloidal gelatin gels into porous titanium scaffolds would 
result in a mechanically strong and biologically active composite bone substitute 
material suitable for bone regeneration in large segmental defects. 
Table 4. Fracture locations of the three-point bending tests. 
Groups Host 
bone 
Bone-implant 
interface 
Implant 
Unloaded  2/5 3/5 
bFGF  3/5 2/5 
BMP-2  4/4  
BMP-
2/bFGF 
5/5   
Incorporation of colloidal gelatin gels into porous titanium scaffolds was easily 
obtained (Fig 1C and D) owing to shear-thinning and self-healing capacity of the gels, 
which were shown by fast recovery from severe network destruction during 
rheological testing (Fig. 2). Moreover, these gels were shown to exhibit a strong 
capacity for controlled and sustained delivery of multiple GFs by employing different 
subpopulations of gelatin nanospheres of different crosslinking densities[20]. Loading 
bFGF and BMP-2 into gelatin nanospheres of low and high crosslinking densities, 
respectively, have been shown to result in at fast release of bFGF and a sustained 
release of BMP-2. These in vitro release kinetics indicated that bFGF release 
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subpopulations of gelatin nanospheres of different crosslinking densities[20]. Loading 
bFGF and BMP-2 into gelatin nanospheres of low and high crosslinking densities, 
respectively, have been shown to result in at fast release of bFGF and a sustained 
release of BMP-2. These in vitro release kinetics indicated that bFGF release 
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reaches a peak rate after two weeks, and BMP-2 release continues until four 
weeks[20].  
Generally, the results confirmed load-bearing and osteoconductive properties of 
porous titanium scaffolds, as well as the biological efficacy of GFs delivery by 
nanostructured colloidal gelatin gels. As indicated by in vivo micro-CT, the presence 
of colloidal gels inside the porous space did not hamper bone regeneration. Total BV 
formed in the defect grafted with porous titanium scaffolds containing unloaded gels 
was comparable to total BV formed in our previous in vivo study, in which empty 
porous titanium scaffolds were used[33]. In all groups, direct bone-titanium contact 
was observed on histological sections, but occasionally a zone with cartilage-like 
tissue was formed at some parts of the bone-titanium interface (Fig. 8E). This 
cartilage-like tissue at the interface may indicate that micromotion had been possible 
at some areas of the interface between the titanium scaffold and surrounding tissues. 
Although bone healing generally benefits from a certain degree of micromotion, 
excessive micromotion is known to inhibit bone calcification especially at fracture 
union site[39]. This could also explain the fact that, although grafting with titanium 
scaffolds containing BMP-2/bFGF gels or BMP-2 gels resulted in almost complete 
bridging of most defects, none of the defects was fully bridged (Fig. 8F). The inability 
to bridge the defect can likely be overcome by the use of more rigid methods that are 
widely available in clinical orthopaedics. 
Incorporation of BMP-2/bFGF gels resulted in significantly more bone after 12 weeks 
than incorporation of unloaded gels. However, no significant difference in total bone 
volume was observed between different GF-loaded gels. Based on previous studies 
related to BMP-2 delivery in 6 mm segmental bone defects in rat femurs, a BMP-2 
dosage of 3 µg per defect was considered safe and efficient in stimulating 
osteogenesis[40]. BMP-2 gels exerted a stimulatory effect on early stages of bone 
healing (0-8 weeks), as reflected by significantly more bone at four and eight weeks 
compared to unloaded gels (Fig. 6A). This early effect of BMP-2 gels on 
osteogenesis was also observed in a previous in vivo study, where BMP-2 gels in rat 
femoral condyle defects led to significant enhancement of bone formation[20]. After 
eight weeks, bone regeneration slowed down. This may be explained by the 
complete release of GFs from the colloid gelatin gels that where shown to degradate 
within four weeks time[20]. 
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On the other hand, delivery of 0.6µg bFGF per defect resulted in comparable 
amounts of bone formed after twelve weeks as delivery of a five times higher doses 
of BMP-2 (i.e. 3 µg per defect). This stresses stimulatory effects of low dose bFGF (in 
sub-microgram amounts) on bone regeneration in vivo[41]. The osteogenic potential of 
bFGF showed a biphasic behavior, characterized by limited osteogenesis at early 
stages (0-4 weeks) and a more pronounced stimulatory effect on bone formation at 
later stages (after 4 weeks) (Fig. 6A). Although it was not possible to elucidate the 
exact mechanism of action of bFGF, it can be speculated that bFGF mainly 
stimulated proliferation of cells committed to osteogenic lineage at early phases, thus 
creating an expanded pool of osteoprogenitor cells that resulted in massive bone 
formation at later phases[41, 42]. In addition, the angiogenic effect of bFGF can 
potentially lead to enhanced vascularization which can in turn benefit bone 
regeneration[28, 43]. Moreover, in spite of the absence of significant differences in total 
BV at twelve weeks between BMP-2 and bFGF gels, significantly higher bone 
volumes were observed within the medullary canal for bFGF gels compared to BMP-
2 gels (Fig. 7C). This may have been caused by the more pronounced proliferative 
effects of bFGF on endosteal rather than periosteal cells[44, 45]. 
BMP-2/bFGF gels incorporated into titanium scaffolds resulted in continuous increase 
in total BV. Although total BV after twelve weeks was not statistically different 
compared to BMP-2 gels or bFGF gels, significantly more bone was formed outside 
the porous titanium scaffolds. A possible explanation for this phenomenon could be 
the higher availability or more efficient attraction of osteoprogenitor cells from soft 
tissues on the outer side of titanium scaffolds compared to inner parts. A previous 
study by Wang et al. showed inhibitory effects on in vivo bone regeneration when 
colloidal gelatin gels loaded with 1:1 dose ratio of BMP-2 and bFGF (2 µg per defect). 
This inhibitory effect was attributed to overdosing of bFGF relative to BMP-2[20]. 
Similar observations have been reported on combined delivery of BMP-2 and bFGF, 
indicating that higher doses of bFGF (in µg scale) in combination with lower or equal 
doses of BMP-2 generally hampered bone formation[23-25, 46]. However, lower doses 
of bFGF (in ng scale) in combination with higher doses of BMP-2 stimulated 
osteogenesis[23, 25, 28, 29, 31, 32, 42, 46]. Our results are in line with those observations, 
since a 5:1 dose ratio of BMP-2:bFGF resulted in more bone formation around the 
titanium scaffolds than the single delivery of either BMP-2 or bFGF. 
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The mechanical strength of the grafted femurs was assessed using a three-point 
bending test, which aimed to evaluate strength of the interface between porous 
titanium scaffolds and adjacent host bone. Despite the absence of significant 
differences in fracture force (Fig. 9), fracture locations of grafted femurs may indicate 
that the degree of integrity between bone tissue and titanium scaffolds differed 
between groups after twelve weeks (Table 4). Bending femurs that were grafted with 
titanium scaffolds containing unloaded gels, BMP-2 gels or bFGF gels resulted in 
fractures located at either the bone-implant interface or inside the titanium scaffolds. 
This indicates that the amount of bone ingrowth into the porous scaffolds was not 
sufficient to prevent fracture at the direct vicinity. The amount and extend of bone 
regenerated in the defect grafted with scaffolds containing BMP-2/bFGF gels shifted 
the weakest link of the femurs from the scaffolds to the surrounding femoral host 
bone. This observation confirmed the efficacy of material combination of titanium 
scaffolds and GF-loaded gels as a potential bone substitute material to graft critical-
sized segmental bone defects. 
 
5. Conclusions 
In this study, nanostructured colloidal gelatin gels loaded with BMP-2 and/or bFGF 
were incorporated in porous titanium scaffolds for the treatment of a critical-sized 
segmental bone defect in rat femurs. The in vivo study demonstrated obvious 
stimulatory effects of GF-loaded gels on bone regeneration. Bone regeneration starts 
at distal sites and progressed towards the center of the defect, leading to nearly 
complete bridging in most defects grafted with porous titanium scaffolds containing 
BMP-2/bFGF gels or BMP-2 gels. Moreover, after twelve weeks the effect on bone 
regeneration of low doses of bFGF (0.6µg per defect) was similar to the five-fold 
higher doses of BMP-2 (3 µg per defect), confirming the osteogenic potential of bFGF. 
BMP-2/bFGF gels resulted in significantly more bone outside the porous titanium 
scaffolds. Although three-point bending tests did not show significant differences in 
fracture force, fracture patterns indicate that BMP-2/bFGF gels resulted in sufficient 
reinforcement of the porous scaffolds, since the weakest point of the grafted femurs 
was shifted to surrounding femoral host bone. In summary, nanostructured colloidal 
gelatin gels incorporated into porous titanium scaffolds provide a mechanically strong 
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grafting material capable to enhance bone regeneration through controlled delivery of 
growth factors. 
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regenerated in the defect grafted with scaffolds containing BMP-2/bFGF gels shifted 
the weakest link of the femurs from the scaffolds to the surrounding femoral host 
bone. This observation confirmed the efficacy of material combination of titanium 
scaffolds and GF-loaded gels as a potential bone substitute material to graft critical-
sized segmental bone defects. 
 
5. Conclusions 
In this study, nanostructured colloidal gelatin gels loaded with BMP-2 and/or bFGF 
were incorporated in porous titanium scaffolds for the treatment of a critical-sized 
segmental bone defect in rat femurs. The in vivo study demonstrated obvious 
stimulatory effects of GF-loaded gels on bone regeneration. Bone regeneration starts 
at distal sites and progressed towards the center of the defect, leading to nearly 
complete bridging in most defects grafted with porous titanium scaffolds containing 
BMP-2/bFGF gels or BMP-2 gels. Moreover, after twelve weeks the effect on bone 
regeneration of low doses of bFGF (0.6µg per defect) was similar to the five-fold 
higher doses of BMP-2 (3 µg per defect), confirming the osteogenic potential of bFGF. 
BMP-2/bFGF gels resulted in significantly more bone outside the porous titanium 
scaffolds. Although three-point bending tests did not show significant differences in 
fracture force, fracture patterns indicate that BMP-2/bFGF gels resulted in sufficient 
reinforcement of the porous scaffolds, since the weakest point of the grafted femurs 
was shifted to surrounding femoral host bone. In summary, nanostructured colloidal 
gelatin gels incorporated into porous titanium scaffolds provide a mechanically strong 
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grafting material capable to enhance bone regeneration through controlled delivery of 
growth factors. 
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1. Introduction 
Colloidal gels are a particularly attractive class of hydrogels since these materials 
allow for “bottom-up” synthesis of functional, self-healing materials by employing 
micro- or nanoscale particles as building blocks to assemble into shape-specific bulk 
materials[1-6]. To this end, interparticle interactions such as electrostatic forces[4, 5], 
magnetic forces[4], hydrophobic interactions[7] and steric hindrance[8] can be exploited 
to induce self-assembly of micro- or nanoparticles into integrated scaffolds. For 
applications in regenerative medicine, charged micro- or nanospheres made of 
biocompatible polymers are the most obvious candidates to serve as building blocks, 
since the physicochemical properties of polymeric particles can be tailored to desire 
in terms of size, charge and chemical derivatization. Therefore, colloidal gels have 
been formed by self-assembly of oppositely charged microspheres (e.g. chemically 
functionalized dextran[9]) or nanospheres (e.g. chemically functionalized poly(lactic-
co-glycolic acid (PLGA) nanospheres[5])[3, 5, 9-12]. Recently, our group has developed a 
novel class of colloidal gels made of oppositely charged gelatin nanospheres, which 
displayed superior mechanical and biological properties over microstructured 
colloidal gelatin gels[10, 13]. Although the general mechanism of heteroaggregation has 
been studied as of recently[14, 15], this knowledge has not yet been translated towards 
the development of colloidal composite gels made of biocompatible organic and 
inorganic nanoparticles for biomedical applications. For regeneration of hard tissues, 
the introduction of inorganic building blocks into colloidal gels could offer 
considerable advantages over purely organic colloidal gels by i) increasing stiffness 
and strength, ii) modulating gel degradation and corresponding release kinetics of 
loaded biomolecules, and iii) improving the biological tissue response owing to the 
osteoconductive properties of inorganic nanoparticles made of e.g. calcium 
phosphate (CaP)[16-18]. 
Still, it is not known if interparticle forces between organic and inorganic 
nanoparticles can be sufficiently strong to allow for the formation of cohesive colloidal 
composite gels for application in regenerative medicine. Therefore, we have studied 
the feasibility of forming colloidal composite gels by introducing neutral or charged 
CaP nanoparticles into colloidal gelatin gels. CaP nanoparticles were selected in view 
of their osteoconductivity[16] as well as inherent affinity to proteins such as collagen, 
gelatin and growth factors[19-23], and because charged CaP nanoparticles can be 
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easily obtained by decorating CaP nanoparticle surfaces with e.g. negatively charged 
citrate anions that have a strong affinity for CaP surfaces[24]. Gelatin (Gel) was 
selected as source for organic nanoparticles since both positively (type A) and 
negatively charged (type B) gelatins are commercially available. As such, self-
assembly between oppositely charged organic and inorganic nanoparticles was 
studied without the need for additional chemical functionalizations, which might 
compromise the biocompatibility of the final constructs, thereby opening a simple and 
promising route for the fabrication of nanostructured composite biomaterials of 
improved functionality. 
The phenomenon of heteroaggregation of CaP and gelatin nanoparticles was studied 
with Dynamic Light Scattering (DLS) by monitoring the self-assembly process of 
colloidal mixtures at diluted conditions (~ 0.02 w/v%) as a function of parameters 
such as particle charge, CaP to gelatin ratio (CaP/Gel ratio) and ionic strength, 
whereas rheometry was used to investigate the gel formation at higher solid contents 
of up to 20 w/v% as a function of solid content, CaP/Gel ratio, and ionic strength. 
Moreover, the biological performance of the resulting Gel-CaP colloidal composite 
gels composed of gelatin and CaP nanoparticles was studied in vitro by evaluating i) 
gel degradation, ii) release kinetics of a (radiolabeled) osteogenic protein (bone 
morphogenetic protein-2 (BMP-2)), and iii) the cellular response of bone marrow 
stem cells cultured in contact with the colloidal composite gels. 
 
2. Experimental 
2.1. Materials 
Gelatin A (GelA, from porcine skin, 300 Bloom, isoelectric point (IEP) ~9) and gelatin 
B (GelB from bovine skin, 225 Bloom, IEP ~5) were purchased from Sigma-Aldrich. 
Calcium hydroxide (Ca(OH)2, 98+%, extra pure), sodium citrate tribasic dihydrate 
(Na3C6H5O7·2H2O), and glutaraldehyde (GA, 25 wt% solution in water) were 
purchased from Acros Organics. Phosphoric acid (H3PO4, 85%) and acetone were 
from J.T. Baker. Recombinant Human Bone Morphogenetic Protein-2 (BMP-2, 
carrier-free, catalog number: 355BM/CF, molecular mass 13 kDa, isoelectric point 
(IEP) 8.5) was supplied by R&D systems. All other materials were purchased from 
Sigma-Aldrich. 
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gelatin and growth factors[19-23], and because charged CaP nanoparticles can be 
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easily obtained by decorating CaP nanoparticle surfaces with e.g. negatively charged 
citrate anions that have a strong affinity for CaP surfaces[24]. Gelatin (Gel) was 
selected as source for organic nanoparticles since both positively (type A) and 
negatively charged (type B) gelatins are commercially available. As such, self-
assembly between oppositely charged organic and inorganic nanoparticles was 
studied without the need for additional chemical functionalizations, which might 
compromise the biocompatibility of the final constructs, thereby opening a simple and 
promising route for the fabrication of nanostructured composite biomaterials of 
improved functionality. 
The phenomenon of heteroaggregation of CaP and gelatin nanoparticles was studied 
with Dynamic Light Scattering (DLS) by monitoring the self-assembly process of 
colloidal mixtures at diluted conditions (~ 0.02 w/v%) as a function of parameters 
such as particle charge, CaP to gelatin ratio (CaP/Gel ratio) and ionic strength, 
whereas rheometry was used to investigate the gel formation at higher solid contents 
of up to 20 w/v% as a function of solid content, CaP/Gel ratio, and ionic strength. 
Moreover, the biological performance of the resulting Gel-CaP colloidal composite 
gels composed of gelatin and CaP nanoparticles was studied in vitro by evaluating i) 
gel degradation, ii) release kinetics of a (radiolabeled) osteogenic protein (bone 
morphogenetic protein-2 (BMP-2)), and iii) the cellular response of bone marrow 
stem cells cultured in contact with the colloidal composite gels. 
 
2. Experimental 
2.1. Materials 
Gelatin A (GelA, from porcine skin, 300 Bloom, isoelectric point (IEP) ~9) and gelatin 
B (GelB from bovine skin, 225 Bloom, IEP ~5) were purchased from Sigma-Aldrich. 
Calcium hydroxide (Ca(OH)2, 98+%, extra pure), sodium citrate tribasic dihydrate 
(Na3C6H5O7·2H2O), and glutaraldehyde (GA, 25 wt% solution in water) were 
purchased from Acros Organics. Phosphoric acid (H3PO4, 85%) and acetone were 
from J.T. Baker. Recombinant Human Bone Morphogenetic Protein-2 (BMP-2, 
carrier-free, catalog number: 355BM/CF, molecular mass 13 kDa, isoelectric point 
(IEP) 8.5) was supplied by R&D systems. All other materials were purchased from 
Sigma-Aldrich. 
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2.2. Preparation of gelatin nanospheres 
Gelatin nanospheres were prepared using a two-step desolvation method as 
reported previously[10]. Subsequently, GA was used to stabilize gelatin nanospheres 
with a molar ratio of GA relative to[NH2]gelatin of 1:1
[10]. After crosslinking at room 
temperature for 16 h, glycine solution (100 mM) was added to the nanosphere 
suspension to block unreacted aldehyde groups. The nanospheres were washed and 
finally suspended in deionized water, after which the pH of nanosphere suspension 
was adjusted to pH 7.0. The particle size of gelatin nanoparticles dispersed in 
deionized water (solid content 0.01 w/v%) was determined using Dynamic light 
scattering (DLS, Zetasizer Nano-S, Malvern Instruments Ltd.), whereas the ζ-
potential of gelatin nanospheres (dispersed in 5 mM HEPES buffer at pH 7.0) was 
measured by laser doppler electrophoresis using a Zetasizer Nano-Z (Malvern 
Instruments Ltd.). 
 
2.3. Preparation and characterization of CaP nanoparticles 
Apatitic CaP nanoparticles were prepared using an established wet-chemical 
precipitation method based on the following reaction between calcium hydroxide and 
ortho-phosphoric acid[25]: 
5Ca(OH)2 + 3 H3PO4Ca5(PO4)3(OH) + 9H2O 
Briefly, 100ml H3PO4 solution (75mM) was added dropwise into an aqueous 
suspension of 100ml Ca(OH)2 (125mM) under continuous stirring for 14-16h at room 
temperature, followed by adjustment of the pH to 7.0. CaP nanoparticles were 
centrifuged (2767 g, 1min) and resuspended in deionized water three times and 
finally stored as aqueous suspension (40mg/ml) after adjustment of the pH to 7.0. 
Sodium citrate was used to render CaP nanoparticles negatively charged by surface 
adsorption as described before[26]. CaP nanoparticles were suspended in 10 mM 
aqueous solution of sodium citrate dihydrate at 10 mg ml-1 under continuous stirring 
at room temperature for 14-16h, after which sodium citrate-treated CaP nanoparticles 
were rinsed in deionized water and stored in aqueous suspension (10 mg/ml) after 
adjusting the pH value to 7.0. The lyophilized CaP powders were analyzed using 
attenuated total reflectance-fourier transform infrared spectroscopy (ATR-FTIR, 
Perkin Elmer), x-ray diffraction (XRD, Phillips X’Pert, PW3710), and ζ-potential 
measurement by laser doppler electrophoresis using a Zetasizer Nano-Z (Malvern 
Chapter 7 
 
163 
 
Instruments Ltd.). The morphology of the particles was visualized by transmission 
(TEM, JEOL 1010) and scanning electron microscopy (SEM, JEOL 6301). 
 
2.4. Self-assembly of CaP and Gel nanoparticles 
The particle size of mixed dispersions of CaP and/or gelatin nanoparticles in 
deionized water was monitored by DLS as a function of time. The effect of ionic 
strength and CaP/Gel ratio on self-assembly of oppositely charged C-CaP and GelA 
nanoparticles was investigated (total solid content (Gel+CaP) of 0.02 w/v%) by 
increasing the salt concentration (at 0, 10, 100 and 1000 mM NaCl) or CaP/Gel ratio 
(at CaP/Gel of 0.1, 0.5, 1 and 5), respectively, followed by monitoring the (change of) 
particle size by DLS. 
 
2.5. Gel formation 
Lyophilized gelatin nanospheres were mixed with CaP nanoparticle suspensions (pH 
7.0) of different CaP concentration in either 2 ml Eppendorf® tubes followed by 
vortexing (for rheological studies) or in two connected 1ml BD® Luer-lockTM syringes 
(for cell culture studies). This latter syringe system allows for formation of 
homogeneous colloidal dispersions (solid gelatin content between 20 w/v% and 
CaP/Gel ratios between 0.1) by repeated extrusion (20x) between two syringes. The 
resulting colloidal dispersions were stored at 4 ºC for >2 h to allow for complete 
swelling of gelatin nanospheres. 
 
2.6. Rheological characterizations 
The viscoelastic properties of colloidal dispersions made of CaP and/or gelatin 
nanospheres were characterized using a rheometer (AR2000ex, TA Instruments). 
Oscillatory time, frequency and strain sweeps confirmed that all rheological 
characterizations were performed within the linear viscoelastic region 
(Supplemental data Fig. S1). All measurements were performed using a flat steel 
plate geometry (20 mm diameter) at 25 ºC. The storage modulus G’, loss modulus 
G” and tan(delta) were determined using an oscillatory time sweep test for 5 min 
at a constant strain of 1% and frequency of 1 Hz. Recovery kinetics of the 
colloidal dispersions after shearing were evaluated by adopting a method as 
described by Haines-Butterick et al.[38], which mimics the clinical injection 
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procedure (i.e. single gel destruction by high shear forces upon extrusion through 
syringes with narrow needles). To this end, viscoelastic properties (G’ and G’’) of 
Gel-CaP colloidal dispersions (20 w/v% solid content) were measured as a 
function of time in an oscillatory time sweep (5 min, 1 % strain, 1 Hz frequency) 
before and after severe destruction of the gel network (1000 % strain, 1 min, 1 Hz 
frequency). Creep experiments were performed to evaluate gel deformation (i.e. 
strain) under a constant shear stress of 10 Pa (for 1 min) followed by measuring 
gel recovery (strain) for 3 min. 
 
2.7. In vitro degradation 
The degradability of colloidal gels consisting of gelatin nanospheres (20 w/v% 
solid content) with or without the addition of CaP nanoparticles (CaP/Gel ratio of 
0.1) was evaluated by incubation in phosphate buffered saline (PBS) solution 
containing collagenase 1A, and measuring total protein release in the supernatant 
using the bicinchoninic acid (BCA) assay at various time points. Briefly, 5 mg 
gelatin nanospheres were mixed with 25 µl CaP nanoparticle suspension (20 
mg/ml CaP, pH 7.0) in 2 ml Eppendorf® tubes and stored at 4 ºC overnight to 
allow for complete swelling of gelatin. 1 ml of PBS containing 400 ng/ml 
collagenase 1A and 0.001 w/v% sodium azide was then added into the tube which 
was thereafter incubated at 37 ºC on a rotating plate. At each time point, 0.9 ml of 
supernatant was collected for the BCA assay after centrifugation (2767 g, 5 min) 
to separate colloidal gels, and similar volumes of medium (i.e. 0.9 ml) were added 
afterwards. 
 
2.8. In vitro growth factor release 
The preparation of 125I-labeled BMP-2 was described previously[13] using the 
iodogen method[39]. 12.5 µl of a solution containing radiolabeled BMP-2 (at 24 
µg/ml) and 12.5 µl of CaP nanoparticle suspension (40 mg/ml) were mixed with 5 
mg of lyophilized gelatin nanospheres in a 2 ml Eppendorf® tube to form a 
homogeneous BMP-2-loaded Gel-CaP colloidal composite gel with a solid gelatin 
content of 20 w/v% and a CaP/Gel ratio of 0.1. To ensure complete sorption of 
biomolecules by the gels, less volume of liquid than required for complete swelling 
of gelatin nanospheres was used. A dose of 60 ng BMP-2 per mg gelatin was 
used[40]. The mixtures were stored at 4 ºC overnight to allow for complete sorption 
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of the proteins. 1 ml PBS containing 400 ng/ml collagenase 1A and 0.001 w/v% 
sodium azide was added to the tube and then incubated at 37 ºC on a shaking 
plate (70 rpm). At each time point, 0.9 ml of supernatant was refreshed with a 
similar volume of medium (i.e. 0.9 ml) after centrifugation (2767 g, 5 min) to 
sediment the colloidal composite gel. The release of BMP-2 at each time point 
was monitored by measuring the residual γ-irradiation from the samples using a 
gamma counter after refreshing the supernatant media. Consequently, the 
cumulative release of BMP-2 was determined by normalizing radioactivity at each 
time point with starting radioactivity of each sample. The decay of I125 was taken 
into account by recording the remaining radioactivity of labeled BMP-2 which was 
not loaded onto the colloidal gels. 
 
2.9. Cell culture study 
Frozen stocks of primary bone marrow stem cells (BMSCs) obtained from rat femurs 
were cultured for 6 days in proliferation medium (Dulbecco’s modified Eagle medium 
(DMEM, Sigma-Aldrich), supplemented with 10% v/v fetal bovine serum (FBS, Gibco), 
at 37°C, 95% relative humidity and 5% CO2
[41]. The medium was changed after 1 day 
to remove non-adherent cells, and it was refreshed after every three days of culture. 
At ~80% confluency, cells were washed twice with PBS, detached using 
trypsin/EDTA (0.25 % w/v trypsin/0.02 % EDTA) for 5 min and resuspended in 
osteogenic medium, i.e., DMEM supplemented with 10% v/v FBS, 10 nM 
dexamethasone (Sigma), 10 mM β-glycerophosphate (Sigma), 50 mg/L ascorbic acid 
(Sigma-Aldrich) and 50 mg/L gentamicin (Gibco). 
Gelatin nanospheres were freeze-dried for 48 h and CaP suspension was sterilized 
by wet autoclavation. These nanospheres were dispersed in either 1 mM NaCl 
solution (pH 7) or CaP nanoparticle suspension (pH 7) using the above-mentioned 
Luer-lock syringe system, and 100 µl of the resulting composite gels (solid gelatin 
content of 20 w/v%, CaP/Gel ratio of 0.1) were injected into 8-micron translucent 
inserts for 24-well plates (Greiner-Bio One). Additionally, gels for qualitative 
LIVE/DEAD assays were injected (200 µl) into circular PTFE molds (10 mm diameter) 
and incubated in 12-well plates. The gel-loaded molds were soaked in 1 ml (for 100 
µl-gels) or 4 ml (for 200 µl-gels) of culture medium and incubated at 37°C overnight. 
Subsequently, BMSCs were seeded on top of the gels at 5000 cells/cm2 and allowed 
to attach for 1 hour. Subsequently, 2 ml of osteogenic medium was added followed 
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by another medium change after 1 day and subsequent medium changes every 3 
days during the 24-day culture period to prevent nutrient exhaustion. 100 µl-gels 
were removed at day 4, 8, 12, 16 and 24 day post-seeding for quantitative analysis of 
cell proliferation, whereas 200 µl-gels were removed at day 4, 16 and 24 day for 
qualitative assessment of cell viability. 
Cell survival was determined using a LIVE/DEAD Viability/Cytotoxicity Kit (Molecular 
Probes). To this end, gels were washed in sterile PBS for 30 min at 37°C prior to 
incubation for 30 min at room temperature with 2 mM calcein-AM (green-fluorescent 
dye to indicate intracellular esterase activity for live cells) and 4 mM ethidium 
homodimer (red-fluorescent dye to indicate loss of plasma membrane integrity for 
dead cells) in PBS solution. After incubation, gels were rinsed in PBS and examined 
using an Olympus FV1000 confocal laser scanning microscope with a 40x water-
immersion objective (CLSM, Olympus, Center Valley, PA, USA). 
In view of proliferation analysis, samples were washed in PBS, incubated in 1000 µL 
double-distilled water (ddH2O) and stored at -20°C before analysis. Upon analyses, 
scaffolds were subjected to three freeze-thaw cycles, and DNA content was 
measured using Quant-iTTM PicoGreen Kit (Invitrogen) according to the instructions 
of the manufacturer. Briefly, 100 µl of samples or DNA standards (from 0 to 2000 
ng/mL) were incubated with 100 µl of PicoGreen working solution and allowed for 
incubation at room temperature for 2-5 min in the dark. The excitation of the solution 
at 485 nm and fluorescence measurement at 530 nm was performed using a 
fluorescence microplate reader (n=3). 
 
2.10. Statistics 
All results are depicted as average ± standard deviation. The statistical analyses 
were performed using GraphPad InStat software. Differences among groups were 
determined by one-way Analysis of Variance (ANOVA) with a Bonferroni (multiple 
comparison) post test, and a value of p < 0.05 was considered as significantly 
different. 
Table 1. Zeta-potential values of calcium phosphate (CaP), citrate-treated CaP (C-CaP), 
gelatin A (GelA) and gelatin B (GelB) nanoparticles (n=3). 
Groups CaP C-CaP GelA GelB 
zeta-potential (mV) +3.0±0.2 -20.8±0.7 +9.3±0.3 -20.0±0.4 
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Figure 1. The effect of citrate adsorption onto CaP nanoparticles on the stability of the 
aqueous suspensions (in deionized water) evaluated by DLS (A) and TEM (B, C). A) Particle 
size of nanosphere suspensions monitored by DLS (insert showing suspensions of CaP and 
C-CaP nanoparticles after 20 min equilibration). TEM images of CaP (B) and C-CaP (C) 
nanoparticles (scale bar = 500 nm), dispersed in deionized water at a CaP content of 0.01 
w/v%. 
 
Figure 2. Particle size in suspensions containing GelA (A, B) or GelB (C, D) nanospheres 
and CaP or C-CaP nanoparticles characterized by DLS (A, C) or photography of the samples 
after 20 min of equilibration (B, D). The CaP (or C-CaP) and gelatin nanoparticles were 
mixed in deionized water at CaP/Gel weight ratio of 1 and a total solid content (Gel+CaP) of 
0.02 w/v%. 
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mixed in deionized water at CaP/Gel weight ratio of 1 and a total solid content (Gel+CaP) of 
0.02 w/v%. 
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3. Results  
3.1. Preparation and characterization of CaP nanoparticles 
Formation of CaP nanoparticles using an established wet-chemical precipitation 
method[25] resulted into the formation of needle-shaped apatitic crystals with a typical 
length of 100-200 nm and a width of about 15 nm. The addition of sodium citrate to 
suspensions containing these CaP nanoparticles shifted the ζ-potential of CaP 
nanoparticles from relatively neutral (~+3mV) to highly negative (~-21 mV) (Table 1), 
corresponding to effective adsorption of citrate anions onto CaP nanoparticles as 
described in previous studies[24, 26]. CaP nanoparticle suspensions displayed a linear 
increase in particle size as a function of time (Fig. 1A), which resulted into 
sedimentation of large aggregates of CaP nanoparticles after 20 min of equilibration 
(Fig.1A, insert). In contrast, particle size in citrate-treated CaP nanoparticle (further 
abbreviated as C-CaP) suspensions was constant, reflecting that the repulsive 
electrostatic forces between negatively charged C-CaP particles were sufficient to 
prevent agglomeration. This phenomenon was also confirmed using transmission 
electron microscopy (TEM), which revealed pronounced aggregation of CaP 
nanoparticles (Fig. 1B) that was absent for C-CaP nanoparticles (Fig. 1C). 
 
Figure 3. TEM images of colloidal suspensions containing GelA (A) or GelB (D) nanospheres 
(scale bar = 5 µm) or gelatin nanospheres mixed with CaP (B, E) or C-CaP nanoparticles (C, 
F) (scale bar = 2 µm), dispersed in deionized water at a CaP/Gel weight ratio of 1. Inserts are 
TEM images at higher magnification (scale bar = 200 nm). 
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Regarding the chemical structure of precipitated CaP nanoparticles, ATR-FTIR 
spectroscopy of pure CaP showed pronounced phosphate absorption peaks typical 
for apatitic CaP (560, 603, 960, 1030, 1090 and 3570 cm-1) and weak absorption 
bands at 873 and 1415 cm-1 characteristic for type B carbonate-for-phosphate 
substitutions within the apatitic lattice[27], whereas an additional peak for citrate (1588 
cm-1) was observed for C-CaP nanoparticles[24], confirming the presence of citrate on 
the CaP crystallites (Supplemental data. Fig. S1). The XRD pattern of CaP confirmed 
the poorly crystalline apatitic crystal structure of the precipitated CaP nanoparticles, 
while the adsorption of citrate anions did not alter the crystal structure of the 
precipitated crystals (Supplemental data. Fig. S2). 
 
Figure 4. Effect of ionic strength (A, B) and CaP/Gel ratio (C, D) on the self-assembly of C-
CaP and GelA nanoparticles characterized by DLS (A, C) and photography of the samples 
after 20 min equilibration (B, D). A, B) C-CaP and GelA nanoparticles were mixed in 
deionized water (0 mM) or aqueous solutions of 10, 100 and 1000 mM NaCl (pH 7) at a 
CaP/Gel weight ratio of 1. C, D) C-CaP and GelA nanoparticles of various CaP/Gel ratios 
(w/w) (0.1, 0.5, 1 and 5) were mixed in deionized water at a total solid content (Gel+CaP) of 
0.02 w/v%. 
3.2. Self-assembly of gelatin and CaP nanoparticles 
To study the interaction between gelatin and CaP nanoparticles in more detail, DLS 
was used to monitor the particle size in suspensions of gelatin nanospheres with or 
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without addition of CaP and C-CaP nanoparticles as a function of time (Fig. 2A and 
C). For GelA or GelB nanosphere suspensions, the particle size did not change in 
time, indicating that repulsive interparticle forces between similarly charged 
nanospheres stabilized the suspension by preventing particle aggregation (Fig. 2B 
and D (left vials)). Upon addition of CaP nanoparticles, on the contrary, particle sizes 
increased considerably irrespective of gelatin nanoparticle charge, resulting into 
heteroaggregation of organic and inorganic nanoparticles (Fig. 2B and D (middle 
vials)). The addition of C-CaP nanoparticles to oppositely charged GelA 
nanoparticles resulted into a similar increase in particle size and corresponding 
sedimentation of large aggregates (Fig. 2B (right vial)), whereas a constant particle 
size without any sedimentation was observed upon mixing of C-CaP with similarly 
charged GelB nanospheres. 
Corresponding TEM characterizations confirmed the observations made using DLS 
by revealing severe clustering of spherical GelA nanoparticles with oppositely 
charged needle-like C-CaP (Fig. 3C) as well as CaP nanoparticles with GelA or GelB 
nanospheres (Fig. 3B and E). Such clusters were absent in suspensions containing 
solely GelA or GelB nanospheres (Fig. 3A and D) and hardly present in suspensions 
containing spherical GelB nanospheres and C-CaP nanoparticles (Fig. 3F). 
Since the charge difference between organic and inorganic nanoparticles and 
resulting particle aggregation was highest for C-CaP and GelA nanoparticles (see 
Table 1 and Fig. 2B), this combination of nanoparticles was selected for further 
investigations on the nature of the interparticle forces. The ionic strength did not 
affect the formation of heteroaggregates between C-CaP and GelA nanoparticles at 
NaCl concentrations of up to 100 mM, as reflected by the constant increase in 
particle size (Fig. 4A) and rapid sedimentation of the aggregates (Fig. 4B). Only the 
highest ionic strength of 1M NaCl was effective to inhibit sedimentation of C-CaP and 
GelA nanoparticles. Fig. 4D shows the self-assembly process of C-CaP and GelA 
nanoparticles as a function of CaP/Gel ratio. The particle size increased considerably 
in suspensions containing C-CaP and GelA nanoparticles with moderate CaP/Gel 
ratios of 0.5 and 1 (w/w) resulting into rapid sedimentation of aggregates, whereas at 
either low or high CaP/Gel ratios (i.e. 0.1 or 5), self-assembly between organic and 
inorganic nanoparticles was hampered. 
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3.3. Gel formation 
3.3.1. Effect of CaP nanoparticles on storage moduli of colloidal composite 
gels 
The effect of CaP and C-CaP nanoparticles on viscoelastic properties of Gel-CaP 
colloidal composite gels (gelatin solid content 10 w/v%) is shown in Fig. 5. By adding 
citrate-free CaP nanocrystals (C-CaP), storage moduli G’ (Fig. 5A) strongly increased 
from 0.5-0.8 kPa for CaP-free colloidal gelatin gels to 4-9 kPa for gels at a low 
CaP/Gel ratio of 0.1 up to 8-48 kPa for gels at a CaP/Gel ratio of 1. This reinforcing 
effect upon addition of a nanostructured CaP phase was observed to a much less 
extent for colloidal gels comprising negatively charged C-CaP nanoparticles 
(especially at a high CaP/Gel ratio of 1.0). Finally, it was observed that Gel-CaP 
composite gels containing GelB nanospheres displayed higher storage moduli than 
gels containing GelA nanospheres.  
 
Figure 5. Storage moduli (G’) of colloidal dispersions composed of GelA or GelB 
nanospheres mixed with CaP or C-CaP nanoparticles as a function of (A) CaP/Gel weight 
ratio (gelatin solid content 10 w/v%, dispersions in deionized water) or (B) ionic strength 
(gelatin content of 10 w/v%, CaP/Gel ratio of 0.1) (n=3). 
Gel elasticity of colloidal gels made of citrate-free CaP nanoparticles and gelatin 
nanospheres was hardly dependent on the ionic strength (Fig. 5B), whereas colloidal 
gels made of C-CaP and gelatin nanoparticles revealed a more pronounced 
dependency of gel elasticity on ionic strength as reflected by a continuous decrease 
of G’ from 4.5 to 2.5 kPa or from 6.0 to 3.5 kPa for gels containing GelA or GelB 
nanospheres, respectively, with NaCl concentrations increasing from 10 to 1000 mM. 
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Figure 6. Effect of CaP/Gel ratios on storage moduli (A) and corresponding tan(delta) values 
(B) of the colloidal composite gels containing gelatin and CaP nanoparticles dispersed in 
deionized water at a total solid content (Gel+CaP) of 20 w/v% (n=3). 
3.3.2. Effect of CaP/Gel ratio on viscoelastic properties of colloidal composite 
gels 
Since organic-inorganic colloidal composite gels containing citrate-free CaP 
nanoparticles exhibited superior viscoelastic properties over gels containing C-CaP 
nanoparticles, only colloidal gels consisting of gelatin and citrate-free CaP 
nanoparticles were used for further rheological characterizations. These studies were 
performed at a fixed total solid (CaP+Gel) content of 20 w/v% instead of a fixed total 
gelatin content in order to identify the optimal CaP/Gel ratio for further biological 
characterizations (sections 3.4 and 3.5). Additionally, a fixed total solid content in the 
colloidal dispersions could minimize the influence of the volume fraction of colloidal 
particles on gel strength[5], thus providing indications of the contribution of 
interparticle cohesion on colloidal gel strength. CaP-free colloidal gelatin gels 
(CaP/Gel ratio of 0) were elastic characterized by G’ values of 7-10 kPa and 
corresponding tan(delta) values of about 0.02 (Fig. 6A and B). At similar total solid 
contents, colloidal composite gels composed of CaP and gelatin nanoparticles at 
CaP/Gel ratios of 0.1, 0.5 and 1 revealed considerably higher storage moduli than 
CaP-free gels. The reinforcing effect of CaP nanoparticles was more pronounced for 
composite gels containing GelB nanospheres, whose G’ value increased from ~7kPa 
without CaP to 48 kPa for gels at a CaP/GelB ratio of 0.5 (Fig. 6A), vs. 24 kPa for 
GelA+CaP gels at a similar CaP/GelA ratio of 0.5 in comparison to ~10 kPa for GelA 
gels without CaP. By increasing the amount of CaP even further up to a CaP/Gel 
ratio of 5, the storage moduli of colloidal composite gels containing either GelA or 
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GelB nanoparticles strongly decreased to less than ~4 kPa while corresponding 
tan(delta) values increased to about 0.2 (Fig. 6B). Gelatin-free CaP dispersions 
(CaP/Gel ratio of ∞) displayed lowest G’ values (<1 kPa) and highest tan(delta) 
values (>0.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Effect of CaP/Gel ratio 
on creep (A) and self-healing 
behavior (B and C) of colloidal 
dispersions composed of GelB 
and CaP nanoparticles 
(dispersed in deionized water at 
total solid content (Gel+CaP) of 
20 w/v%). A) Region I and II 
show the deformation of 
colloidal dispersions upon 
stress application (10 Pa for 
1min) and the following 
response upon stress removal, 
respectively. B) Region I, II and 
III display initial gel strength, gel 
destruction (1000 % strain for 
1min) and gel recovery, 
respectively, of the colloidal 
dispersions. 
 
Since composite colloidal gels consisting of GelB and CaP nanoparticles displayed 
superior viscoelastic properties, this combination of organic and inorganic 
nanoparticles was selected for final testing of creep and self-healing behavior as 
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Since composite colloidal gels consisting of GelB and CaP nanoparticles displayed 
superior viscoelastic properties, this combination of organic and inorganic 
nanoparticles was selected for final testing of creep and self-healing behavior as 
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shown in Figure 7. Creep tests revealed that CaP-free colloidal gelatin gels were 
instantaneously deformed up to an almost constant value of 0.2% after 60 s of shear 
stressing at 10 Pa, followed by instantaneous recovery to 0.015% strain upon 
removal of this shear stress. At CaP/gelatin ratios of 0.1 and 0.5, respectively, 
straining of samples was also hardly dependent on the time of stress application, but 
the overall resistance against deformation was increased considerably as evidenced 
by lower strain values of about 0.03% after 60 s of stress application and <0.0001 
and ~0.007% after stress removal for each experimental groups, respectively. At 
CaP/Gel ratios of 5 or higher, the colloidal dispersions displayed a continuously 
increasing strain (up to ~6 % strain for gels at a CaP/Gel ratio of 5 and ~21 % strain 
for pure CaP dispersions), followed by hardly any strain recovery upon removal of the 
external stress. 
 
Figure 8. In vitro gelatin degradation (A) of and BMP-2 release (B) from the colloidal gels 
composed of gelatin nanospheres (gelatin content of 20 w/v%) or gelatin and CaP 
nanoparticles (gelatin content of 20 w/v%, CaP/Gel ratio of 0.1) (n=4). 
The amount of recovery of gel strength after severe gel network destruction was 
characterized in more detail using a method to test self-healing behavior of gels 
adopted from Haines-Butterick et al[28] (Fig. 7B and C). CaP-free colloidal gelatin gels 
displayed a strong capacity for self-healing characterized by almost 70% recovery of 
initial gel elasticity within 5 min after severe gel network destruction. The increase in 
CaP/Gel ratios resulted into reduced self-healing behavior with recovery of initial gel 
strength decreasing from 60-70% at CaP/Gel ratios of 0-0.1 to 30-40% at CaP/Gel 
ratios of 0.5-1 (Fig. 7C). At a CaP/Gel ratio of 5, colloidal composite gels behaved 
similar to gelatin-free CaP dispersions characterized by poor (<20%) recovery of 
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initial gel elasticity. Storage moduli of pure CaP dispersions gradually decreased as a 
function of time, corresponding to liquid-like behavior. 
3.4. Degradation and growth factor release 
In vitro degradation studies (Fig. 8A) revealed that addition of CaP to colloidal gelatin 
gels (CaP/Gel ratio of 0.1) strongly increased the resistance to enzymatic 
degradation even though the initial gelatin content was equal for all samples (20 
w/v%). After 4 weeks, CaP-free GelA or GelB colloidal gels were degraded for 71 ± 
2 % and 80 ± 2 %, respectively, vs. 10 ± 2 % and 28 ± 0.01 % gelatin degradation for 
GelA+CaP or GelB+CaP colloidal composite gels, respectively. Gels containing GelB 
nanospheres degraded faster than GelA-containing gels (with or without CaP 
nanoparticles), which can be attributed to the higher Bloom number (and thus 
molecular weight) of GelA[29]. 
The corresponding sustained release profiles of BMP-2 were also strongly dependent 
on the addition of CaP nanoparticles to the colloidal gelatin gels (Fig. 8B). BMP-2 
was released faster from CaP-free colloidal gelatin gels (~90% of total BMP-2 
release after 4 weeks) compared to CaP-containing gels (65 ±1% BMP-2 release 
after 4 weeks at a CaP/Gel ratio of 0.1). The type of gelatin (GelA or GelB) did not 
influence the BMP-2 release pattern as reflected by the absence of statistically 
significant differences between GelA and GelB-containing colloidal gels. 
 
Figure 9. LIVE/DEAD assay of BMSCs after 16 (A-D) and 24 days (E-H) of culture on top of 
colloidal gels composed of GelA (A, E) or GelB (C, G) nanospheres, and of GelA+CaP (B, F) 
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or GelB+CaP (D, H) nanoparticles (gelatin content of 20 w/v%, CaP/Gel ratio of 0.1). Scale 
bar = 20 μm. 
3.5. Cell culture studies 
In order to obtain preliminary data on the in vitro behavior of colloidal composite gels, 
viability and proliferation of bone marrow stem cells (BMSCs) cultured (for 24 days) 
on top of selected Gel-CaP colloidal composite gels were evaluated by performing 
qualitative LIVE/DEAD assays and quantitative measurements of total DNA content. 
The LIVE/DEAD assay clearly confirmed the viability of BMSCs on GelA and 
GelA+CaP gels after 16 and 24 days of cell culture, as shown by abundant spreading 
of a high number of live cells (stained green) (Fig. 9A, B, E and F). A different cellular 
behavior was observed for GelB-containing gels (either with or without CaP 
nanoparticles), for which fewer live cells were observed that remained spherical 
during the entire period of culture (Fig. 9C, D, G and H). 
Cell proliferation was further quantified by measuring the total DNA content at various 
time points (Fig. 10). Generally, cells cultured on colloidal composite gels showed a 
continuous increase in total DNA content for the entire duration of the cell culture 
experiment. After 24 days of cell culture, however, no significant differences in total 
DNA content were observed between GelA-based and GelB-based colloidal gels. 
 
Figure 10. Total DNA content of BMSCs after 4, 8, 12, 16 and 24 days of culture on top of 
colloidal gels composed of GelA or GelB nanospheres, and of GelA+CaP or GelB+ CaP 
nanoparticles (solid gelatin content of 20 w/v%, CaP/Gel ratio of 0.1) (n=3). 
4. Discussion 
Electrostatic interparticle forces are the most widely employed non-covalent 
interactions between colloidal particles for the formation of colloidal gels[3-5, 9-11, 30]. 
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Our group recently discovered that colloidal gels made of oppositely charged gelatin 
nanospheres were surprisingly cohesive, elastic and self-healing, while their 
beneficial properties for growth factor release were recently confirmed in vitro and in 
vivo[13, 31]. Building on this concept, the current study showed that simple mixing of 
organic gelatin and inorganic calcium phosphate (CaP) nanoparticles also results into 
the formation of colloidal composite gels. At CaP/Gel ratios between 0.1 and 0.5, the 
CaP nanoparticles improved the mechanical properties of these gels without 
compromising the flexibility and self-healing behavior characteristic for the use of 
gelatin nanospheres. Moreover, it was shown in vitro that CaP nanoparticles can be 
used as an additional tool to reduce the degradation rate of otherwise fast-
degradable gelatin nanospheres and fine-tune the control over release of growth 
factors. 
In order to maximize the charge difference with positively charged GelA nanospheres, 
citrate was adsorbed onto CaP nanoparticles to render them negatively charged (Fig. 
1). Using DLS, TEM and sedimentation experiments (Figs. 2 and 3), it was shown 
that these negatively charged C-CaP nanoparticles were able to self-assemble with 
oppositely charged GelA nanoparticles into organic-inorganic heteroaggregates that 
rapidly sedimented. On the contrary, the repulsive interactions between similarly 
charged C-CaP and GelB nanoparticles were sufficiently strong to prevent particle 
aggregation, thereby stabilizing the colloidal suspensions. 
Nevertheless, adsorption of citrate anions onto CaP nanoparticles was not a 
prerequisite to induce self-assembly of CaP and gelatin nanoparticles, as confirmed 
by the observation that citrate-free, neutral CaP nanoparticles aggregated with both 
cationic GelA and anionic GelB nanospheres. Furthermore, the ionic strength had 
only marginal effects on the self-assembly process of gelatin and C-CaP 
nanoparticles. Sedimentation of GelA-C-CaP aggregates could only be avoided by 
employing a high ionic strength (1M NaCl), which contrasted previous observations 
on CaP-free colloidal gelatin gels where self-assembly between oppositely charged 
gelatin nanospheres of comparable surface charges (i.e. +9 and -20 mV for GelA and 
GelB nanospheres, respectively) was already strongly disturbed at an ionic strength 
of 100 mM NaCl[10]. Moreover, it should be stressed that dimensions and shapes of 
needle-like CaP nanoparticles differed considerably from geometrically more simple, 
spherical gelatin nanoparticles. Therefore, it can be concluded that the self-assembly 
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Figure 10. Total DNA content of BMSCs after 4, 8, 12, 16 and 24 days of culture on top of 
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Our group recently discovered that colloidal gels made of oppositely charged gelatin 
nanospheres were surprisingly cohesive, elastic and self-healing, while their 
beneficial properties for growth factor release were recently confirmed in vitro and in 
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degradable gelatin nanospheres and fine-tune the control over release of growth 
factors. 
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Nevertheless, adsorption of citrate anions onto CaP nanoparticles was not a 
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on CaP-free colloidal gelatin gels where self-assembly between oppositely charged 
gelatin nanospheres of comparable surface charges (i.e. +9 and -20 mV for GelA and 
GelB nanospheres, respectively) was already strongly disturbed at an ionic strength 
of 100 mM NaCl[10]. Moreover, it should be stressed that dimensions and shapes of 
needle-like CaP nanoparticles differed considerably from geometrically more simple, 
spherical gelatin nanoparticles. Therefore, it can be concluded that the self-assembly 
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process of gelatin and CaP nanoparticles cannot be explained merely by simple 
electrostatic forces at particulate level. 
To provide evidence for the formation of Gel-CaP colloidal composite gels, the nature 
of the interparticle forces was also investigated by measuring the viscoelastic 
properties of highly concentrated dispersions (10-20 w/v% gelatin content). 
Formation of colloidal gels was confirmed for all combinations of CaP and gelatin 
nanoparticles, but pronounced and remarkable differences were observed between 
various nanoparticle combinations (i.e. GelA or GelB combined with CaP or C-CaP). 
Surprisingly, the adsorption of citrate onto CaP nanoparticles strongly reduced the 
storage moduli of colloidal composite gels (Fig. 5A). Moreover, storage moduli of gels 
containing C-CaP nanoparticles reduced with increasing ionic strength, whereas gels 
containing citrate-free CaP nanoparticles were hardly dependent on the ionic 
strength (Fig. 5B). These results stressed that electrostatic interparticle forces were 
not the main cohesive forces responsible for the formation of colloidal composite gels. 
Although the exact mechanism underlying gel formation remains to be elucidated, 
possible explanations can be postulated on basis of the data obtained in the current 
study. It is known that the strong affinity of CaP and proteins is mainly caused by 
molecular interactions. These molecular interactions induce the formation of 
coordination complexes between CaP–Ca2+···-OOC–Gel or CaP–PO4
3-···+H3N–Gel
[19-
23]. Since more –COOH groups are present in both cationic and anionic gelatin as 
compared to –NH2 groups
[29], CaP–Ca2+···-OOC–Gel coordination complexes are 
suggested to dominate the interactions between CaP surfaces and gelatin 
macromolecules at a molecular level. Although these complexes are non-covalent 
bonds, the nanoscale dimensions of the organic and inorganic building blocks 
increase the specific surface area and thus the number of these non-covalent 
interactions, thereby rendering colloidal Gel-CaP gels elastic and cohesive. In that 
respect, the stronger cohesion and elasticity of colloidal gels made of anionic GelB 
nanospheres can be explained by the higher number of –COOH group present in 
GelB (118 COOH groups/mol) as compared to cationic GelA (77 COOH 
groups/mol)[29], thus allowing for the formation of more coordination complexes 
between GelB and CaP nanoparticles. Citrate adsorption onto CaP surfaces reduces 
the amount of Ca2+ ions available for coordination complex formation[24], which most 
likely explains the lower storage moduli observed for colloidal gels made of C-CaP 
and gelatin nanoparticles even though the charge difference between GelA and C-
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CaP nanoparticles was maximal. Summarizing, it can be concluded that the 
formation of colloidal gels out of CaP and gelatin nanoparticles was dominated by 
interactions at a molecular rather than particulate scale. These molecular interactions 
were short-ranged and are most likely caused by amino acid residues in gelatin 
macromolecules forming intermolecular contacts at the binding interface (such as 
coordination complexes). Long-range electrostatic effects induced by modifying the 
surface charge of nanoparticles (using citrate adsorption) hardly contributed to the 
attractive particle interactions that are responsible for colloidal gel cohesion[4]. 
Therefore, colloidal gels composed of pure CaP nanoparticle and gelatin 
nanospheres were selected for further optimization studies.  
Regarding the ratio between CaP and gelatin (CaP/Gel ratio), it was observed that 
small additions of CaP nanoparticles (CaP/Gel = 0.1) were remarkably effective in 
increasing gel elasticity compared to CaP-free colloidal gelatin gels without 
compromising the beneficial self-healing and creep behavior derived from the use of 
gelatin nanoparticles (Figs. 6 and 7). At higher CaP/Gel ratios, however, the elasticity 
of the colloidal gels increased considerably, but at the expense of the capacity for 
self-healing (Fig. 7), which can be explained by the lack of reversible interactions 
between intrinsically hard and stiff CaP nanoparticles. Colloidal dispersions of high 
CaP/Gel ratios (≥ 5) displayed a liquid-like behavior similar to pure CaP pastes 
without any self-healing capacity or resistance to deformation. Therefore, CaP/Gel 
ratios ranging from 0.1 to 0.5 were shown to be optimal for the formation of organic-
inorganic colloidal composite gels, which combine high elasticity with self-healing 
behavior as desired for clinical application where gels are extruded from medical 
syringes through narrow needles. 
In addition to the improvement of viscoelastic properties, the addition of CaP 
nanoparticles to colloidal gelatin gels also improved the biological properties with 
respect to control over gel degradation and growth factor release. The addition of 
CaP to colloidal gelatin gels strongly reduced the rates of gelatin degradation and 
corresponding growth factor (BMP-2) release (Fig. 8). As described above, molecular 
interactions between gelatin macromolecules and CaP nanoparticle surfaces are 
suggested to be responsible for the high affinity of proteins (both gelatin and BMP-2) 
to CaP nanoparticles, which stabilized the organic-inorganic particulate network. 
These results are in line with previous investigations on the effect of similar CaP 
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nanocrystals incorporated into gelatin microspheres, where it was shown that CaP 
nanocrystals can act as physical crosslinkers of gelatin macromolecules[32]. 
Finally, in vitro cell culture studies confirmed that colloidal Gel-CaP composite gels 
supported viability and proliferation of BMSCs (Figs. 9 and 10), while the addition of 
CaP nanoparticles did not show obvious difference in cellular behavior. The natural 
presence of RGD sequences in gelatin macromolecules allowed for culturing the cells 
by surface seeding rather than by encapsulation, which can be regarded as an 
advantage over gels (e.g. polyethylene glycol-based gels) that lack these sequences 
and do not show spreading of encapsulated mesenchymal stem cells[33-35]. 
Surprisingly, GelA-based colloidal gels (with or without CaP) displayed a degree of 
cell spreading that was superior to GelB-based gels, since cultured cells remained 
spherical after culture onto GelB and GelB-CaP gels. It has been reported in previous 
studies that surfaces of the biomaterials with intermediate hydrophilicity, positive 
surface charge favored cell attachment[36, 37]. Based on these results, we speculate 
that the relatively strong negative surface charge (approx. -20 mV) of GelB 
nanospheres might have compromised cell attachment by repulsive interactions with 
negatively charged cell membranes, but more research is necessary to confirm this 
hypothesis. 
 
5. Conclusions 
The current study has provided firm evidence for the facile bottom-up synthesis of 
organic-inorganic colloidal composite gels using CaP nanoparticles and gelatin 
nanospheres as building blocks. Depending on the ratio between gelatin and CaP 
nanoparticles, these novel colloidal Gel-CaP composite gels exhibited a strongly 
enhanced gel elasticity, self-healing behavior, and gel stability at high ionic strengths 
without the need for chemical - potentially cytotoxic - functionalizations to introduce 
sufficiently strong cohesive interactions. Moreover, it was shown in vitro that CaP 
nanoparticles can be used as an additional tool to reduce the degradation rate of 
otherwise fast-degradable gelatin nanospheres and fine-tune the control over release 
of growth factors. Finally, it was shown that these colloidal composite gels supported 
attachment, spreading and proliferation of cultured stem cells. Based on these results, 
it can be concluded that proof-of-principle has been obtained for the design of novel 
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advanced composite materials made of nanoscale particulate building blocks, which 
exhibit great potential for use in regenerative medicine. 
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7. Supplemental data 
 
Figure S1. ATR-FTIR spectra of CaP nanoparticles (characteristic absorptions marked with 
“*”), C-CaP nanoparticles (characteristic absorptions marked with “^”), GelA nanospheres 
(characteristic absorptions marked with “+”), and mixtures of GelA and CaP nanoparticles (at 
a CaP/Gel weight ratio of 1). The characteristic peaks of GelA macromolecules showed that 
amide I (carbonyl stretching vibration of amide group) absorptions were observed at 1634 
cm-1, amide II absorptions (N-H bending and C-N stretching vibration) at 1533 cm-1, and 
amide III absorptions (C-N stretching and N-H bending) at 1425 cm-1[42]. 
 
 
Figure S2. XRD patterns of CaP nanoparticles (diffraction peaks characteristic for 
carbonated hydroxyapatite marked with “*”), C-CaP nanoparticles, GelA nanospheres (broad 
diffraction maxima marked with “^”), and a mixture of GelA and CaP nanoparticles (at a 
CaP/Gel weight ratio of 1). Diffraction peaks at 2θ=25.9º, 31.8º, 32.2º, 32.9º, 34.0º and 39.8º 
correspond to (002), (211), (112), (300), (202) and (310) reflections of crystalline 
hydroxyapatite, the positions and peak widths of which are unaltered upon mixing with 
gelatin (which revealed a broad bump at 2θ=20º). 
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1. Summary 
I 
Colloidal gels for biomedical applications based on oppositely charged polymeric 
micro- or nanospheres were first described by Van Tomme et al. using charged 
dextran-based microspheres. Following this approach, several other colloidal gel 
systems have been developed based on oppositely charged particulate biopolymers 
as building blocks. However, translation of the obtained knowledge on colloidal gels 
into practical applications are hardly reported, which can be most likely attributed to 
the suboptimal physicochemical and biological properties as well as unfavorable 
functionalization methods of previously used polymeric particles. Therefore, in the 
current PhD thesis, colloidal gelatin gels have been developed with a specific focus 
of translating knowledge on materials synthesis and characterization towards 
practical applications in the biomedical field. 
A general introduction on bone tissue regeneration as well as a brief description of 
the objectives of this PhD thesis is given in chapter 1.  
 
II 
Since the majority of colloidal gels are composed of micron- or nanosized spherical 
building blocks, chapter 2 focuses on recent developments with respect to the 
general use of micro- and nanospheres for bone regeneration. Micro- and 
nanospheres were categorized by material class (polymers, ceramics and 
composites) while the main strategies that employ these spheres to improve the 
functionality of scaffolds for bone tissue engineering were reviewed as well. It was 
concluded that scaffolds comprising micro- and nanospheres display several 
advantages compared to traditional monolithic scaffolds that are related to i) an 
improved control over sustained delivery of therapeutic agents, signaling 
biomolecules and even pluripotent stem cells, ii) the introduction of spheres as 
stimulus-sensitive delivery vehicles for triggered release, iii) the use of spheres to 
introduce porosity and/or improve the mechanical properties of bulk scaffolds by 
acting as porogen or reinforcement phase, iv) the use of spheres as 
compartmentalized microreactors for dedicated biochemical processes, v) the use of 
spheres as cell delivery vehicle, and finally vi) the possibility to prepare injectable 
and/or moldable formulations to be applied using minimally invasive surgery.  
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III 
Colloidal gels have recently been identified as a promising “bottom-up” strategy for 
design of highly functional scaffolds by employing micro- or nanoscale particles as 
building blocks to assemble into shape-specific bulk materials. In chapter 3 we have 
provided firm evidence for a feasible bottom-up approach for the preparation of 
injectable gels by employing oppositely charged gelatin nanospheres as building 
blocks. Compared to previous studies on comparable colloidal gels systems, gels 
based on gelatin nanospheres displayed significantly improved performance (e.g. 
enhanced gel elasticity, favorable injectability and improved stability at high ionic 
strength) without the need to chemically modify these commercially available 
macromolecules. In addition, the inherent presence of cell-binding peptide 
sequences will ensure beneficial biological behavior in terms of cell attachment, 
proliferation and differentiation. Due to their favorable clinical handling, ease of 
functionalization and cost-effectiveness, these nanosphere-based gels show great 
potential for application as injectable gels for tissue regeneration and/or programmed 
drug release of multiple biomolecules at predetermined release rate. 
 
IV 
Colloidal gels made of biodegradable polymer micro- or nanospheres have been 
widely investigated over the past few years, but a direct comparison between micro- 
vs. nano-structured colloidal gels has not been made yet. Therefore, chapter 4 has 
compared the viscoelastic properties and capacity for drug release of colloidal gels 
made of oppositely charged gelatin microspheres vs. nanospheres. Viscoelastic 
properties of the colloidal gelatin gels were characterized by rheology and simple 
injectability tests, and in vitro release of two selected osteogenic proteins (i.e. bone 
morphogenetic protein-2 (BMP-2) and alkaline phosphatase (ALP)) from the colloidal 
gelatin gels was evaluated using radiolabeled BMP-2 and ALP. Nano-structured 
colloidal gelatin gels displayed superior viscoelastic properties over microsphere-
based gels in terms of elasticity, injectability, structural integrity, and self-healing 
behavior upon severe network destruction. In contrast, micro-structured colloidal 
gelatin gels exhibited poor gel strength and integrity, unfavorable injectability, and did 
not recover after shearing, resulting from the poor gel cohesion due to insufficiently 
strong interparticle forces. Regarding the capacity for drug delivery, sustained growth 
factor (BMP-2) release was obtained for both micro- and nanosphere-based gels, the 
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kinetics of which were mainly depending on the particle size of gelatin spheres with 
the same crosslinking density. Therefore, the optimal gelatin carrier for drug delivery 
in terms of particle size and crosslinking density still needs to be established for 
specific clinical indications that require either short-term or long-term release. It can 
be concluded that nano-structured colloidal gelatin gels show great potential for 
sustained delivery of therapeutic proteins, whereas micro-structured colloidal gelatin 
gels are not sufficiently cohesive as injectables for biomedical applications. 
 
V 
During the process of bone regeneration, a multitude of morphogenetic signaling 
factors regulate cellular behavior and ultimately tissue response. These factors are 
presented to cells under strong spatial and temporal control, which stresses the 
relevance of controlled delivery of multiple growth factors for bone tissue 
regeneration. This demand for biomimetic delivery has prompted the development of 
a novel generation of biomaterials that is capable of delivering multiple growth factors 
in a controlled manner. Therefore, chapter 5 has exploited the strong capacity of 
colloidal gels solely made of oppositely charged gelatin nanospheres to obtain 
controlled release of angiogenic and osteogenic growth factors. The release kinetics 
of dual delivery of osteogenic bone morphogenetic protein-2 (BMP-2) and angiogenic 
basic fibroblast growth factor (bFGF) were investigated in vitro by radiolabeling the 
respective growth factors and monitoring their release in vitro. Furthermore, the effect 
of single or dual delivery of BMP-2 and bFGF on bone regeneration was evaluated in 
vivo using a rat femoral condyle defect model. The in vitro results confirmed that the 
delivery kinetics of BMP-2 and/or bFGF are more dependent on the degree of 
crosslinking than on the type of gelatin. Sequential release characterized by rapid 
release of angiogenic bFGF and more sustained release of BMP-2 was obtained by 
loading bFGF onto cationic nanospheres of low crosslinking density and BMP-2 onto 
anionic nanospheres of high crosslinking density. The in vivo study demonstrated the 
biocompatibility and biodegradability of bare colloidal gelatin gels, and did not show 
any adverse effects on the process of bone healing after 4 week of implantation since 
the volumes of new bone formation were comparable to empty control defects. An 
obvious stimulatory effect on bone regeneration was observed for the colloidal gels 
loaded with BMP-2, whereas bFGF-loaded colloidal gelatin gels did not influence the 
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rate of bone regeneration. In contrast, the combined delivery of BMP-2 and bFGF 
resulted into an inhibitory effect on osteogenesis under the current experimental 
conditions. Summarizing, the current study proved that nanostructured colloidal 
gelatin gels are suitable carriers for programmed and sustained release of multiple 
therapeutic proteins for tissue regeneration. 
 
VI 
Grafting large segmental bone defects is still a major challenge in trauma surgery 
because of high demands of grafting materials to provide mechanical stability and 
enhance bone regeneration. In chapter 6, critical-sized segmental bone defects in rat 
femurs were grafted with porous titanium scaffolds incorporated with nanostructured 
colloidal gelatin gels loaded with bone morphogenetic protein-2 (BMP-2), basic 
fibroblast growth factor (bFGF) or both (BMP-2/bFGF). The effect of growth factor 
(GF) delivery from these gels was evaluated using in vivo and ex vivo micro-CT, 
histology and three-point bending test. All porous titanium scaffolds that contained 
GF-loaded gels resulted in more bone formation than titanium scaffolds with 
unloaded gels. BMP-2 gels had an early effect on bone regeneration (0-4 weeks), 
whereas bFGF gels had a late effect (8-12 weeks). After twelve weeks, 0.6 µg bFGF 
resulted in similar bone volume regenerated as 3 µg BMP-2. BMP-2/bFGF gels 
resulted in more bone formation outside porous titanium scaffolds and completely 
bridged most defects. Fracture location observed after three-point bending tests 
suggests stronger bone-implant integrity with BMP-2/bFGF gels. In conclusion, 
porous titanium scaffolds incorporated with GF-loaded nanostructured colloidal 
gelatin gels provide mechanically strong and biologically active grafting material for 
large segmental bone defects. 
 
VII 
Colloidal gels are a particularly attractive class of hydrogels since these materials 
allow for “bottom-up” synthesis of functional, self-healing materials by employing 
micro- or nanoscale particles as building blocks to assemble into shape-specific bulk 
materials. So far, however, the synthesis of colloidal composite gels composed of 
both organic and inorganic particles has hardly been investigated. Chapter 7 has 
focused on the development of colloidal organic-inorganic composite gels using 
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micro- or nanoscale particles as building blocks to assemble into shape-specific bulk 
materials. So far, however, the synthesis of colloidal composite gels composed of 
both organic and inorganic particles has hardly been investigated. Chapter 7 has 
focused on the development of colloidal organic-inorganic composite gels using 
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calcium phosphate (CaP) nanoparticles and gelatin (Gel) nanospheres as building 
blocks. These novel Gel-CaP colloidal composite gels exhibited a strongly enhanced 
gel elasticity, self-healing behavior, and gel stability at high ionic strengths, while 
chemical – potentially cytotoxic – functionalizations were not necessary to introduce 
sufficiently strong cohesive interactions. Moreover, it was shown in vitro that 
osteoconductive CaP nanoparticles can be used as an additional tool to reduce the 
degradation rate of otherwise fast-degradable gelatin nanospheres and fine-tune the 
control over release of growth factors. Finally, it was shown that these Gel-CaP 
colloidal composite gels support attachment, spreading and proliferation of cultured 
stem cells. Based on these results, it can be concluded that proof-of-principle has 
been obtained for the design of novel advanced composite materials made of 
nanoscale particulate building blocks, which exhibit great potential for use in 
regenerative medicine. 
 
2. Closing remarks and future perspective 
This thesis describes the development of novel, injectable colloidal gels according to 
a bottom-up strategy using gelatin and calcium phosphate nanoparticles. These gels 
formed a cohesive network owing to a sufficient amount of collectively strong, non-
covalent interparticle forces. As a result, these gelatin-based colloidal gels revealed 
high elasticity, self-healing behavior, tunable injectability and moldability, controllable 
biodegradability, strong efficacy for controlled delivery of multiple biomolecules as 
well as biocompatibility. This combination of properties renders gelatin-based 
colloidal gels highly suitable for application in bone regeneration, as evidenced also 
by the positive in vitro and in vivo results.  
Nevertheless, several hurdles can be identified before widespread application of 
these gels can occur. First, only in vitro studies on gel degradation and growth factor 
release from the colloidal gels have been performed to date, but in vitro and in vivo 
data on degradation and drug release cannot be correlated. Therefore, in vivo 
characterization of biomolecule release needs to be performed in future studies to 
understand and optimize the observed effects of growth-factor loaded colloidal gels 
on in vivo bone regeneration. Second, the exact biological mechanism behind the 
stimulatory/inhibitory effects on osteogenesis resulting from the combined delivery of 
BMP-2 and bFGF from colloidal gelatin gels has not been unraveled yet, thereby 
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limiting the full clinical potential of dual delivery of BMP-2 and bFGF. Third, the 
current thesis mainly focused on the development of the colloidal gels and the 
translation of proof-of-principle into practical use for regenerative medicine, but the 
exact influence of particle size, shape and charge on the gelation mechanism and 
subsequent biological properties (e.g. gel degradation, cellular responses to the 
colloidal particles) remains to be elucidated. Fourth, to facilitate future clinical trials 
and commercialization of this nanosphere-based material system, a robust technique 
should become available that allows for upscaling of nanoparticles production to yield 
well-defined nanoparticles of high reproducibility. In that respect, promising 
preliminary results have been obtained (in collaboration with Future chemistry BV) 
with respect to production of gelatin nanoparticles using microfluidic devices as a 
commercially viable alternative to conventional processing of nanoparticles using 
batch chemistry. 
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1. Samenvatting 
 
I 
Colloïdale gels voor biomedische toepassingen zijn voor het eerst beschreven door 
Van Tomme et al. die tegengesteld geladen polymere microsferen gebruikte als 
bouwstenen voor zelf-assemblerende gels. Voortbordurend op deze aanpak zijn er 
verschillende andere colloïdale gel systemen ontwikkeld op basis van tegengesteld 
geladen (bio)polymere bouwstenen. Kennis over deze systemen is echter in zeer 
beperkte mate vertaald naar praktische toepassingen, wat waarschijnlijk te wijten valt 
aan de suboptimale fysisch-chemische en biologische eigenschappen van de 
polymere deeltjes alsmede de ongunstige methoden die zijn gebruikt om de deeltjes 
te functionaliseren. In dit proefschrift zijn dan ook colloïdale gels ontwikkeld met als 
concreet doel om de opgedane kennis te vertalen naar praktische toepassingen in de 
biomedische sector. 
Hoofdstuk 1 van dit proefschrift is een algemene inleiding over botweefselregeneratie, 
alsmede een korte beschrijving van de doelstellingen van dit proefschrift. 
 
II 
Aangezien de meerderheid van colloïdale gels bestaan uit bolvormige bouwstenen 
geeft hoofdstuk 2 een overzicht van recente ontwikkelingen met betrekking tot het 
gebruik van micro-en nanosferen voor botregeneratie. Micro-en nanosferen zijn 
hierbij  gecategoriseerd op basis van materiaalklasse (polymeren, keramiek en 
composieten). Daarnaast zijn de belangrijkste strategieën besproken die kunnen 
worden ingezet om de functionaliteit van scaffolds voor botregeneratie te verbeteren. 
Geconcludeerd werd dat scaffolds met micro- en nanosferen verschillende voordelen 
bezitten ten opzichte van monolithische steigers die samenhangen met i) een 
verbeterde controle over langdurige afgifte van therapeutica, signaal-moleculen en 
pluripotente stamcellen, ii) mogelijkheid tot stimulus-gevoelige afgifte, iii) het gebruik 
van bollen om porositeit te vormen en / of de mechanische eigenschappen van bulk 
scaffolds te verbeteren, iv) het gebruik van bolletjes als microreactoren voor 
specifieke biochemische processen, v ) het gebruik van bolletjes om cellen te 
transporteren, en tenslotte vi) de mogelijkheid om injecteerbare en / of vervormbaar 
formuleringen te bereiden via minimaal invasieve chirurgie. 
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III 
Colloïdale gels zijn veelbelovend voor het ontwerp van functionele scaffolds 
bestaande uit micro-of nanodeeltjes als bouwstenen. In hoofdstuk 3 hebben we 
bewezen dat injecteerbare gels gevormd kunnen worden volgens een bottom-up 
benadering door gebruik te maken van tegengesteld geladen gelatine nanosferen als 
bouwstenen. Vergeleken met eerdere studies naar vergelijkbare colloïdale systemen 
lieten gels op basis van gelatine nanosferen aanzienlijk verbeterde eigenschappen 
zien (zoals o.a. een verbeterde gel-elasticiteit, gunstige injecteerbaarheid, en 
verbeterde stabiliteit bij hoge ionsterkte) zonder dat de gelatine nanosferen chemisch 
gemodificeerd dienden te worden. Bovendien zal de aanwezigheid van celbindend 
peptide sequenties zorgen voor een gunstige biologische respons in termen van 
celhechting, proliferatie en differentiatie. Door hun gunstige praktische 
hanteerbaarheid, het gemak van functionalisatie en lage kosten zijn deze colloïdale 
gels zeer bruikbaar voor toepassing als injecteerbare gels voor weefselregeneratie 
en / of geprogrammeerde afgifte van verschillende typen geneesmiddelen op een 
van tevoren bepaalde afgifte-snelheid.  
 
IV 
Colloïdale gels zijn de laatste jaren uitvoerig onderzocht, maar een directe 
vergelijking tussen micro-vs. nanogestructureerde colloïdale gels is nog niet eerder 
uitgevoerd. Daarom zijn in hoofdstuk 4 de visco-elastische eigenschappen alsmede 
de afgifte-eigenschappen onderzocht van colloïdale gels bestaande uit tegengesteld 
geladen gelatine microsferen vs. nanosferen. De visco-elastische eigenschappen 
van de colloïdale gelatine gels werden bestudeerd met behulp van rheometrie en 
simpele injecteerbaarheidstesten, terwijl de in vitro afgifte van twee osteogene 
eiwitten (d.w.z. bot morfogenetische proteïne-2 (BMP-2) en alkalische fosfatase 
(ALP)) vanuit colloïdale gelatine gels werd geëvalueerd met behulp van met 
radioactief gelabeld BMP-2 en ALP. Nanogestructureerde colloïdale gelatine gels 
vertoonden superieure visco-elastische eigenschappen ten opzichte van 
microgestructureerde gels voor wat betreft de elasticiteit, injecteerbaarheid, 
structurele integriteit, en zelfhelend gedrag. Microgestructureerde colloïdale gelatine 
gels daarentegen kenmerkten zich door een matige gelsterkte en integriteit, 
ongunstige injecteerbaarheid, en zeer beperkt zelfhelend gedrag, wat erop  duidt dat 
de krachten tussen microsferen onvoldoende groot zijn om cohesieve gels te vormen. 
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Gecontroleerde afgifte van de BMP-2 werd verkregen voor zowel micro- als 
nanosfeer-gebaseerde gels waarbij de afgiftekinetiek hoofdzakelijk afhing van de 
deeltjesgrootte.  Geconcludeerd kan worden dat nanogestructureerde colloïdale 
gelatine gels veelbelovende formuleringen zijn voor langdurige afgifte van 
therapeutische eiwitten, terwijl microgestructureerde colloïdale gelatine gels 
onvoldoende samenhang bezitten voor biomedische toepassing als injecteerbare gel. 
 
V 
Botregeneratie wordt gereguleerd door diverse morfogenetische signaalmoleculen 
die het cel- en weefselgedrag aansturen. Deze factoren worden zeer gecontroleerd 
aangeboden aan cellen, wat de relevantie van gecontroleerde afgifte van meerdere 
groeifactoren voor botweefselregeneratie benadrukt. In hoofdstuk 5 is de capaciteit 
van colloïdale nanogestructureerde gelatine gels benut voor de gecontroleerde 
afgifte van angiogene en osteogene groeifactoren. De afgiftekinetiek van simultane 
afgifte van BMP-2 en de angiogene basische fibroblast groeifactor (bFGF) is 
onderzocht door deze groeifactoren radioactief te labellen en hun afgiftepatroon  in 
vitro te monitoren. Daarnaast werd ook een in vivo (ratten)studie uitgevoerd om het 
effect van enkelvoudige of gecombineerde afgifte  van BMP-2 en bFGF op 
botregeneratie te bestuderen. De in vitro resultaten bevestigden dat de afgifte-
kinetiek van BMP-2 en / of bFGF het meest bepaald werd door de mate van 
crosslinking dan het type gelatine. Sequentiële afgifte gekenmerkt door snelle afgifte 
van angiogene bFGF en langdurige afgifte van BMP-2 werd verkregen door 
cationische nanosferen met lage crosslinking dichtheid te beladen met bFGF en 
anionische nanosferen van hoge crosslinking dichtheid te beladen met BMP-2. De in 
vivo studie toonde aan dat de colloïdale gelatine gels biocompatibel waren en geen 
nadelige effecten op de botgenezing veroorzaakten. Belading met BMP-2 bracht een 
stimulerende effect op botregeneratie teweeg, , terwijl bFGF-beladen colloïdale 
gelatine gels geen aantoonbare  invloed hadden op de snelheid van botregeneratie. 
Daarentegen resulteerde gecombineerde afgifte van BMP-2 en bFGF in een 
remmend effect op botvorming, wat waarschijnlijk veroorzaakt is door een 
overdosering van bFGF opzichte van de BMP-2 dosering. Samenvattend kan worden 
gesteld dat nanogestructureerde colloïdale gelatine gels geschikte dragers zijn voor 
geprogrammeerde en langdurige afgifte van meerdere therapeutische eiwitten voor 
weefselregeneratie. 
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VI 
Het repareren van grote segmentale botdefecten is nog steeds een grote uitdaging in 
de traumachirurgie vanwege de hoge eisen die aan botvervangers worden gesteld. 
In hoofdstuk 6 werden grote segmentale botdefecten in dijbenen van ratten opgevuld 
met poreus titaan opgevuld met nanogestructureerde colloïdale gelatine gels die 
beladen waren met geladen BMP-2, bFGF of een combinatie van beide groeifactoren. 
Het effect van afgifte van groeifactoren op botregeneratie werd geëvalueerd aan de 
hand van in vivo en ex vivo micro-CT, histologie en driepuntsbuigproeven. Alle 
poreuze titanium scaffolds die belande waren met groeifactor-beladen gels lieten 
meer botvorming zien dan titanium scaffolds met gels zonder groeifactor-belading. 
BMP-2 beladen gels hadden een vroege invloed op de regeneratie van bot (0-4 
weken), terwijl bFGF gels op een later tijdstip een effect lieten zien (8-12 weken). Na 
twaalf weken implantatietijd bleek dat 0.6 mg bFGF evenveel botregeneratie 
induceerde als 3 ug BMP-2. BMP-2- en bFGF-beladen gels veroorzaakten meer 
botvorming buiten het poreuze titanium waardoor de meeste defecten volledig 
opgevuld werden. De driepuntsbuigproeven lieten zien dat de binding tussen het bot 
en het implantaat sterker was voor gels beladen met BMP-2 en bFGF. Samenvattend 
kan worden gesteld dat poreus titaan opgevuld met groeifactor-beladen colloïdale 
gelatine gels een optimale combinatie vormen van mechanische sterkte en 
biologische activiteit voor regeneratie van bot in grote segmentale botdefecten. 
 
VII 
Colloïdale gels zijn een opkomende klasse van hydrogelen aangezien deze 
materialen het mogelijk maken om functionele, zelfherstellende materialen op te 
bouwen door gebruik te maken van micro-of nanodeeltjes als bouwstenen voor 
macroscopische bulkmaterialen. Tot dusverre is de synthese van colloïdale 
composietgels bestaande uit zowel organische als anorganische deeltjes echter 
nauwelijks onderzocht. In hoofdstuk 7 is de ontwikkeling beschreven van colloïdale 
organisch-anorganische composietgels bestaande uit calciumfosfaat (CaP) 
nanodeeltjes en gelatine nanosferen als bouwstenen. Deze nieuwe colloïdale 
composietgels vertoonden een sterk verbeterde elasticiteit, zelfhelende 
eigenschappen en stabiliteit bij hoge ionsterkte, terwijl chemische – en mogelijk 
cytotoxische – functionalisaties niet nodig waren om voldoende sterke interacties 
tussen de deeltjes te bewerkstelligen. Bovendien werd aangetoond dat 
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osteoconductieve CaP nanodeeltjes kunnen worden gebruikt om de afbraaksnelheid 
van snel afbreekbaar gelatine nanosferen te vertragen en daarmee de controle over 
de afgifte van groeifactoren te verbeteren. Tenslotte werd aangetoond dat deze 
colloïdale composietgels hechting, spreiding en proliferatie van gekweekte 
stamcellen kunnen ondersteunen. Op basis van deze resultaten kan worden 
geconcludeerd dat nieuwe geavanceerde composietmaterialen kunnen worden 
gemaakt op basis van nanodeeltjes als functionele bouwstenen, die een groot 
potentieel vertonen voor gebruik in de regeneratieve geneeskunde. 
 
2. Slotopmerkingen en toekomstperspectief 
 
Dit proefschrift beschrijft de ontwikkeling van nieuwe, injecteerbare colloïdale gels 
volgens een bottom-up strategie met behulp van gelatine en calciumfosfaat 
nanodeeltjes. Deze colloïdale gelatine gels waren biocompatibel, elastisch, 
zelfhelend, injecteerbaar en biologische afbreekbaar, effectieve dragermaterialen 
voor afgifte van groeifactoren. Deze combinatie van eigenschappen maakt gelatine-
gebaseerde colloïdale gels uitermate geschikt voor toepassingen in de 
botregeneratie, zoals ook is gebleken uit de gunstige in vitro en in vivo resultaten. 
Toch zijn er nog een aantal hindernissen te nemen voordat deze gels breed ingezet 
kunnen worden. Ten eerste zijn er tot op heden slechts in vitro testen uitgevoerd 
naar de snelheid van biodegradatie, terwijl bekend is dat in vitro en in vivo data over 
afbraak en afgifte-snelheden van geneesmiddelen niet kunnen worden gecorreleerd. 
Derhalve dienen in vivo studies uitgevoerd te worden naar de afgiftesnelheid van 
biomoleculen om de afgifte van groeifactoren te begrijpen en te optimaliseren. Ten 
tweede is het exacte biologische mechanisme achter de stimulerende / remmende 
effecten van gecombineerde afgifte van groeifactoren op botvorming vanuit colloïdale 
gelatine gels nog niet opgehelderd, waardoor de klinische effectiviteit niet volledig 
kan worden benut. Ten derde dient te worden benadrukt dat dit proefschrift met 
name gericht was op de ontwikkeling van colloïdale gels en vertaling van deze 
kennis richting praktisch toepassingen in de regeneratieve geneeskunde. De 
precieze invloed van de deeltjesgrootte, vorm en lading op de gelvorming en 
biologische eigenschappen (zoals bijv. degradatiesnelheid en celgedrag) moeten nog 
worden opgehelderd. Ten vierde dient onderzoek plaats te vinden naar  een robuuste 
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techniek om industriële opschaling van de productie van goed gedefinieerde en 
reproduceerbare nanodeeltjes mogelijk te maken (en daarmee klinische translatie en 
commercialisatie). Recentelijk is echter aangetoond (in samenwekring met Future 
Chemistry BV) dat gelatine nanodeeltjes kunnen worden geproduceerd in continue 
flowchemie met behulp van microreactoren, wat een commercieel aantrekkelijk 
alternatief zou kunnen zijn ten opzichte van de meer gangbare productie van 
nanodeeltjes via batch-chemie. 
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When I started my journey to the Netherlands for my PhD study in October of 2008, I 
wanted to finish the journey as soon as possible like an ascetif monk because I was 
thousands of kilometers away from my wife and family. After one year of hardworking 
in the lab, no improvement was achieved for my research project. It is never easy to 
work on something novel, not even to mention that the term of “colloidal gels” was not 
little explored in the field of regenerative medicine. There were some moments I 
started to doubt myself whether it was possible to finish this PhD project. That was 
the beginning period of my PhD, confronted with so many experimental problems, 
unclear future and so many uncertainties in my life.  
 
It says that “After bitterness comes sweetness”, but to taste this sweetness took me a 
long and difficult journey. The past four years has been the most difficult, tiring, but 
fruitful and happiest period in my life. The completion of this thesis is the most 
remarkable achievement in my career until now, which would have never been 
possible without the help and support from the wonderful people around me. I would 
like to take this opportunity to express my deepest gratitude to them, I owe them so 
much and hope to have proven that it has been worthy to give me their help, trust, 
time and love. Although it is not possible to mention everyone by name, I would like 
to specifically acknowledge the following people. 
 
First and foremost, I would like to express my deepest gratitude to my supervisor Prof. 
Dr. John Jansen. Dear John, you brought me into this project and offered me the 
opportunity to pursue my PhD in your renowned group in the Netherlands, I would 
have never experienced such a wonderful journey if you didn’t open the door for me. 
Your broad knowledge, profound understanding and solid expertise in Biomaterials 
research and clinical applications always provided me helpful guidances and 
suggestions when I met with experimental problems in my project. Your energetic 
and highly efficienct attitude for work, your implicit and easy-going personality to the 
people surround you make it such a pleasure to work with you. From you I learned 
how to work and think as a scientist, and to cooperate with and earn appreciation 
from the others. Dear John, you gained my deepest respect and admiration. 
 
I am also deeply grateful to my Chinese supervisor Prof. Dr. Yubao Li. Dear Prof. Li, 
you opened the avenue of scientific research to me and guided me the first step into 
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the world of Biomaterials. Your extensive knowledge, strong expertise and creativity 
enlightened and set a great example for me over those years when I was an 
armature in this field, and taught me how to address problems and develop my own 
ideas. Thank you for your scientific and personal guidance, thank for your confidence 
and trust, without which I wouldn’t have been able to succeed. 
 
I would like to further express my greatest appreciation to my co-supervisor, Dr. 
Sander Leeuwenburgh. Dear Sander, it has been a wonderful journey for me during 
the past four years, and it was my fortune to have you as my fellow traveler in this 
journey. You revealed a totally new field in Biomaterials for me; you inspired me to 
explore my potential to improve myself in both work and life; you encouraged me to 
surmount all the difficulties in both scientific research and regular life; you kept faith in 
me at the most difficult moment in my research project. Not only in science, your 
broad knowledge in social science and history, you deep understanding of the 
cultural difference between Western and Eastern world make it so pleasant and 
inspiring to work with you. It was from you that I found the valueable philosophy of my 
own be charitable but generous, modest but confident, be energetic, efficient, well-
prepared, and be a gentleman. Nothing better descirbes my appreciation to you 
than this Chinese proverb “良师益友 (Liang Shi Yi You)”, which means you are 
scholary mentor but also beneficial friend of mine. Thank you so much for all you did 
for me in the past four years! 
 
I would like to extend my gratitude to my colleague Dr. Fang Yang. Dear Fang, I was 
so lucky and pleased to work with you during the past few years. Your solid 
background and expertise in the field of Biomaterials always provided me with helpful 
advices and critical comments. You are more than a colleague to me, I felt you like 
an elder sister of mine despite I do not have one. Your kindness and meticulous 
consideration gave me so much help to overcome my nostalgia and adapt to the 
Dutch life during the beginning of my PhD. You taught me how to understand and 
appreciate the European culture and Dutch society, but to remain the valuable spirit 
in our Chinese culture. So many joyful moments we shared together in the past years 
are still vivid to me; the delicious Chinese foods in Oriental Plaza, the cheerful 
Karaoke parties in your home, the “serious” poker games with Ronald, and the 
wonderful diners to celebrate our festivals. Many thanks for your accompany during 
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the past years in Nijmegen, and I am looking forward to reunion with Ronald and you 
in China soon! 
 
I would like to express my deep appreciation to my colleagues Dr. Joop Wolke, Dr. 
Frank Walboomers and Dr. Jeroen van der Beuken. Dear Joop, Frank and Jeroen, 
your profound knowledge and solid expertise in Materials or Life Science provided 
me strong support for my research. Your sharp insight and inspiring criticism 
regarding scientific research stimulated me to improve myself to think and work as a 
rigorous and efficient scientist. More than that, as typical Dutch like you guys (from 
what I understand), I learned from all of you the optimistic, critical and straight-
forward attitude for both work and normal life. Dear Joop, as the oldest man in our 
group, you turned out to be such a warm-hearted and easy-going person. I would 
never forget our trip to Amsterdam, you guided us to explore so many impressive 
scenes I would have never known. Dear Frank, it was an exciting and inspiring 
journey together with you to Barcelona for the China-Europe conference, I 
appreciated that you did include Taiwan as part of China in the slice you showed. 
Dear Jeroen, I can still recall many of those juicy jokes you made in the coffee corner, 
you are a good teacher of Dutch humor and sarcasm. Dear Joop, Frank and 
Jeroen, I wish you and your family all the best!  
 
Furthermore, I would like to express my sincere gratitude to all the collaborators in 
my PhD project for their open mind, motivation for teamwork and problem-solving, 
and intention in shearing their expertise. Prof. Dr. Otto Boerman, I am deeply grateful 
to you for the pleasant cooperation with you and your helpful advices and comments 
from your strong background in biomedical research. It was a great pleasure to work 
together with your team, which eventually resulted into three joint publications. 
Especially, I would like to mention the technicians of your group, Cathelijne Frielink, 
Danny Gerrits and Gerben Franssen, for assistance on preparation and 
measurement of radiolabeled biomolecules. 
 
Prof. Jan van Hest, I highly appreciate the successful and continuous cooperation 
with you and your team. My research project has benefited a lot from your broad 
knowledge in chemistry and life science, and your intention of shearing and problem-
solving. Our pleasant and efficient cooperation resulted into one of the most 
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important publications in this thesis. I would like to specialize my gratitude to Morten 
Hansen, thank you for your patient assistance in teaching me to prepare liposomes, 
and characterize nanoparticles using DLS. From you I’ve learned many useful skills 
and knowledge in organic chemistry. Wish you succeed in your career!  
 
I cannot miss the name of Johan van der Stok from UMC Erasmus. Dear Johan, the 
cooperative prject we worked on together turned out to be such an innovative, highly 
efficient, and successful preliminary trial of the colloidal gelatin gels for future clinical 
applications. I highly appreciated to your open-mind, easy-going personality, and 
your motivation to shear and learn. I would have never finished this thesis on time 
without your hardworking and genuine contribution for this project during the last 
period of my PhD. Your professional suggestions and positive comments as a 
medical doctor on this colloidal gelatin gel system strengthened my confidence in 
applying this novel biomaterial to clinical application, and solid my intention to 
develop biomaterials that can be seriously used for clinics. Dear Johan, I wish you 
succeed in your PhD soon! 
 
Without any doubt, I am deeply indebted to all the colleagues from the Department of 
Biomaterials. I cannot imagine how colorless my life in Nijmegen would have been if 
without the companion of each of you. My appreciation “from the bottom of my 
heart” first goes to Arnold Nijhuis. Dear Arnold, I have never expected to have such 
a genuine and tight friendship with a Dutch guy before, considering the huge 
geographical distance and totally different culture and life style. But you have proven 
me that we can build up solid friendship despite of those differences. Actually I found 
out we have so many things in common, and you make me feel you are my brother 
eventhough I don’t really have one. This made me cherish our friendship even more. 
Thank you for sharing the good and difficult moments of your life, and thank you to 
be a caring listener of the happy and sad stories of my life. More than that, what I 
appreciated the most is your intention of shearing and helping the others around you. 
I cannot remember how many times I turned to you and asked “Arnold, help me on 
this.” Besides, your solid background in chemistry, your serious working attitude and 
your motivation in problem-solving helped me a lot to run over many hurdles in my 
work. I should have put your name in each publications I have in the past four 
years. Dear Arnold, my friend, my brother, it wouldn’t have been such a wonderful 
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